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C H A P T ER 1
Introduction
Cancer is a life-threatening disease that is associated with severe physical problems 
and with aggressive treatments with debilitating side effects. When diagnosed with 
cancer, many patients are overwhelmed by fear and a sense of loss of control over their 
lives. They have to face a multitude of uncertainties such as the consequences of the 
disease, the treatment options, the prognosis and the chances of a full recovery. 
To help them cope with their malignant disease, patients need information from their 
physicians 1,2. Most cancer patients want as much information as possible, not only 
about the diagnosis but also, among other issues, about the prognosis, treatment 
options and their alternatives and possible side effects 1-3. By learning to understand 
what is going on, patients may regain a sense of control and can actively participate in 
the consultations with their  doctors and in treatment decision-making. 
Apart from their being distressed by the malignancy of their disease, cancer patients 
also face numerous uncertainties about potential anti-cancer treatments, causing 
 additional anxiety and information needs 1,4. Many patients are troubled by feelings of 
loss of control and anxiety about the treatment’s toxicity and its adverse effects 4. 
Besides an adequate supply of information, oncologists and other clinicians will hence 
have to offer their patients sufficient support to help them cope with their malignant 
disease and their uncertainties about projected treatments. 
The main modalities for treating cancer are surgery, radiotherapy (or radiation 
 treatment) and chemotherapy. Surgery and radiotherapy have in common that they are 
local  treatments whilst chemotherapy is a systemic treatment. Radiotherapy can be 
used as a single treatment modality or it may be combined with surgery and/or chemo-
therapy (See Box 1 on page 21 for a more detailed description of radiotherapy). Cancer 
therapy can either have curative or palliative treatment intent. Curative therapy is aimed 
at complete eradication of the tumour and long-term survival (over 2 years) seems 
 possible for a significant proportion of patients. In case of palliative treatment, the 
intention is to  improve symptoms and possibly to prolong life, but long-term survival 
(over 2 years) is highly unlikely. 
Underlining the important role of adequate information provision for patients, in 1995 
the ‘Medical Treatment Agreement Act’ (WGBO 1995) was introduced in the Netherlands. 
The act stipulates that each physician is obliged to provide all the information that, as 
a patient, any mentally capable person would need in order to make a rational decision 
regarding a proposed medical treatment 5. Thus, information has to be provided about 
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the diagnosis and its consequences, about the prognosis, the nature and purpose of 
the proposed treatment, the potential risks and side effects, and about alternative 
 (treatment) options. In addition, the physician has to ask the patient’s consent for a 
proposed treatment. Informed consent presupposes that patients have received 
 comprehensive and comprehensible information, that they are able to understand the 
information received and that they are capable to participate in treatment decisions 
with full understanding of the factors relevant to their care. In the last two decades, 
several other western countries have adopted similar acts. 
Around the time that the abovementioned act was introduced, the doctors and nurses 
at the Department of Radiation Oncology of the University Medical Centre Nijmegen 
had already developed doubts whether their patients referred for palliative treatment 
fully understood the consequences and limitations of the treatment offered. They had 
noted that despite the limited prospects and the serious expected adverse effects of 
the  therapy very few patients decided to refrain from treatment. This raised the 
 question whether the requirements for informed consent were in fact fully implemented 
and whether patients who had been offered palliative treatment actually understood 
the nature and the consequences of their disease and the proposed treatment. 
To answer these questions, our research group launched a pilot study to explore the 
current  informed-consent procedures and the decision-making process in patient-
physician interactions during consultations in which palliative radiotherapy was first 
discussed in depth. 
Detailed analyses of 26 such consultations showed that the topic of formal informed 
consent was rarely explicitly brought up by the radiation oncologists or by the patients 
and their accompanying proxies 6. Although the physicians provided ample medical 
information and despite the often-mentioned high information needs of cancer 
patients, they and their proxies hardly asked any questions and rarely questioned the 
treatment decision.
The pilot study raised several new questions and considerations. Firstly, it was 
 questioned whether the operationalization of informed consent and patient  participation 
as assessed using the categories of the Roter Interaction Analysis System (RIAS) was 
sufficiently specific. If, moreover, the treatment decision, i.e. specific palliative radio-
therapy, was hardly ever discussed with the radiologist, the question is at what time 
patients then gave their  consent to the treatment proposal. Prior to the patients’ first 
consultation with their  radiation oncologist, the nature of their cancer had already been 
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diagnosed in previous examinations conducted at other clinical departments, and, 
generally, the physician who first told them the diagnosis had already discussed likely 
treatment options and  potential outcomes with them. Had patients who were referred 
for palliative radiotherapy already participated in the treatment decision at any of these 
previous occasions?
Considering the severe stress the patients are likely to have experienced, it was also 
questioned whether they had been fully able to perceive the extent of the information 
their radiation oncologists provided. In several other studies, it has been shown that 
cancer patients often do not fully understand or recall the information they receive 
which might hinder the decision-making process 7-9. Some reports demonstrated that 
under stressful circumstances information processing could be severely hampered 9-11. 
Thus, it is a legitimate question whether patients (recently) diagnosed with incurable 
cancer can properly comprehend the information they are presented.
Additionally, the patients’ psychological circumstances may not only influence the 
 perception of their doctors’ communicative behaviours, but also their own  communicative 
behaviours. Many patients in Verhaak et al.’s pilot study 6 had only recently been 
 informed about the life-threatening nature of their disease. The stress provoked by such 
a devastating diagnosis may evoke different cognitive strategies to cope with these 
frightening circumstances. One cognitive coping style is to confront or monitor the 
situation to hence reduce uncertainty 12. More specifically, patients start gathering as 
much information about the disease, the treatment possibilities and their side effects 
as possible. Conversely, for some patients temporary avoidance of information about 
the disease can be adaptive 13,14 ;they may choose to temporarily ignore or blunt infor-
mation and to try to shift their attention. Could the passive behaviour of the patients in 
Verhaak et al’s study then be explained by a blunting strategy their patients adopted to 
allow them to deal with the threatening knowledge of suffering from incurable cancer?
Furthermore, in the exploration of informed consent, the focus was on decision making, 
whilst patient participation encompassed more issues that in stressful circumstances 
might be beneficial to patients. Patients who actively interact with their doctors tend to 
obtain more information and have a better understanding and recollection of the received 
information than patients who act passively 15,16. Moreover, participation in medical 
 interactions can help patients to cope better with their illness and treatments and might 
help them to reduce their anxiety 17-21. The patients in the pilot study seemed rather 
passive in discussing informed consent, but does that imply that they hardly participated 
during the exchanges? Possibly, they were more active in discussing other issues.
13
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Finally, in view of the importance of active patient involvement, we pondered whether 
and how cancer patients can be encouraged to participate more in the interaction with 
their radiation oncologist.
In the following sections, we will address these various questions in more detail.
The patient’s perception of information and support:
Observational studies of communication during cancer consultations report that 
oncologists offer their patients a great deal of medical information and support 6,22,23. 
Nevertheless, many cancer patients leave the consultation room with the sense that 
their basic needs for information and support have not been satisfied 1,3,8,24-27. These 
contradicting findings are often explained by gaps in the clinicians’ patient-oriented 
 communication, but as we discussed before, the patients’ insufficient perception and 
understanding of what their doctors are trying to tell them are at least also important 
factors that might hinder their participation. Active patient involvement can only be 
achieved if patients recognize and understand the content of their physicians’ 
 communication and are able to participate to the decision making process. In addition, 
the perception that they have not received sufficient information and support might 
cause patients additional distress 1,28.
Cancer patients recently diagnosed with (incurable) cancer tend to be quite tense and 
for many patients discussing anti-cancer treatment options with unfamiliar doctors 
adds to their distress. It has long been established that tension interferes with the 
patients’ ability to process information 9-11. However, it is as yet unclear to what extent 
cancer patients’ perceptions of the content of their oncologists’ communications is 
hampered by the stressful circumstances and to what extent by their oncologists failing 
to meet their needs as regards information and support.
Threatening information and cognitive style
In general, the provision of medical information can for many patients have distress-
 reducing effects. It may have a positive or reassuring content or may reduce their 
 uncertainty by providing a clearer picture of what they can expect 29-31. Detailed 
 information may also help patients to understand and cope with previous and imminent 
events, to regain a sense of control and to participate actively in the consultations with 
their doctors and crucial decision-making moments. In cancer settings, however, the 
content of the medical information can also be very threatening and might increase 
rather than decrease the patients’ distress. 
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Individuals adopt different ways of coping with potentially threatening information, 
which cognitive styles are commonly denoted as monitoring or blunting 32,33. Monitoring 
is defined as ‘the tendency to seek threat-relevant information’, and blunting as ‘the 
 tendency to cognitively avoid threat-relevant information and to seek distraction from 
threat’ 12,34. 
But when or how do these cognitive styles influence cancer patients’ communicative 
behaviour during medical consultations? Do patients verbally communicate what they 
need? In their study on cancer patients’ cognitive coping styles and doctor-patient 
 communication, the only association Ong and colleagues found was that high monitors 
asked their oncologists more questions than low monitors did 35. Evidently, the 
 relationship between patient coping styles and information-seeking behaviour warrants 
further scrutiny.
Patient participation
As stated earlier, communication entails more than doctors informing their patients as 
fully as possible and asking for their consent for a treatment proposal. Inviting patients 
to actively participate in the consultation is often beneficial for the patients’ well being, 
also when no treatment decisions have to be made. Patients who are actively involved 
tend to obtain more information and have a better understanding and recollection of 
the information received than patients who adopt a passive attitude 15,36-39. Moreover, 
 partaking in medical interviews can help patients cope better with their illness and 
 treatments and may help reduce their anxiety 17-21,40. Unfortunately, few cancer patients 
tend to do so and many rather seem to prefer to wait for their doctors to provide the 
information they desire 1,18,41.
Doctors can facilitate patient participation by adopting specific communicative 
 behaviours such as asking open-ended questions to assess the patients’ medical and 
psychosocial condition, by showing personal attention and support, by exploring the 
patients’ ideas about their medical condition, by expressing concern about their 
 medical situation, and by asking them for their treatment preferences 17.
Several studies have shown that health professionals working with cancer patients can 
be trained to manifest specific communicative behaviours in their consultations 40,42-45. 
Yet, whether in addition to improving oncologists’ patient-participation-eliciting 
 behaviours, specific communication training has an impact on patients’ participation to 
the interaction has as yet not been investigated.
15
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The present study
In this thesis, we focus on cancer patients’ participation in their first consultation with 
their radiation oncologist prior to the start of radiotherapy by studying the  communicative 
behaviours of the patients as well as the verbal behaviours of their accompanying 
proxies and the clinicians. We wished to shed more light on several of the topics 
 discussed above that have as yet not received attention. We evaluated the influence of 
palliative or curative treatment intent on patient participation, the relationship between 
the  oncologist’s communications and the patient’s perception of these, as well as the 
effects of the patients’ cognitive styles on the nature of their (verbal) involvement. 
We furthermore trained the participating radiation oncologists in those communicative 
behaviours that are assumed to facilitate patient participation. Following the training, 
we first assessed whether the oncologists indeed used the trained behaviours more 
frequently than they had before the training, and, secondly, we investigated whether in 
the post-training  consultations patients participated more actively than the patients that 
were seen prior to the oncologists’ training. 
At the Department of Radiation Oncology of the University Medical Centre Nijmegen 
where all studies to be reported were conducted, 45 minutes are allotted for the initial 
consultation. The radiation oncologists spend ample time informing and gauging their 
patients: they ask numerous questions to get a detailed picture of each patient’s status 
to enable them to plan an optimal treatment schedule. They comprehensively explain 
the patients and their accompanying proxies what the proposed radiotherapy entails, 
i.e. its aim, the procedures and the possible side effects. Commonly, the first visit does 
not comprise a planning session (‘simulation’) or actual treatment.
The present research project, which was approved by the medical ethics committee 
of the University Medical Centre Nijmegen, was launched in 1999. All twelve radiation 
 oncologists working at the department were invited to take part in the study, of whom 
eight consented to participate. The patients were recruited from a consecutive cohort 
of newly referred patients visiting one of the eight participating physicians between 
April 2000 and May 2002. At the start of the consultation, the oncologist briefly 
 described the study to the patient and invited him or her to participate. Excluded were 
patients that had an insufficient command of the Dutch language, as well as patients 
younger than  18 years and those with a life expectancy lower than 3 months. If the 
patient agreed to join the study, one of the researchers was called in to explain the 
study in more detail, provide written information and obtain the patient’s consent, 
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after which the subsequent consultation was videotaped. Following the  consultation, 
the researcher handed the patient a questionnaire with the request to complete it 
at home, and  explaining that within three days the patient would be  telephoned for 
an interview. Subsequent information on radiation-therapy treatment intent (palliative 
or curative) and patient demographics were obtained from the patients’ medical 
records. 
Communication analysis
To analyze the verbal communications of the videotaped consultations, like in our pilot 
study, we used the Roter Interaction Analysis System (RIAS). The system was  originally 
designed for the observation of physician-patient communication in primary-care 
 settings but several modifications have been made to adapt it to other, among which 
oncological, settings 22,46. With the RIAS, all speakers’ utterances need to be assigned 
to mutually exclusive and exhaustive categories. An utterance is defined as the smallest 
distinguishable speech segment to which a coder can assign a classification, i.e. one 
speaking turn can include several utterances. The RIAS has been demonstrated to 
have good interrater reliability and validity, also in oncological settings 6,22,38,47.
In the literature the process of clustering the RIAS categories is described in various 
ways. Originally, Roter distinguished two separate dimensions or clusters of RIAS 
 categories: ‘task-related’ or ‘instrumental’ or ‘cure-oriented’ behaviour (comprising 
among other subcategories open and closed questions, information provision, and 
counselling), and ‘affective’ or ‘socio-emotional’ or ‘care-oriented’ behaviour (including 
the subcategories showing agreement, paraphrasing, conveying empathy, expressing 
concern) 48. 
In oncological settings, however, due to the highly medical content of cancer 
 consultations, emotional topics also emerge when medical, lifestyle and psychosocial 
issues are being dealt with, topics that, in the original Roter classification, are all part of 
the instrumental cluster. Discussion of emotional topics contains both the instrumental 
and affective dimension concurrently and indivisibly. Hence, this type of RIAS  clustering 
into ‘task-related’ and ‘affective’ clusters of categories might not be suited to identify 
and classify the various components of oncological exchanges 49. To organize the RIAS 
 categories, we therefore opted for only functional clustering of the RIAS-categories 
based on the Three Function Approach to the Medical Interview of Bird 50,51. 
The three functions of the medical interview are reflected in the RIAS categories as 
 follows: the Patient education and counselling and the Gathering data to understand 
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the patient’s problems functions are served by the ‘Information giving and counselling’ 
and the ‘Question asking’ categories. The third function Building a relationship and 
 responding to patient’s emotions is reflected by the ‘Relationship building’ categories, 
i.e. positive, emotional and negative talk. Additionally, although not explicitly defined by 
the authors of the functional model, the use of communicative strategies to facilitate the 
patient’s capacity to engage in an effective partnership with his/her physician deserves 
special note. To accommodate for this aspect, Roter added a fourth interview function: 
Facilitating, activating and partnership building, which is reflected by utterances like 
‘paraphrases’, ‘checks’, and ‘orientations on procedures’ [(Roter & Larson, 2002b)]. 
Since we were specifically interested in exchanges relating to decision making, we, 
moreover, added the explicit function Decision making reflecting all expressions 
 entailing requests for and provision of information about the proposed treatment, other 
treatment options and about the possibility of refraining from treatment. An overview of 
the medical interview functions and RIAS categories we used is given in Appendix A 
(on page 164-165), along with an example of an actual utterance for each category. 
Outline of the thesis
Chapter 2 reports about patient participation in the discussion of palliative radiotherapy 
during the initial consultation with the radiation oncologist. The pilot study discussed 
above demonstrated that formal informed consent was only rarely explicitly raised in 
the consultations prior to the start of the palliative radiotherapy, seldom by the radiation 
oncologists and even less by the patients or their proxies, and that the latter two parties 
hardly asked any questions 6. Hence, the aims of the present study were to further 
 investigate the extent to which manifestations of patient participation and decision 
making can be observed in consultations prior to their palliative radiation therapy and 
to chart any developments in the clinicians’ interactions with their patients since the 
pilot study.
To do so, we made several adaptations to our coding system and monitored a larger 
number of consultations. Fifty-four patients referred for palliative radiotherapy, 
 accompanied by their proxies, and 8 radiation oncologists took part in this descriptive 
study. The consultations were videotaped and the verbal communications of the three 
parties analyzed using the Roter Interaction Analysis System (RIAS). Two days after the 
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consultation the patients were asked (by telephone) at what point they had decided to 
undergo the proposed treatment and at what moment they had received the  information 
they needed to reach that decision.
The research questions on which we based our study were: How do patients scheduled 
for palliative treatment and their proxies participate in the consultation with their  radiation 
oncologist? Do the radiation oncologists use the communicative behaviours that have 
been suggested to stimulate patient participation? How often are treatment decision and 
consent explicitly discussed?
In Chapter 3, the patient-doctor communication in palliative and in curative  radiotherapy 
consultations is compared. As was shown in the pilot study 6, patient participation in 
consultations involving palliative treatment is rather low. We reviewed the literature to 
gather findings on patient participation in curative treatment settings and to identify 
 differences with palliative treatment settings.
Because discussing palliative treatment is more demanding for doctors and more 
 specifically for their patients, some authors suggest that patients are more likely to be 
less active during the consultation than they would were it to concern curative treatment 
52,53. Others have shown that the patient’s desire for information and the inclination to 
participate in the decision-making process lessens when the treatment advances from 
curative to palliative therapy 54-57.
The study presented in this third chapter comprising 160 medical consultations 
 analyses the exchanges between cancer patients and their proxies on the one hand 
and their radiation oncologists on the other. In half of the consultations palliative 
 treatment was discussed, in the other half curative treatment. The specific research 
question we addressed in this study was: In what way do consultations in which 
 palliative or curative treatment is discussed differ with respect to information sharing, 
emotional talk and decision making.
Chapter 4 reports on the relationship between the communicative behaviours radiation 
oncologists’ display and the patients’ perception of these. Evidently, cancer patients 
need adequate medical information as well as their doctors’ support to help them cope 
with their malignant disease. However, and despite the oncologists’ awareness of these 
needs and their professional efforts, patients often feel that both needs are  insufficiently 
being met. We know that cancer patients can be quite distraught following the 
 diagnosis, and discussing treatment options with new and unfamiliar doctors is likely to 
19
1I n T R o d u C T I o n
aggravate their distress. Since tension interferes with a patient’s ability to process 
information,  it remains unclear whether patients are sufficiently capable to grasp the 
information their doctors are providing.
Studies in different medical settings have not shown any or only few associations 
 between physicians’ observed behaviour and the patients’ perception of their conduct 
58-60. As yet, little is known about the relationship between the communicative  behaviours 
of oncologists and their patients’ perceptions of the information and support received 
as well as about what oncologists do to facilitate patients’ perceptions of the 
 communication. The study described in this chapter served to clarify this relationship. 
The study included 173 oncology patients referred for radiotherapy. We videotaped the 
initial consultations subsequently assessed the communicative behaviours of the 
 oncologists using the RIAS. Two days later, a researcher called the patients with the 
request to rate the medical information and support provided during a brief  standardized 
interview.
The research questions in this study were: How do cancer patients’ perceptions of 
 information and support received relate to the information-giving and supportive 
 behaviours their radiation oncologists displayed? Which of the clinicians’ communicative 
behaviours influenced the patients’ perceptions of the information and support provided?
Chapter 5 deals with the effects the cancer patients’ cognitive coping styles of 
 monitoring and blunting have on their communicative behaviours. As is described in 
the literature, high monitors are inclined to seek confrontation with threatening medical 
information to enhance the controllability of their situation while high blunters are prone 
to cognitively avoid threat-related information and seek distraction from threat. Most 
studies assessed their patients’ coping styles based on self-reported preferences and 
not on behavioural indicators and even less is known about the coping styles of cancer 
patients and the impact of these strategies on their communicative behaviours during 
their interactions with their physicians.
To amend this lack, the study presented in Chapter 5 investigates the association 
 between the cognitive coping styles of 116 oncology patients and their verbal 
 communicative behaviours towards their radiation oncologists. For 56 patients 
 treatment intent was palliative and for the remaining 60 curative. The patients’ 
 communicative behaviours were assessed using the Roter Interaction Analysis System 
(RIAS). Within three days of their hospital visit the patients completed a monitoring and 
blunting  inventory and six weeks later they were requested to evaluate their perceptions 
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regarding the treatment decision and treatment information by postal questionnaire.
The research questions we addressed in this study were: How do cancer patients’ 
 cognitive styles influence their communicative behaviours and their evaluation of the 
inter action with their radiation oncologist?
In Chapter 6 we explored whether a targeted, adaptive communication training for 
 radiation oncologists would have a positive effect on their patients’ involvement in 
 medical interviews. Several earlier studies demonstrated that active participation is 
indeed beneficial for the patients’ processing of information and their quality of life. 
Unfortunately, cancer patients tend to undergo their consultations rather passively and 
rarely actively interact with their oncologists.
In the present study, the patient-doctor exchanges during 160 consultations of eight 
radiation oncologists before and after targeted communication training were  compared. 
The oncologists saw 80 cancer patients in the pre-training and the other 80 in the post-
training condition. During the training session following the first batch of consultations 
the radiation oncologists learnt to use specific communicative behaviours that are 
 assumed to encourage patient participation, among which were joint discussion of the 
agenda setting, using open-ended questions when asking the patient about his/her 
medical and psychosocial status, exploring the patient’s ideas about specific medical 
issues, expressing support, mentioning the likely emotional impact of the treatment, 
and an explicit discussion of the proposed treatment. Moreover, special attention was 
paid to communicative requirements in the first minutes of the consultation.
The research questions for this study were: Do radiation oncologists use trained 
 communicative behaviours in the interactions with their patients? More importantly, is an 
increase use of specific doctors’ behaviours related to a rise in the patients’ participative 
behaviours?
The final chapter (Chapter 7) starts with a summary of the main findings of the various 
studies reported, after which some methodological issues and limitations are briefly 
discussed. The chapter ends with a discussion of potential practical implications of the 
current findings and several suggestions for future research are made.
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Box 1 Radiotherapy
The main modalities for treating cancer are surgery, radiotherapy (or radiation 
 treatment) and chemotherapy. Surgery and radiotherapy have in common that they 
are local treatments whilst chemotherapy is a systemic treatment. Radiotherapy can 
be used as a single treatment modality or it may be combined with surgery and/or 
chemotherapy. A great advantage of radiotherapy is that sometimes mutilating 
 surgery may be prevented. Examples of organ preservation are breast-conserving 
therapy, where radiotherapy is combined with surgery, or the radiation of ENT 
tumours (larynx, tongue). 
Approximately half of the patients undergoing radiotherapy are treated with a 
 curative intent, the other half with palliative intent. Most curative radiation schemes 
involve a high radiation dose given in relatively small fraction sizes over a period of 
4 to 8 weeks. When radiotherapy is  administered to palliate or prevent symptoms an 
 effective radiation dose is given in an as short a time span as possible. Most 
 palliative radiation schemes vary from 1 to 10 fractions with a generally high fraction 
size. Sometimes, curation can be achieved by radiotherapy alone. A good example 
is the high cure rates (in excess of 90%) for the radiotherapeutic treatment of small 
ear, nose and throat (ENT) tumours 61. In other treatment protocols (e.g. breast and 
rectal  cancer), curative radiotherapy is often combined with surgery and/or chemo-
therapy. 
Most patients with distant cancer metastases cannot be cured. Palliative radio-
therapy to alleviate debilitating symptoms like pain or dyspnoea may, however, be 
very  effective. Radiotherapy to alleviate pain complaints caused by bony  metastases 
may, for instance, result in a reduction or elimination of the pain in as much as 80% 
of the patients 62,63. Because palliative treatment does not result in full recovery but 
still may have various burdensome side effects, not only the patients’ medical status 
but also their psychosocial condition need to be taken into account when deciding 
whether to recommend palliative radiation treatment 28,64.
X-ray radiation of living cells and tissues leads to an interaction and energy  deposition 
that  causes DNA damage. As a result cells stop dividing. Only if all  malignant cells are 
lethally damaged can a full recovery be achieved. The problem with the irradiation of 
malignant tumours is that the malignant cells are surrounded by normal tissues, parts 
of which are also irradiated. The sensitivity of the normal surrounding tissues and the 
associated adverse effects determine what radiation dose can be given. 
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In the Netherlands, radiotherapy is a so-called tertiary referral centre,  which means 
that a patient can only be referred to a radiation oncologist by another medical 
(secondary care) specialist. Thus, when a patient is referred for an initial radio-
therapy consultation, the nature and extent of the disease have already been deter-
mined through previous examinations. Generally, the  radiation oncologist will take 
the patient’s medical history and (s)he will enquire about the actual medical 
 condition and complaints. The (curative or palliative) intent of the radiotherapy will 
be discussed together with the possible side effects. 
After the initial consultation, preparations are needed in order to administer the 
 radiotherapy. Sometimes, special aids (head mask, intra-oral mould) are necessary 
to facilitate optimal  treatment delivery. Subsequently, the part of the body indicated 
for irradiation is localized using either a conventional simulator or a CT scanner.  The 
radiation oncologist determines the  radiation dose for the specified area(s) and also 
delineates surrounding sensitive normal  structures that should be spared if  possible. 
Specialized software computes and simulates the actual radiation treatment, 
 allowing individual modifications. The exact irradiation site (or sites) indicating 
where the rays should enter the body is subsequently marked on the patient’s skin 
to ensure that every radiation session the same area is treated identically. Radiation 
treatment fields typically include the tumour or tumour bed, and, if indicated, the 
lymph nodes draining the area. The amount of radiation depends on treatment 
intent, the extent and localization of the tumour, the type of cancer as well as the 
patient’s general state of health. The positive effects of radiotherapy usually take 
some time to show and results depend on the characteristics of the  malignancy 
(radiosensitivity, hypoxia), the disease stage and the patient’s overall condition 
during treatment.
Radiotherapy is usually delivered in a series of treatment fractions administered over 
a preset period that may comprise a single day to eight weeks, often four to five 
times a week. During each treatment session, the patient is positioned on a 
 treatment couch and the irradiation device, a so-called linear accelerator, will direct 
the X-rays at the dedicated site, usually from several different angles. Each  (painless, 
noiseless and odourless) treatment only takes a few minutes during which the 
patient is left alone in the treatment room with the team of radiation technicians 
observing the patient using closed circuit monitors. They can communicate with the 
patient at all times via an intercom. 
As the malignant and unaffected tissues adjoin, healthy tissues cannot be  completely 
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avoided during radiation. Damage to normal tissues may manifest itself in various 
ways, but might  seriously affect the patient’s quality of life. Most adverse effects will 
usually appear during or shortly after treatment, resulting in ‘short term’ side effects 
such as fatigue, skin irritation at the site of the radiation beams, nausea, diarrhoea, 
hair loss and loss of appetite. These side effects may persist till several weeks after 
treatment and then will disappear for most patients. 
Some patients suffer from ‘long term’ side effects that may develop after latent 
 periods of months to years, resulting in e.g. radiation-induced ulceration, fistulas, 
severe fibrosis, strictures, atrophy, vascular damage, neural damage, and a range 
of endocrine and growth-related effects. These late effects tend to be irreversible or 
even progressive in severity. Many people will  experience some side effects during 
their irradiation cycle, with their nature and extent mainly depending on which part 
of the body is being treated and the doses administered.  The incidence and the 
severity or grade of a specific side effect depends on the details of how therapy is 
delivered but shows large variability among patients, even after strictly identical 
 treatment 65.
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Abstract
Cancer patients’ participation in doctor-patient interactions have been shown to be an 
important factor in the emotional processing of their condition, particularly when only 
palliative treatments can be offered. In this study, we assessed incurable cancer 
patients’ participation in initial consultations with their radiation oncologists (ROs). RO 
stimulation of patient participation and discussions about treatment decisions were 
also measured. The entire consultation was videotaped and analyzed using the RIAS. 
Patients’  participation proved to be low on medical information, but high on discussing 
their  experiences and life circumstances. The ROs stimulated patient participation 
mainly by providing medical information and giving patients opportunities to tell their 
stories. Decisions about radiation treatment had previously taken place and were 
rarely  discussed in the consultations studied. The results suggest that patient 
 participation in palliative treatment consultations might be improved for facilitating 
patients’ emotional processing of the incurable nature of their cancer. 
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Introduction
Patients with cancer are often overwhelmed by fear and the sense of loss of control 
over their life. At every stage of their illness, patients need their doctors to provide 
information and support that can help them understand their condition, cope with their 
illness and the treatments, and reduce their anxiety 1-3. Patients actively participating in 
the  consultation room tend to obtain more information and have a better understanding 
of the information than patients who act passively 4-8. Moreover, cancer patients 
 generally benefit both psychologically and physically when they participate in the 
 consultation 1,7,9-17. Patient participation has been operationalized as patients’ relative 
contribution to the conversation 18, their discussing of experiences with the illness 19, the 
number of  questions they ask 14,16,20,21, their expression of concerns and worries 12, and 
their agenda setting talk 17,22. 
Many studies have focused on what doctors can do to stimulate patient participation. 
It has been shown that doctors might stimulate patient participation by providing medical 
information 1, by discussing psychosocial topics and giving patients opportunities to tell 
their experiences 9,19 and by expressing empathetic support and concern 12,15.
Another important issue in patient participation is patient involvement in the treatment 
decision-making process. There is substantial evidence that cancer patients’ physical 
and psychological outcomes are better if they have been involved in making treatment 
decisions 23-25. Before the treatment decision can be made, patients need information: 
about their diagnosis, their prognosis, the expected outcome of the proposed 
 treatment, the expected risks and side effects, alternative treatment options, and the 
anticipated outcome of refraining from treatment. Last but not least, doctors should 
request patients’ explicit consent to the treatment proposal 26. Some studies show that 
patients’ desire to participate in decision-making declines as the illness becomes more 
severe 25,27. Approximately 50% of cancer patients cannot be cured and are given 
 palliative  treatments, which are expected to prolong life and alleviate debilitating 
symptoms,  including psychosocial ones 28,29. Although substantial research on 
 communication has been conducted in cancer settings, little is known about patient 
participation in palliative treatment consultations. 
The Roter Interaction Analysis System (RIAS) 30 has been used to analyze interactions 
in many studies on doctor-patient communication. A pilot study was conducted at the 
Department of Radiation Oncology at the University Medical Centre Nijmegen from 
1995 - 1997 to determine whether the RIAS could be used to analyze palliative radio-
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therapy consultations. With some slight adaptations the RIAS was shown to be suitable, 
and shared decision-making was found not to be a natural part of palliative  radiotherapy 
consultations 31.
The context in which the radiotherapy consultation takes place could have a significant 
affect on its content. When patients visit their radiation oncologists (ROs) to discuss 
 palliative treatment, the incurable nature of their cancer has already been diagnosed 
through previous examinations in other clinic departments. The physician who told the 
diagnosis has discussed treatment options and possible outcomes with the patient. 
Generally, this physician has discussed the benefits and risks of the proposed  treatment 
before referring the patient to the RO. Patients have usually had at least a few days 
 between the consultation where the bad news was disclosed and their visit to the RO. 
Radiotherapy is given to reduce tumor growth and alleviate symptoms, and can have 
several side effects, such as fatigue, nausea, memory problems, diarrhea, skin 
 irritation, and hair loss at the site of irradiation. Radiation treatment is usually given in 
a series, varying from 1 to 35 sessions, usually 4-5 times a week. In addition to the 
diagnosis of incurable cancer, patients facing a palliative treatment have been found to 
be more  anxious and more depressed than patients treated curatively 32. Accordingly, 
ROs have to inform patients about the treatment and its procedures, while at the same 
time support them to cope with anxiety and depression. 
The combination of patients’ poor prognosis and the complexity of information about 
radiotherapy might have contributed to the pilot study findings that shared decision 
making did not frequently take place in palliative radiotherapy consultations. The pilot 
study concentrated on the decision-making process in 26 consultations. In the present 
study, we investigated patient participation in palliative radiotherapy consultations in a 
larger sample by using the RIAS with some adaptations with respect to decision-
making and patient participation. The aim of the present study was to compare data of 
the pilot study with recently obtained data on a larger sample. Additionally, we wanted 
to get more insight into more aspects of patient participation and decision-making 
behavior during consultations where palliative treatment is discussed. 
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Methods 
Subjects and procedures
All 12 ROs at the Department of Radiation Oncology at the University Medical Centre 
Nijmegen were invited to participate in the study. Patients were eligible for the study if 
they came to visit a RO for the first time with their present complaints. Other inclusion 
criteria were that patients had to be able to speak and write Dutch, be over 18 years old 
and have a life expectancy of more than 3 months. Patients were recruited from a 
 consecutive series of newly referred patients during the April 2000 - May 2001 period. 
This study is part of a larger study on communication during radiotherapy consultations 
and its relation with patient outcomes like QOL and psychological health. The study 
included video recordings of consultations with palliative and curative treatment intent 
before and after a training program for the ROs. The Medical Ethical Committee of the 
University Medical Centre Nijmegen, the Netherlands, approved the study. This paper 
reports data on communication in consultations with palliative treatment intent before 
ROs were specifically trained. Their ROs invited patients to participate prior to the start 
of the consultation and briefly described the study. If the patient was willing to participate, 
the researcher explained the study further, and the consultation was videotaped. 
Two days later, the researcher checked patient’s consent by telephone and if consent 
was confirmed, the patient was interviewed. First, we asked patients about the nature 
of the information they had received on their diagnosis, prognosis, and treatment 
 options before their visit to the RO. Then, patients were asked if they had decided to 
undergo radiotherapy and when they had made this decision. Treatment intent, tumor 
site, extent of disease and some demographic characteristics were registered from 
patient’s chart.
The pilot study had been conducted at the same Department of Radiation Oncology 
and patient selection was based on the same inclusion criteria during June 1996 - 
January 1997 31. The aim of the pilot study was to explore to what extent shared 
 decision making and supposed facilitating factors for decision making could be 
observed in consultations prior to palliative radiotherapy and to test the utility of the 
RIAS in that setting. 
Measurement of physician-patient communication
We analyzed the videotaped consultations with an adapted version of the Roter 
Interaction Analysis System (RIAS) 30. The unit of analysis is the smallest meaningful 
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string of words to which classification can be assigned. Every utterance is assigned to 
one of the mutually exclusive categories and then condensed into functional  subclusters 
or clusters of categories 33. The RIAS has been developed to analyze interactions in 
general practice, but the system is flexible and responsive to study context when 
 tailored categories are added or elaborated 34. The RIAS has been used in several 
physician-patient communication studies in oncology and has been adapted when 
necessary 31,35-39. 
Some adaptations in the RIAS were made for the present study (see Table 1). In the 
Information giving and Question asking categories, we added categories on diagnosis 
and prognosis to measure whether these topics were discussed. All other biomedical 
exchange was categorized as information or questions on ‘general medical’ issues. 
The RIAS Facilitation cluster contains the category ‘Directions and Instructions’, which 
refers to utterances that explain the speaker’s agenda as well as to utterances to direct 
the patient to make certain movements or follow other instructions during the physical 
examination. To measure patients’ expression of their agenda, we coded ‘Agenda 
setting’ as a separate category and coded directive and instructive utterances together 
with ‘Procedural information on issues other than treatment’ in the category ‘Other’. 
Based on the pilot study outcomes 31, we added a ‘Decision making’ cluster with 6 
 categories (shown in Table 1). These adaptations resulted in 23 categories (all 
 categories used are shown in Table 1).
Operationalization of research questions
We set out to investigate patient participation, ROs’ stimulation of patient participation, 
and decision making during the consultation and to compare the present study with our 
pilot study on these items. Based on the literature above, the following items are 
 regarded as indicators of patient participation: patient’s relative contribution to the 
consultation, and patient’s contribution to: psychosocial information, questions, 
 concerns, and  agenda setting. 
As indicators of RO’s stimulation of patient participation, we measured RO’s talk about 
medical information, psychosocial questions, and their expressions of support and of 
concern.
Regarding the demands of decision making, we focused on the discussion about the 
diagnosis and prognosis, and on three specific aspects of the decision-making 
 process: the exchange of information about other treatment possibilities, the exchange 
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Function
Cluster
Information giving 
and counselling *
 
Question asking
 
Relationship building
 
 
 
Facilitating
Communication behaviour
Subcluster and categories
Biomedical 
  general medical topics  
 diagnosis 
 prognosis; life expectancy; 
  chance of cure  
Psychosocial
  psychosocial information  
& counselling *
Biomedical questions
 general medical
 
 diagnosis 
 prognosis; life expectancy; 
  chance of cure
Psychosocial questions
Positive talk
 social talk, jokes
 agreement 
Negative talk 
Emotional talk
 support: (empathy, 
 legitimization,  
 reassurance)
 
 concern 
Participatory facilitators
 paraphrase/ check 
 asking for general opinion
Examples
Radiotherapy can make you 
feel tired.
The pain in your head is caused 
by cancer in your brain.
We think you’ve got months, 
not years to live. /There is no 
change that you will be cured of 
the cancer
To see other patients can be 
stressful for you.
How did you discover the 
breast tumor?
That tumor, can’t it be an 
infection?
How long will it take the cancer 
to come back? 
Is your family supportive?
Nice color you are wearing.
Hmm. / I see./ Yeah.
You kept me waiting for half an 
hour!
I can imagine that you are 
worried. / Don’t worry, we will 
closely monitor you, even after 
the treatment is finished. 
But I’m not sure we can get  
rid of the cancer. It is a very  
aggressive type.
So, you had surgery 3 weeks 
ago.
You do not want to continue 
taking dexamethasone?
Table 1  RIAS categories and interrater Spearman correlation coefficients
r
.90
.87 
.91 
 
.85
.95 
.98 
.99 
.97
.98
.83
--- 
.86 
 
 
.65 
 
.91 
.81
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of  information about refraining from treatment and, last but not least, the RO’s request 
for patient’s consent and patient’s consenting to the treatment proposal.
Coding and statistics
Coding was carried out directly from videotape. Average coding time was  approximately 
3 times the duration of the consultation. The two coders (LT and MvR) coded 5 video-
tapes from the pilot study together to train for RIAS coding. A random sample of 10 tapes 
was coded independently by both coders to assess intercoder reliability. Spearman 
 correlation coefficients were calculated to estimate intercoder reliability. The mean 
 reliability was 0.88 for all categories and the range was 0.65 to 0.99 (see Table 1). 
Function
Cluster
Facilitating
 
 
 
 
Decision making 
Communication behaviour
Subcluster and categories
Procedural talk
 agenda setting  
 & orientation
 other ( instructions  
 & procedural issues)
Information giving
 consent to treatment **
 other treatment options 
 refraining from treatment 
Question asking
 consent to treatment  ***
 other treatment options
 refraining from treatment
Examples
Today I’ll talk to you, I’ll look at 
your scar and I’ll listen to your 
heart.
Please lift your arm. / Taxi forms 
are provided by the assistant. 
OK, it’s clear. Let’s do it.
An operation would be too 
dangerous for you.
If you are not treated, the 
cancer will cause problems 
very soon.
So, what do you think? Should 
we start this?
Would an operation be an 
alternative?
If I don’t want this treatment, 
what will happen
r
.96 
 
.94 
.65
.98 
-- 
-- 
.75 
--
*  medical counseling and psychosocial counseling are RO categories only 
**  for the RO, this category reflects the RO’s opinion of the treatment proposal with respect 
 to this individual patient
***  for the patient and proxy, this category reflects their questions about the RO’s opinion of  
the treatment for this individual patient 
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Other researchers using the RIAS in oncology settings have reported similar levels of 
intercoder reliability 31,35,36. Finally, each of the two coders coded half of the tapes.
Frequencies of utterances as observed with the RIAS were counted per speaker per 
category. The frequency distributions of utterances were rather skewed. For this reason, 
we provide the median number of utterances per category. To compare consultation 
content independently of differences in lengths of consultations, we also calculated the 
mean percentages of each speaker’s utterances in the clusters and subclusters.
For some categories, it is more important to know whether any utterances of these 
 categories are being used than to know how much utterances are expressed. Whether 
e.g. the diagnosis is discussed at all is more important than to know the number of 
 utterances with which the diagnosis is discussed. That is why we calculated the 
 percentage of consultations in which utterances in the categories on diagnosis, 
 prognosis, and decision-making were used. 
If data was available, a comparison of the pilot and the present study was made. Since 
the utterances of patients and their proxies were coded as one speaker in the pilot 
study, we did the same with the data in the present study. Chi2 tests, t-tests and 
 nonparametric tests were used to compare data from the present and pilot studies.
Results
Study sample
All 12 ROs at the Department of Radiation Oncology were invited to participate in the 
study. Eight agreed to do so, 3 staff members and 5 residents. The 4 remaining ROs 
were not available for our study because they were involved in other research projects. 
The mean age of the 8 participating ROs was 33 years (range = 26 - 58), of which were 
7 men and 1 woman. Their mean years of experience was 6 (range = 1 - 28). A total of 
66 patients were asked to participate, of whom 58 (= 88%) were willing. The non-
participating patients felt too ill (n = 3) or failed to give any reason (n = 5) for their 
 nonconsent. The consultation of the 58 participating patients was videotaped. Due to 
technical problems, recording of 4 consultations was incomplete. The remaining 
54 videotapes were used for analysis. In 93% of the consultations (n = 50) patients 
were accompanied by at least one proxy, usually their partners (70%). Table 2 shows 
patients’ demographic and disease characteristics.
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In the pilot study, 6 ROs (4 men and 2 women, i.e. 3 staff members and 3 residents) 
and 26 patients participated. Ninety-two percent of the patients were accompanied by 
at least one proxy, mainly partners (69%). Table 2 shows demographic and disease 
 characteristics for both patient groups. 
Comparison of the present and previous patient groups did not reveal any significant 
differences in age and disease characteristics. There was a gender difference in 
the groups studied: a significantly higher percentage of the patients were women in the 
present group.
Patient’s participation
The proportion of utterances made by the patient is our first indication of patient 
 participation. Table 3 shows the speakers’ relative contribution in the present and the 
Table 2  Patients’ demographic and disease characteristics 
 Present Pilot P-value
Patients (N) 54 26  
Age     
 Mean years (SD) 57 (15) 62 (9) .08
 Minimum 23 46 
 Maximum 79 72
Gender 
 Female 52 % 27 % .03
 Male 48 % 73 %
Cancer type
 Brain 20 % 15 % .28
 Breast 15 % 15 %
 Gastrointestinal 6 % 15 % 
 Head and Neck 12 % 8 % 
 Lung 17 % 35 % 
 Urogenital 20 % 8 % 
 Other tumors 9 % 4 % 
Disease extent     
 Primary tumor 35 % 54 % .35
 Metastases  65 % 46 %
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Table 3  distribution of utterances of the Patient + proxy and of the Ro
   Patient + proxy  Radiation oncologist  
 
 
 
Proportion of all  
utterances   41   43     59   57 
Clusters, subclusters,  
categories                
Information giving  
+ counseling 209  61.1     59.7       142  35.5     38.8     
 Biomedical 125  39.1    46.9   138  32.9    37.8   
  general  119   37.6      108   27.3      
  diagnosis 3   1.2      8   2.3      
  prognosis 1   .3      12   3.2      
  Psychosocial 76  22.7    12.8  ** 9  2.6    1.0 
Question asking 12 4.6     3.9       61 15.5     15.0     
 Biomedical 11  4.3    3.8   50  12.6       
  general 9   3.6      43   12.4   14.1   
  diagnosis 0   .1      0   .1      
  prognosis 1   .6      0   0      
 Psychosocial 1  .3    .1  * 12  2.9    .9  **
Relationship building 87  26.6     27.4       113   27.2     19.4    **
 Positive talk 79  25.2    23.4   85  20.8    15.9  *
 Negative talk 0  0    2.1  ** 0  0    .2  **
 Emotional talk 3  1.4    1.9   25  6.4    3.3  **
  support 0   0    0  20   5.2    1 **
  concern 3   1.4    1.9  3   1.2    2 **
Facilitation  15 6.1     8.6       92  20.3     25.5    *
 Participatory 
 facilitators 7  2.4    2.5   29  7.2    9.2   
 Procedural talk 6  3.7    6.1   58  13.1    16.3  **
  agenda setting 1   1.0     28   6.4    
Decision making  1 .8     .3        3 1.4     1.2     
Total  339 100     100       472 100     100     
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Mdn: the median number of utterances within the category    
M: the mean percentage of utterances within the (sub-) cluster    
*  p < 0.05          
** p < 0.01 
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pilot studies. Patients and their proxies contributed about the same proportion of all 
utterances to the conversation in both studies.
Regarding providing psychosocial information, Table 3 shows that 22.7% of the 
patients’ and their proxies’ utterances were related to this topic (see the ‘Information 
giving and counseling’ cluster). This was substantially larger in the present study than 
in the pilot study (22.7 % vs. 12.8%, respectively). 
With respect to question asking, Table 3 shows that patients and proxies asked their 
questions with a mean percentage of 4.6% (see the ‘Question asking’ cluster). This was 
about the same in the pilot study. Together, patients and proxies had a median of 12 
utterances for questions, predominantly with general medical content (11). 
Patients and proxies expressed with only 1.4% of their utterances concerns (see the 
‘Relationship building’ cluster). This was about the same in the pilot study (1.9%). 
Patients and their proxies expressed their agenda with a mean of 1% of their utterances, 
i.e. a median of 1 utterance per consultation (see the ‘Facilitation’ cluster). 
Radiation oncologist’s stimulation of patient participation 
As indicated in Table 3 (see the ‘Information giving and counseling’ cluster), the ROs 
gave medical information in 32.9% of their utterances, most dedicated to general 
 medical subjects, which was a median of 138 utterances. Their contribution to medical 
 information was about the same in the pilot study (37.8%). 
Psychosocial questions were asked in 2.9% of the ROs’ utterances, i.e. a median of 12 
utterances (see the ‘Question asking’ cluster). This is a significantly higher percentage 
than in the pilot study (0.9%). 
The ROs expressed support in 5.2% of their utterances (see the ‘Relationship building’ 
cluster). In the pilot study, the ROs gave significantly less support (1.0%). Concerns 
were expressed in 1.2% of the ROs’ utterances; this is less than in the pilot study 
(2.0%).
Decision making 
Table 4 shows the percentage of consultations in which the decision-making behavior 
studied occurred in the present and the pilot studies. Pilot study data was not available 
for all categories. 
The ROs provided information about the diagnosis in 91% of the consultations. Patients 
or their proxies asked questions about the diagnosis in 28% of the consultations. ROs 
gave information about the prognosis in 93% of the consultations. Patients or their 
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proxies asked questions about the prognosis in 37% of the consultations. This means 
that the ROs gave information in most consultations about the diagnosis and the 
 prognosis, even if no questions were asked on these topics. 
The ROs gave information about other treatment options in 30% of the consultations 
and information about refraining from treatment in 20% of the consultations. In the pilot 
study, at least one of these 2 categories was used in 46% of the consultations. Patients 
requested information about other treatment possibilities in 11% of the consultations, 
and about refraining from treatment in 7%. 
In 19% of the consultations, the ROs explicitly asked for the patients’ consent to the 
treatment proposal. Patients explicitly consented in 44% of the consultations. In the 
pilot study, the percentage of consultations in which the RO asked for patient’s consent 
was about the same is in the present study. 
Telephone interview
In the telephone interview 2 days after their consultation, most patients reported that 
they had been aware of the diagnosis (98%) and the incurable nature of their disease 
(91%), before visiting their RO. Most patients (44 = 81%) consented to this treatment 
before seeing their RO. Three patients (6%) told that they had not been sure they 
Table 4  Percentages of consultations in which decision-making items  
were discussed
decision making % of present  n = 54 % of pilot  n = 26
RO gives info on diagnosis 91 -
Patient asks info on diagnosis 28 -
RO gives info on prognosis 93 -
Patient asks info on prognosis 37 -
RO gives information about * 45 46
 Other treatment options 30 -
 Refraining from treatment 20 - 
Patient asks questions about * 16 -
 Other treatment options  11 -
 Refraining from treatment 7 -
Doctor requests consent 19 24
Patient gives consent 44 -
* subcategories do partly overlap
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 wanted to undergo the proposed radiation treatment and needed their RO’s information 
to make a decision. Seven patients (13%) did not remember when they had consented 
to undergo radiation therapy.
Discussion and conclusion
Our objective was to assess the extent to which elements of patient participation could 
be observed in consultations prior to palliative radiation therapy. Patient participation 
was studied in patient behavior and in the ROs’ behavior suggested to stimulate patient 
 participation. 
Patients’ relative contribution to the interaction was quite moderate and comparable to 
the pilot study 31. Patients and proxies used only about 12 (of more than 300) utterances 
for questions. This was about the same as in the pilot study. The low participation in 
asking questions might partly be explained by the considerable amount of information 
the ROs provided. Patients’ information needs could have been satisfied without any 
questions of patients. However, it is well known from other studies that cancer patients 
often ask only a few questions, because they are afraid to receive threatening information 
40. Most patients in our study were aware of their limited prognosis, and that knowledge 
is likely to have inhibited them to ask more questions.
Patients and their proxies provided more than one fifth of their utterances psychosocial 
information. This was substantially more than in the pilot study and in other studies in 
oncology settings 34,36,37. In the present study, the proportion of female patients was 
higher than in the pilot study. Some studies have shown that female patients discuss 
more psychosocial topics with their doctors than male patients 42,43. We explored 
 gender differences in the present data and found that the male patients talked more 
about psychosocial issues than the female patients did, which means that female 
 gender cannot account for the difference found on psychosocial exchange. Another 
explanation for the considerable amount of psychosocial information is a change in 
clinical communication in recent years. The ROs obviously gave room for the patients 
to discuss their experiences, and the patients were confident to participate from their 
own  perspective and not only to respond to the ROs’ medical questions.
In spite of their conversation from their own perspective, patients did not express many 
concerns. The mean proportion of concerns did not differ from that of the pilot study or 
from other studies in oncology settings 12,35,44. It has been shown that cancer patients 
who disclose their concerns to their doctor have better psychological adjustment to 
their disease 11,45. The problem is that cancer patients who are palliatively treated do not 
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 disclose their concerns spontaneously 11,45. That is why in several studies, doctors are 
helped to inquire about patients’ concerns 11,45. 
Patients and their proxies did not say much about their agenda for the consultation. 
The preferences of cancer patients for the amount of information they receive vary 
widely 17. The more patients can express what they need, the more the ROs can give 
individually adapted information and support. The patients in our study did hardly 
express their needs spontaneously, and participated mainly by telling their own story. 
The ROs provided a considerable amount of medical information (about one third of 
their talk). Much of this information dealt with the effects of radiotherapy on cancer and 
normal tissue cells, the aim of the treatment, possible side effects and treatment 
 procedures. All patients received this kind of information, even when no question was 
asked about these subjects. The amount of medical information provided was about 
the same in the pilot study and in other studies in oncology settings 35,36,41. This  provision 
of medical information might have encouraged patient participation since most cancer 
patients need a lot of information 1. On the other hand, providing mainly medical 
 information might also have a contrary effect, resulting in patients’ closing up when 
psychosocial aspects are neglected 11,12. This seems not to be the case in the 
 consultations we studied, because psychosocial aspects were amply discussed by all 
participants. The ROs asked their patients more psychosocial questions and patients 
dedicated a  considerable part of their talk to psychosocial information. 
The ROs gave their patients more support than in the pilot study, but like the patients, 
they did not express much concern about the seriousness of the patients’ situation. 
In more than 90% of the consultations, the RO provided some information about 
 diagnosis and prognosis. Alternative treatment options and the possibility of refraining 
from treatment were mentioned in less than half of the consultations, which was 
 approximately the same as in the pilot study and in an Australian study on decision 
making in palliative treatment consultations 46. Patients explicitly consented to the 
treatment proposal in nearly half of the consultations without their ROs explicit asking 
for consent. As we learned in the telephone interviews, most patients were aware of 
their diagnosis and prognosis and had decided to undergo radiotherapy before visiting 
the RO. Obviously, the need for discussion about the treatment decision is reduced by 
previous clinical consultations. However, since patients might not be able to  understand 
the impact of received information, repeated attention for the decision making process 
is never superfluous.
At the beginning of the radiotherapy treatment period, patients did not seem very 
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active in seeking information, but seemed to concentrate more on building a  relationship 
with the new physician treating them. This is in accordance with The 47, who suggested 
in her qualitative study on communication in a palliative treatment setting that 
 information might be less important for patients than a doctor who cares and gives 
attention to the impact of the cancer on their life. Moreover, incurable cancer patients 
might not be able to cope with the information unless they have a caring relationship 
with their doctor 3,48. Although the ROs provided a lot of biomedical information, they 
also seemed to give attention to the relationship building process by allowing their 
patients to take the floor and by demonstrating their caring with supportive remarks. 
Our findings indicate that, since the pilot study was conducted, patient participation 
and stimulation of it by the ROs has been increased in some aspects of the 
 communication, while conversation about concerns remained to get little attention. 
Limitations
We are aware of several limitations in the present study. Firstly, only a limited number 
of the elements of patient participation and the decision-making process were studied. 
Secondly, cancer patients treated palliatively have been shown to vary in their desire to 
participate in the interaction and decision-making process. We analyzed the ‘average’ 
interaction, which in reality does not exist. Thirdly, we did not analyze how the 
 participants in the consultations responded (sequentially) to each other’s 
 communications. Finally, like much of all communication between people, patient 
 participation and decision-making are not restricted to verbal utterances, but can also 
take place nonverbally. Nonverbal behavior was not measured. 
Implications in practice
The findings of this study could have some implications for ROs working with incurable 
cancer patients. In consultations prior to radiation therapy, a vast quantity of procedural 
and biomedical information has to be provided to patients. Many studies have shown 
that most cancer patients prefer to receive as much information as possible, regardless 
of whether it is good or bad 49. In palliative treatment settings, however, besides helping 
patients regain a sense of control, information can confront patients with  consequences 
that are difficult to cope with. Moreover, incurable cancer patients often are in great 
 distress, and high levels of negative emotions interfere with patients’processing of 
 information and with their ability to actively participate 50-52. This means that many 
 incurable cancer patients need support in a caring relationship with their doctor before 
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being capable of understanding and processing any new information. When a 
 relationship is established, repeating threatening information may stimulate emotional 
processing 50. E.g. most patients knew their diagnosis and prognosis before their visit 
to the RO. Nevertheless, the ROs provided once more information about the diagnosis 
and  prognosis. This rehearsal of threatening information can be beneficial when, at the 
same time, ROs give their patients support and help to cope with the fact that curation 
cannot be achieved. Provision of individually adapted information and support was 
likely  hampered in the consultations we studied, since patients asked few questions, 
 expressed few concerns and said little about their agenda for the conversation.
The ROs’ communication tasks in palliative consultations are complicated. Building a 
caring relation in a situation in which much biomedical information has to be exchanged 
might not be learned in a time constrained setting with vast technical developments. 
Therefore, the ROs should be helped to elicit patients’ concerns and build a caring 
 relationship and communicate so that patients can really participate in the palliative 
 treatment decision.
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Summary
Objective: 
To assess whether communication in radiotherapy consultations is affected by  palliative 
or curative treatment intent.
Subjects and methods:
The study involved 160 patients and 8 radiation oncologists. Eighty patients visited 
the radiation oncologist (RO) for palliative treatment and 80 for curative treatment. 
The consultation prior to radiation treatment was analyzed with the Roter Interaction 
Analysis System (RIAS). Within three days, patients completed a quality-of-life 
 questionnaire (EORTC-QLQ-C30).
Results:
In palliative radiotherapy (PRT) consultations, ROs asked more (closed-ended) 
 biomedical and psychosocial questions and provided more information on prognosis 
than in consultations for curative radiotherapy (CRT). Patients in both groups provided 
a great deal of psychosocial information but asked few questions. The ROs expressed 
more concerns in the PRT consultations, while patients did not. PRT patients received 
fewer supportive remarks than CRT patients. In both groups, explicit decision-making 
received little attention. Proxies who accompanied the patients took a more active role 
in PRT than in CRT consultations.   
Conclusion:
Communication in radiotherapy is affected by treatment intent with respect to the main 
contents of the consultation.
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Introduction
Over the past few decades, communication between cancer patients and their 
 physicians has been intensively studied with respect to several factors 1-14. As far as we 
know, however, the impact of treatment intent on communication has not yet been 
explored. Treatment intent is considered as either curative (when there is a good 
chance a patient will survive the cancer) or palliative (when the patient seems  incurable, 
due to the  cancer’s nature or metastases) 15. 
Radiotherapy is one of the most effective treatments to obtain local control of cancer 
cells, and it might cure, or improve patients’ quality of life (QOL) and extend many 
patients’ survival 16. In western countries about 40-50% of all cancer patients get radio-
therapy. Approximately 50% of these patients is treated with curative intention, whereas 
the other 50% is treated palliatively 17. For curative radiotherapy (CRT), there is scientific 
agreement on the methods and applications for many types of cancer. Palliative radio-
therapy (PRT), however, is often more difficult to decide for radiation oncologists (ROs), 
due to uncertainties in the progress of the illness and the outcome of treatment.
Since all cancer therapies can have several side effects and are time and energy 
 consuming, the outcome of treatment should counterbalance these costs. In curative 
treatment, tumor-free survival can be measured and the benefits are obvious. 
In  palliative treatment, evidence of treatment effects on symptoms is meager and much 
of the  evaluation of the treatment outcome is subjective and depending on patients’ 
personal character and QOL before treatment 18. For optimal palliative cancer treatment 
tumor shrinkage and prolonged survival are not the only wanted outcomes, but also the 
 physical, emotional and social outcomes have to be implied 15. Therefore, the oncologist 
has to get insight into the patient’s physical, psychological and social functioning 8,19. 
The integration of palliative treatment options, with attention to possible sequelae, 
 inconvenience, and impact on the patient and the family, requires more communication 
between the oncologist, the patient and the family than curative treatment 15. 
Moreover, the choice of therapeutic intervention depends on the trade-offs between 
side effects and possible gains in the quality of life, about which only patients can 
decide 20. Hence, it is emphasized that physicians should explicitly ask for patients’ 
consent to the treatment proposal and offer an opportunity to refrain from treatment, 
particularly in the event of palliative treatment 6,10,13,21.
Sharing information with cancer patients and their family is considered as important in 
helping patients and their family to cope with their illness 22-28. But even if doctors’ 
54
C H A P T ER 3
information giving is brilliant, all information imparted might be lost when a patient is 
severely anxious or depressed because the patient will not recall and understand the 
information 29. Generally, patients treated with palliative intent have lower QOL and are 
more anxious and depressed than those treated with curative intent 18,30 and they often 
wait for their doctor’s invitation to discuss their emotions and need their doctor’s 
 emotional support 31. Therefore, Detmar and colleagues argue that in palliative 
 treatment consultations patients’ emotional functioning like their concerns, anxieties, 
and  depressive mood should be discussed 8. 
Related to patients’ lower QOL, some authors suggest that patients are likely to be less 
active in discussing palliative treatment, and proxies are needed to ask the relevant 
questions and to help to recall the information provided 27,32.
Numerous studies showed that most cancer patients prefer to receive the maximum 
amount of information 33-37. Some evidence has been found that the desire for 
 information lessens when the disease advances 38,39, but in a large study in which more 
than 2000 cancer patients participated, no difference was found in the preference for 
information between patients treated with palliative or curative intent 36. More  specifically, 
Hagerty and colleagues 37 have found that most patients with incurable cancer desire 
detailed prognostic information, with exception of  information about the estimated 
survival time 40. The preference to participate in decision-making, however, seems to 
decline as the  illness becomes more severe 38,41,42.
Studies that investigated not preferences but the factual doctor-patient communication 
in palliative treatment settings have found that oncologists provided very little 
 information on topics like the prognosis, expected outcomes when refraining from 
 treatment, or the emotional side-effects of treatment 6,7,8,10,13,14. 
There has been just one study in which a comparison of oncologists’ communication 
in palliative treatment and in curative treatment is described 9. It was found that 
 prognostic information was more frequently provided to patients scheduled for curative 
treatment than to patients coming for palliative treatment. Other aspects of 
 communication were not compared. As far as the communication of  patients 
 themselves is concerned, in discussing palliative treatment patients have been found 
to ask very few questions and to express not much concerns 6,14. Furthermore, no 
 relations have been found between patients’ communication preferences and their 
actual communication 8. 
Despite the above-mentioned value of the participation of the cancer patients’ proxies 
to the medical interaction, no data could be found on the communication of the proxies 
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themselves in palliative or curative treatment consultations. Since palliative and  curative 
consultations differ in the medical and psychosocial issues that have to be considered, 
and in the intensity of emotions patients and their proxies have to deal with, we aimed 
to gain more insight into the impact of treatment intent on the communication of the 
ROs, the patients, and their proxies. Based on literature on communication in cancer 
settings, we will focus on sharing of information on biomedical and psychosocial 
issues, on  discussing emotions, and on treatment decision-making. That is why we 
have investigated the following research questions with respect to the communication 
of ROs, patients and their proxies in PRT and CRT consultations:
•	 	The	participation	of	patients	and	proxies	to	the	interaction
•	 	Sharing	information:	
 -  We examined the ROs’ provision of general biomedical and prognostic  information.
 -  We explored patients’ and proxies’ questions, including those about the prognosis.
 -  We expected the ROs to ask more questions pertaining to medical history in PRT 
consultations than in CRT consultations.
 -  We expected the ROs to ask more questions about the patient’s life in PRT 
consultations than in CRT consultations.
•	 	Emotional	talk:
 - We expected more emotional talk in PRT consultations than in CRT consultations.
•	Decision-making:
 - We examined communication related to decision-making.
2. Methods
 
Subjects and procedures 
This study was part of a larger study investigating several aspects of patients’ 
 com municative participation in radiotherapy consultations with palliative and with 
 curative treatment intent before and after a training session for the ROs. The study was 
approved by the Medical Ethical Committee of the University Medical Centre 
St Radboud Nijmegen, the Netherlands. In the present paper, data will be reported on 
ROs’ and patients’ and their proxies’ communicative behaviors in consultations with 
palliative or curative  treatment intent. The study was conducted at an University 
Medical Centre, where the 12 ROs working in the Department of Radiation Oncology 
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(7 staff members and 5 residents) were invited to take part in the study. Eight agreed, 
3 staff members and 5 residents. The other 4 ROs were unavailable for our study, due 
to other research projects or their working schedules. 
Patients were recruited from a consecutive series of newly referred patients from April 
2000 - May 2002. Patients were eligible for participation if scheduled to consult a 
 radiation oncologist for the first time or for new complaints, able to speak and write 
Dutch, over 18 years of age and having a life expectancy exceeding 3 months. Patients 
were asked to participate before the start of the consultation by their RO, who briefly 
described the study. If a patient was willing to participate, the researcher explained the 
study in more detail and provided written information and a printed copy of a quality of 
life questionnaire. The subsequent consultation was videotaped after receiving the 
patient’s consent. Within 2 days after the consultation, the researcher telephoned the 
participating patients, they were interviewed and asked to complete the QOL 
 questionnaire. QOL was assessed to compare the medical condition of patients 
coming for palliative or curative treatment. 
After the consultations, the ROs indicated in patients’ charts whether treatment intent 
was palliative or curative according to departmental criteria. The researcher recorded 
the treatment intent from the patients’ charts, as well as the tumor site and extent, and 
some demographic characteristics.
Quality of life measurement
Quality of life was measured with 6 scales of the EORTC-QLQ-C30, developed by the 
European Organization for Research and Treatment of Cancer 43. In order to compare 
QOL of the patients coming for PRT or CRT, we used data of the  global QOL scale, 
and the 5 functional scales (physical, role, emotional, cognitive and social functioning). 
The questionnaire was scored according to guidelines provided by the EORTC Quality 
of Life Study Group 43.
Analysis of communication 
We analyzed the verbal communication in the videotaped consultations by means of 
the Roter Interaction Analysis System (RIAS). The RIAS permits classification of all 
utterances by RO and patient into mutually exclusive content categories. The  categories 
can be condensed into subclusters, or clusters of categories 44. 
The RIAS has been developed to analyze interactions in general practice, but the 
system is flexible and responsive to study context by adding or elaborating tailored 
57
PA L L I AT I V E o R C u R AT I V E T R E AT M En T I n T En T A FFEC T S C o M M u n I CAT I o n I n R A d I AT I o n T H ER A P Y C o n S u LTAT I o n S
3
categories 45. The RIAS has been used in several physician-patient communication 
studies in  oncology 5,6,8,11,12,14,46-48, and has been adapted if needed. 
In line with the results of our previous studies in radiotherapy consultations, the RIAS 
was somewhat adapted in order to analyze communication on specific topics relevant 
to our studies and condensed into (sub-) clusters of categories 6,14 (see appendix A for 
the (sub-)clusters used). Inter-coder reliability was satisfactory in all categories (mean 
 reliability, 0.88 for all categories; range, 0.65 - 0.99) 14.
Statistical methods and coding
We used SPSS 12.0 for all statistical analyses. Student’s t-tests and chi-square tests 
were used to compare patient characteristics in the groups scheduled for PRT or CRT. 
For the EORTC-QLQ-C30, mean scores (with SDs) are presented for both patient 
groups and compared with Student’s t-tests.
RIAS communication coding was performed directly from videotape. Frequencies of 
utterances as observed with the RIAS were counted per speaker per category. 
Kolmogorov-Smirnov tests indicated that there was a non-normal distribution for almost 
all categories. For this reason, we present the median number of utterances per 
 category. Mean percentages of utterances are also shown in order to correct for the 
duration of consultations. To assess communication differences between PRT and CRT 
consultations, differences in the median number of utterances were tested with  Mann-
Whitney U-tests and differences in mean percentages with Student’s t-tests. 
To gain insight into the proportion of PRT and CRT consultations in which the treatment 
decision was discussed, we calculated the proportion of consultations in which any 
utterances in the decision-making categories were used. 
We will test whether palliative and curative consultations were unequally distributed 
over the ROs by chi-square tests. Additionally, since several patients of the same ROs 
were included, we will control for the amount of nesting ‘within’ ROs, by calculating 
intraclass correlations coefficients for the selected outcome measures. In case of 
 significant intraclass correlations coefficients, multilevel analysis will be performed.
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Results
Study sample
A total of 224 consecutive patients were asked to participate, of whom 206 (= 92%) 
agreed. Non-participants felt too ill to take part (n = 6) or failed to give a reason (n = 
12) for their non-consent. Complete consultation video recordings and quality of life 
data were available of 172 (83%) patients. Eighty patients were admitted for PRT and 92 
for CRT. To obtain equal numbers of patients in the groups, we matched the 80 PRT 
patients with 80 CRT patients on the basis of age and gender. Communication of these 
160 patients and the 8 ROs will be presented in this study (between 19-28 patients per 
RO). Patients’ demographic information, disease characteristics and QOL are shown in 
Table 1.
Comparison of patients admitted for PRT and CRT did not reveal any differences in age, 
gender or proportion of patients accompanied by a proxy. The primary cancer site and 
QOL differed significantly between the groups, which was related to the difference in 
treatment intent. PRT and CRT consultations were not divided unequally over the 8 
ROs. Intraclass correlations coefficients of RIAS categories and ROs were low and non-
 significant (< .05), indicating that the variance in communicative behaviors between 
the ROs was very small and the 160 consultations are considered as independent 
observations.
Communication in PRT and CRT consultations
Table 2 shows utterances by the ROs, patients, and proxies in median numbers and 
percentages per subcluster and category for the 80 PRT and the 80 CRT consultations. 
Overall, in PRT consultations there was a tendency for all participants to express more 
utterances than in CRT consultations (ROs 489 vs. 429 utterances respectively, patients 
295 vs. 269 utterances respectively), but only the proxies’ contribution was  significantly 
higher (absolutely 61 vs. 35 utterances respectively, and relatively 8.8% vs. 6.1%).  
We compared specific communication in PRT and CRT consultations with regard to 
sharing information (= ‘Information giving’ & ‘Question asking’), emotional talk and 
 decision-making. 
Sharing information: 
ROs provided relatively less general biomedical information in PRT consultations than 
in CRT consultations (27.0% - 33.7%). Relatively more prognostic information was 
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 provided in PRT consultations than in CRT consultations (3.0% - 1.8%). The proportion 
of consultations in which the RO supplied any prognostic information was the same in 
both the PRT and CRT groups (both 93%, data not shown in Table 2).
Patients in both groups asked approximately the same number of questions. They asked 
more questions related to their prognosis in PRT consultations than in CRT consultations 
(.3% - .2%). Similar results were found in proxies. Additionally, the proportion of 
Table 1  Patients’ demographic, disease characteristics and QoL 
Treatment intent Palliative Curative P-value
Patients (N) 80 80  
Age   .75  
 Mean years (SD) 58 (13) 59 (12)
 Minimum 32 28 
 Maximum 83 83
Gender    .75
 Female 41 (51%) 43 (54%) 
 Male 39 (49%) 37 (46%)
Accompanied by proxy   90%    89% .80 
 Primary tumour location
 Brain 20% 1%  
  Breast  15% 44%  
  Gastrointestinal 10% 4%  
  Head and neck 5% 10%  
  Lung 23% 4%  
  Urogenital 20% 26%  
 Other tumours 7% 11%  
Tumour extent    
  No metastases  50% 95% .00 
  Metastases 50%    5%  
 Quality of Life*; mean (SD)    
  Global QOL  54 (26) 70 (20) .00
 Functioning 
 Physical 67 (29) 82 (18) .00 
 Role 49 (34) 72 (31) .00 
 Emotional 66 (19) 73 (21) .03 
 Cognitive 79 (22) 84 (18) .15 
 Social 66 (30) 82 (22) .00
* Higher scores represent better QOL 
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 consultations in which patients asked for information related to their prognosis was 
higher in the PRT group than in the CRT group (PRT 39%, CRT 23 %, data not shown 
in Table 2).
ROs asked more biomedical questions in PRT consultations than in CRT consultations, 
with a substantial number of closed ended biomedical questions (all biomedical 
 questions: 11.9% - 8.5%;  closed ended general biomedical questions: 8.7% - 6.2%). 
Questions related to psychosocial aspects were asked relatively more by the ROs in 
Table 2  distribution of utterances of the Ros, Patients and Proxies                                                    in PRT and CRT consultations
   Ro Patient Proxy   
 
 
% of all utterances    57.8    59.3            34.3     35.3     8.8    6.1   **
Clusters, subclusters, categories  
Information giving    168 36.7   173 43.7   **     178 62.4   145 55.0   ** 28 49.6   11 46.2    
  Biomedical   154  33.7  158  38.8  **     110  38.8  77  31.7  ** 12  26.1  5  18.0  *
   general    116   27.0 139   33.7 **     103   37.1 73   30.4 ** 11   24.4 4   17.1 *
   diagnosis   12   3.2 10   2.7       4   1.4 2   1.2  0   1.1 0   0.7  
   prognosis   12   3.0 7   1.8 **     0   0.3 0   0.2 * 0   0.6 0   0.2 **
  Psychosocial   13   2.9   16   4.9   **     68   23.7   56   23.3     11   23.5   8   28.1    
Question asking   70 15.2   45 11.2   **     6 3.4   8 3.7     5 13.1   4 11.8    
  Biomedical   50  11.9  36  8.5  **     6  3.0  7  3.4   5  12.4  3  10.6   
   closed general   34   8.7 19   6.2 **     _   - _   _  _   - _   -  
   open general   8   3.1 5   2.1 *     5   2.3 6   2.9  4   8.7 3   9.7  
   diagnosis   0   .1 0   .1       0   0.2 0   0.3  0   1.3 0   0.5 **
   prognosis   0   .0 0   .0       0   0.5 0   0.2 * 0   2.4 0   0.5 **
  Psychosocial   16   3.3   12   2.7   *     1   0.3   0   0.3     0   0.6   0   1.2    
Relationship building   130 26.8   102 25.3         72 28.0   81 34.7   ** 12 27.0   10 32.3   *
  Emotional talk   30  6.7  29  7.4        4  1.7  2  1.7   0  2.2  0  2.4   
   concern   4   1.3 2   0.9 *     3   1.7 2   1.7  0   2.1 0   2.3  
    support   21     5.3 26     6.5 **     0     0.0 0     0.0   0     0.0 0     0.0  
  Positive talk   93  20.0  72  17.8        64  26.2  80  32.9  ** 9  24.7  8  29.7  *
  Negative talk   0  0.0  0  0.0        0  0.1  0  0.0   0  0.2  0  0.2   
Decision making   5 1.9   4 2.1         1 1.2   1 1.0    0 2.2   0 1.0   *
Facilitation   91 19.6   73 17.8         12 5.1   13 5.6    4 8.1   2 8.7   *
                                                       
Total    489 100     429 100           295 100    269 100       61 100     35 100      **
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PRT consultations than in CRT consultations (3.3% - 2.7%). No differences were found 
in patients’ and proxies’ provision of psychosocial information. 
Emotional talk
ROs expressed more concerns in PRT consultations than in CRT consultations, but 
there was no difference in expression of concerns between patients in these groups, 
nor for proxies (ROs: 1.3% - .9%, Patients: 1.7% - 1.7%, Proxies: 2.1% - 2.3%). Supportive 
Table 2  distribution of utterances of the Ros, Patients and Proxies                                                    in PRT and CRT consultations
   Ro Patient Proxy   
 
 
% of all utterances    57.8    59.3            34.3     35.3     8.8    6.1   **
Clusters, subclusters, categories  
Information giving    168 36.7   173 43.7   **     178 62.4   145 55.0   ** 28 49.6   11 46.2    
  Biomedical   154  33.7  158  38.8  **     110  38.8  77  31.7  ** 12  26.1  5  18.0  *
   general    116   27.0 139   33.7 **     103   37.1 73   30.4 ** 11   24.4 4   17.1 *
   diagnosis   12   3.2 10   2.7       4   1.4 2   1.2  0   1.1 0   0.7  
   prognosis   12   3.0 7   1.8 **     0   0.3 0   0.2 * 0   0.6 0   0.2 **
  Psychosocial   13   2.9   16   4.9   **     68   23.7   56   23.3     11   23.5   8   28.1    
Question asking   70 15.2   45 11.2   **     6 3.4   8 3.7     5 13.1   4 11.8    
  Biomedical   50  11.9  36  8.5  **     6  3.0  7  3.4   5  12.4  3  10.6   
   closed general   34   8.7 19   6.2 **     _   - _   _  _   - _   -  
   open general   8   3.1 5   2.1 *     5   2.3 6   2.9  4   8.7 3   9.7  
   diagnosis   0   .1 0   .1       0   0.2 0   0.3  0   1.3 0   0.5 **
   prognosis   0   .0 0   .0       0   0.5 0   0.2 * 0   2.4 0   0.5 **
  Psychosocial   16   3.3   12   2.7   *     1   0.3   0   0.3     0   0.6   0   1.2    
Relationship building   130 26.8   102 25.3         72 28.0   81 34.7   ** 12 27.0   10 32.3   *
  Emotional talk   30  6.7  29  7.4        4  1.7  2  1.7   0  2.2  0  2.4   
   concern   4   1.3 2   0.9 *     3   1.7 2   1.7  0   2.1 0   2.3  
    support   21     5.3 26     6.5 **     0     0.0 0     0.0   0     0.0 0     0.0  
  Positive talk   93  20.0  72  17.8        64  26.2  80  32.9  ** 9  24.7  8  29.7  *
  Negative talk   0  0.0  0  0.0        0  0.1  0  0.0   0  0.2  0  0.2   
Decision making   5 1.9   4 2.1         1 1.2   1 1.0    0 2.2   0 1.0   *
Facilitation   91 19.6   73 17.8         12 5.1   13 5.6    4 8.1   2 8.7   *
                                                       
Total    489 100     429 100           295 100    269 100       61 100     35 100      **
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remarks were made less by the ROs in PRT consultations than in CRT consultations 
(5.3% - 6.5%). 
Decision- making
Table 2 shows that the ROs and patients contributed about the same proportion of 
 utterances to the decision-making cluster in the PRT and CRT consultations. The 
proxies in PRT consultations dedicated a higher proportion of their talk to the to the 
decision-making cluster than they did in CRT consultations (2.2% - 1.0%). Table 3 
shows the percentage of consultations in which any utterances in the specified 
‘Decision-making’ categories were used. ROs, patients and their proxies dedicated 
utterances of these categories in about the same proportion of PRT as of CRT 
 consultations. Only the ‘Refraining from treatment’ option was discussed more often in 
the PRT consultations: the ROs gave explicit information about ‘Refraining’ in 29% of 
the PRT consultations and 16% of the CRT consultations. Patients and proxies 
requested information about ‘Refraining’ in twice as many PRT consultations as CRT 
consultations (9% – 4%). Informed consent to the treatment proposal was explicitly 
discussed by the ROs and patients in about the same percentage of PRT and CRT 
consultations.
Table 3  Percentages of consultations in which decision-making items were 
discussed; tested with Chi 2 -tests
decision making % of PRT consultations  % of CRT consultations   
  n = 80 n = 80 
RO gives information about 1   61%   51%
 Other treatment options 45% 41%
 Refraining from treatment  29% 16% *
Patient or proxy asks questions about 1 21% 15%
 Other treatment options  18% 15%
 Refraining from treatment  9% 4% *
RO requests consent 26% 24%
Patient gives consent 54% 54%
1 partial overlap in categories
* sign < .05
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Discussion and conclusion
Our results indicate that communication in radiotherapy consultations is affected by 
the palliative or curative treatment intent with respect to the main contents of the 
 consultations. In PRT consultations, patients and ROs tended to express more 
 utterances than in CRT consultation; the proxies’ contribution was significantly higher 
(absolutely and relatively), indicating a more active role of proxies in PRT consultations. 
This finding is in line with the suggestions of Labrecque et al. 32 and Delvaux et al. 27.
In sharing biomedical information, the ROs provided biomedical information in a lower 
proportion of their talk in PRT consultations, but with approximately the same absolute 
number of utterances as in CRT consultations. Information on the prognosis, however, 
is needed to counterbalance the expected treatment outcome and the treatment costs 
(e.g. time, energy, and the burden of side-effects). As some prognostic information was 
provided in 93% of both groups’ consultations and the ROs’ utterances with regard to 
prognostic information were more frequent in PRT consultations, suggesting that more 
information was conveyed in PRT consultations. This seems in contrasts with findings 
by Leighl and colleagues 9, who found in the oncology consultations they studied 
that prognostic information was provided more often to patients scheduled for curative 
treatment than for those scheduled for palliative treatment. However, comparison of our 
data with that of Leighl et al. 9 might be hampered by different definitions of ‘information 
about the prognosis’ and by the dissimilar methods of data collection (quantitative vs. 
qualitative). Due to our quantitative approach, we can only report about the frequency 
of utterances that were dedicated to the prognosis, while Leighl et al. 9 reported whether 
specific aspects of prognostic information occurred or not. This methodological 
 dissimilarity might lead to significant variation in study results, even when the same 
 situations are investigated. 
In addition, not only the method, but also the context of the study of Leighl et al. 9 differs 
from the present study. In this study, only radiotherapy consultations have been 
 investigated, while Leighl et al. investigated communication in palliative chemotherapy 
and radiotherapy settings 9. Palliative radiotherapy is, in contrast to palliative  chemotherapy, 
in general related to less severe side effects and is often well tolerated by patients with 
poor performance status 49,50. This difference is very important for patients and might 
have impact on the communication in medical or radiation  oncology. Therefore, the 
 findings of Leigh et al. and of the present study should not be compared without caution. 
Patients in both groups asked just a few questions in the approximately forty-five-
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minute consultations. This appears to contradict cancer patients’ generally recognized 
wish for more information at every stage of their illness 36,37. Patients might, however, 
have several reasons for failing to ask for information they want, such as fear of 
 threatening information 51, or appearing foolish and feeling guilty about taking too much 
of their doctors’  time 23,36,52,53.
Patients asked very few questions about their prognosis, slightly more in PRT than in 
CRT consultations. Although this difference was rather small, it is consistent with the 
finding that patients in PRT consultations ask prognostic questions more frequently 
than in CRT consultations (PRT 39%, CRT 23%). Altogether, the ROs provided 
 prognostic information more often than patients requested it, both in PRT and CRT 
consultations. This indicates that the ROs often initiated discussion of the prognosis, 
even when not requested by patients.
In a previous study, we found that most patients scheduled for PRT are aware of their 
prognosis before visiting the RO 14. Patients probably do not want to discuss the details 
of their prognosis in every interaction with all their physicians. This seems in line with 
the findings by Hagerty and colleagues that, although almost all the incurable cancer 
patients surveyed desired prognostic information, they wanted to determine  themselves 
the extent and timing of the information they received 37.
One might remark that PRT consultations may differ dependent on the clinical context: 
patients who were treated with radiation before and now come for another radiation 
 treatment e.g. for a painful metastasis differ from patients for whom PRT is the first and 
only treatment option, e.g. a patient with primary lung cancer. In the first case, one 
might expect that the consultation may be mainly technical, without further discussion 
about prognosis because this has been discussed in the past and by other physicians. 
Whilst in the latter situation, one might expect that treatment intent and prognosis will 
be dealt with in more detail although the referring physician will have discussed these 
items with the patient too. 
In a post-hoc analysis we excluded the PRT consultations with patients who had 
received PRT before and were going to be treated for another metastasis. Without these 
 consultations, the analysis showed the same results concerning communication in PRT 
and CRT consultations as described above. Due to the very small number, however, we 
made no comparison between the PRT consultations with patients already familiar with 
radiation therapy, and the PRT patients who came for their first radiation therapy series. 
The impact of this difference in PRT consultations on the communication has to be 
explored in future research. 
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According to our expectations, the ROs asked more biomedical questions in PRT 
 consultations. The nature and extent of the cancer problem and other physical 
 complaints were extensively explored, mainly with closed ended biomedical questions 
that require only short answers like ‘yes’ or ‘no’. This corresponds to the PRT 
 requirements, in which the individual patient’s condition is a decisive factor in the RO’s 
choice of a radiotherapy treatment plan. Closed ended biomedical questions can be 
quite appropriate for  obtaining specific information on details that could be decisive for 
gaining accurate insight into the patient’s condition. On the other hand, closed ended 
questions could discourage patients from discussing psychosocial issues and 
 concerns. Patient disclosure of such information is shown to be promoted by questions 
that are asked with an open end, that allow patients to answer with their own story 52. 
The ROs asked more questions about their patients’ lives in PRT consultations than in 
CRT consultations. Again, this appears to match the requirements for PRT. The patients, 
however, did not provide more psychosocial information in PRT consultations. 
The importance of patients’ telling their story can hardly be overestimated. Patients who 
discuss their lives and the impact of their cancer on it with their doctors have a better 
understanding and recall of information and are better able to adjust to their illness than 
patients who do not 54. Considering the number of utterances on psychosocial aspects, 
there appeared to be opportunity for patients to discuss their lives and the impact of 
the cancer in both conditions. Nevertheless, patients’ talking about their lives could 
have been somewhat hampered by their ROs’ closed ended questions in the PRT 
 consultations.
As expected, we found that the ROs expressed more concerns in PRT consultations 
than in CRT consultations. This appears suited to the situation: although treatment is 
being offered, survival is limited. The patients and their proxies did not express many 
concerns in the CRT consultations nor, remarkably, in the PRT consultations. Studies 
by Maguire and colleagues have shown that cancer patients who discuss their 
 concerns with their doctors are better able to psychologically adjust to their illness, and 
that doctors can encourage patients to express their concerns by asking open and 
psychosocial  questions 52. This implies that ROs should be trained to encourage 
patients to express their concerns. Otherwise, as has been found by several other 
authors 7,24,51,55, patients who know that their illness is incurable might not want to focus 
on their difficult situation but rather on treatment. Moreover, being anxious and depres-
sed could have inhibited patients’ expression of their concerns 56. 
Due to the limited prognosis and patients’ reduced QOL, we had expected the ROs to 
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provide more supportive remarks in PRT consultations than in CRT consultations. In fact, 
however, they expressed fewer supportive remarks in PRT consultations. A possible 
explanation could be that the ROs refrained from providing much emotional support 
because they were worried about exacerbating their patients’ depressive mood or 
about their inability to cope with their patients’ emotions. In addition, as patients did not 
express many concerns in PRT consultations, the ROs might have been heeding their 
signals, which indicated their desire not to focus on their depressive mood. An 
 alternative explanation might be related to our coding system. Due to the small 
 frequencies of utterances in the ‘Emotional talk’ categories, we coded ‘reassurance’, 
‘empathy’ and ‘legitimize’ in the ‘supportive remarks’ category. In CRT consultations, 
the RO can react to patients’ concerns or other signs of distress with ‘reassurance’. 
Obviously, these types of  supportive remarks are not as easy to provide in PRT 
 consultations, which could have diminished the proportion of ‘supportive remarks’.
Decision-making did not seem to receive much attention in the consultations. Most 
 participants devoted just a small percentage of their talk to explicitly discussing 
aspects of decision making. The ROs provided information related to refraining from 
treatment more often in PRT consultations than in CRT consultations. The proportion of 
PRT  consultations in which patients received this kind of information, however, was not 
very high (29%). Information about other treatment options was more frequently 
 provided in PRT consultations (45%). At the same time, patients enquired in only 21% 
of the  consultations about other treatment possibilities or refraining from treatment. 
Along with the patients’ few prognostic questions and concerns, this could indicate that 
patients in PRT consultations focus on active treatment and that refraining from 
 treatment does not seem to be an option to them (see also 6,7,51). The ROs explicitly 
requested patients’ consent less often than patients explicitly expressed their desire for 
a particular  treatment, suggesting that some patients explicitly consent without being 
explicitly asked. This is another indication that patients focused on active treatment in 
their first visit to the RO, both when curative and palliative treatment was offered.
The finding that decision-making did not receive much attention in the radiotherapy 
consultation should be accepted with reservations. We did not study the decision-
making process during the many interactions with the several physicians that most 
cancer patients had previously consulted. As we have reported elsewhere, most patients 
have consented to be treated with radiotherapy before their first visit to the RO 14. 
Some limitations should be mentioned. Firstly, since we used a quantitative approach, 
we can only report how many utterances are dedicated to a specific subject, and we 
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can not indicate whether the information was comprehensible for patients, nor if 
patients wanted to hear what the ROs told them. In order to analyze whether the ROs 
adapted their communication to patient’s needs individually, other statistical methods 
(e.g., lag sequential analysis, or time series regression) would be necessary. Secondly, 
due to the small frequency of utterances in the ‘Emotional talk’ categories, we 
combined some categories and were unable to distinguish between reassurances and 
expressions of empathy. This might have obscured the results of ROs’ supportive talk. 
Thirdly, no  distinction was made between PRT consultations for short and repeated 
treatment of metastases, and PRT consultations in which first and only radiation 
treatment was  discussed. Further research will be necessary to get more insight in the 
impact of the treatment intent and treatment context. 
In summary, the ROs paid attention to the requirements for designing PRT by enquiring 
about patients’ experiences and life circumstances and by emphasizing the limited 
prognosis. The patients in both groups infrequently asked for additional information, 
and although patients scheduled for PRT asked more about their prognosis than those 
 scheduled for CRT, they did not express more concerns. The ROs did express more 
concerns in PRT than in CRT consultations, but strikingly, they provided less support 
to patients in PRT consultations. Patients with incurable cancer seem to focus on 
 discussions about active treatment, avoiding emotional aspects, and the ROs appear 
to respect their patients’ desire to concentrate on active treatment. 
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Abstract
Objective: 
To investigate the relationship between the perceptions cancer patients have of the 
information and support their radiation oncologist provides and the actual situation. 
In addition, the influence of various patient characteristics was evaluated.
Methods:
Based on the videotaped consultations with 173 cancer patients scheduled for  radiation 
therapy, the communicative behaviors of 8 oncologists were assessed using the Roter 
Interaction Analysis System (RIAS). Two days after the consultation, the patients 
 completed a quality-of-life inventory and a questionnaire assessing their perception of 
the medical information and personal attention provided.
Results:
The patients’ perceptions and the oncologists’ communicative behaviors as measured 
with the RIAS were poorly correlated. Multiple regression analyses showed that the 
patients’ perceptions of the medical information were to a small extent explained by 
their tension, while their ratings of the personal attention received were, besides 
 tension, also affected by the oncologist’s use of psychosocial talk, expression of 
 concerns, and  critical remarks.   
Conclusion:
The data shows that cancer patients often do not fully grasp what their oncologist is 
 trying to convey and that their perceptions are influenced by the situational tension.
Practice implications
When working with cancer patients, physicians can enhance their patients’  understanding 
by adapting to the patients’ tension, by paying attention to the patients’ psychosocial 
issues and life circumstances, by showing their concern about the patient’s situation, 
and by refraining from too many critical remarks.
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Introduction
Cancer patients are not only distressed by the diagnosis, but also by the many 
 uncertainties inherent to the disease: will they recover, what are the treatment options 
and what the likely side effects of any interventions 1-12. Physicians can try and reduce 
this distress by providing their patients with information and support to help them cope 
with their disease 13-16. However, this can only be achieved if patients recognize and 
 understand what their physicians are trying to communicate. Observational studies of 
interactive processes during cancer consultations found oncologists to provide their 
patients with ample medical information and support 17-19. Yet, several other studies 
 showed that many cancer patients leave the consultation room with a sense that their 
basic needs for information and support were not fulfilled 14,20-25, which feeling may 
cause them additional distress 14,24-26.
Studies conducted in various medical settings found little or no correlation between the 
physicians’  behavior, as observed by a third party, and the patients’ perception of this 
behavior 27-29. More specifically, the amount of information the physicians had provided 
did not correlate with the patients’ perception of how informative the physicians had 
been 27,28. Although moderate, there was a positive correlation between physicians who 
posed open-ended questions and their patients’ judgments to what extent their 
 physician had tried to involve them in the conversation 29.
While in cancer settings the effect on other patient outcomes has more extensively 
been examined, little is known about how the communicative behaviors of oncologists’ 
relate to their patients’ perceptions of the information and support provided 16,25,26,30-32. 
What is known is that patient satisfaction and their recall of information are improved 
when  physicians offer information and partnership but that they are adversely affected 
if the physician asks questions and conveys negative opinions (criticism and 
 disapproval) 16. With the present study we tried to extend these findings by evaluating 
the medical  information and support radiation oncologists offer their patients, as 
assessed with the Roter Interaction Analysis System (RIAS), and analyzing how their 
patients perceive these aspects.
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Patients and methods
 
Study site and subjects 
This study was part of a larger study investigating several aspects of patients’ 
 communicative participation in radiotherapy consultations, when radiotherapy was to 
be given for palliative or curative intent. The study was conducted at the Department of 
Radiation Oncology in an academic hospital center, where the 12 radiation oncologists 
(7 staff members and 5 residents) were invited to take part in the study.
Subjects were recruited from a consecutive series of newly referred patients from April 
2000 to May 2002. Patients were referred for radiotherapy after the diagnostic work-up 
for their malignant disease. The first radiotherapy consultation usually lasts 1 hour. 
Patients were asked to participate before the start of the consultation by their radiation 
oncologist , who briefly introduced the study. If a patient gave informed consent, the 
researcher (LMT) explained the study in more detail and provided written information 
and a quality of life questionnaire. The subsequent consultation was videotaped. 
Patients were not included if they were not literate in Dutch, were younger than 18 years, 
or had a life expectancy of less than 3 months.
Within 2 days after the first consultation, patients were asked about their perception of 
the oncologists’ behavior in a structured telephone interview and were also asked to 
complete the quality of life questionnaire. Treatment intent, tumor site, and patient 
demographics were obtained from the patients’ medical records. The Medical Ethics 
Committee of the academic hospital center approved the study.
Measuring communicative behavior
The videotapes were analyzed by means of the RIAS 33, and all utterances of the 
 radiation oncologists were classified into mutually exclusive content categories. The 
categories were adapted to our study and condensed into (sub-)clusters of categories 
19 (see appendix A for the (sub-)clusters used). Inter-coder reliability was satisfactory 
for all categories (mean reliability, 0.88 for all categories; range, 0.65 - 0.99) 19 .
Measurement of patients’ perception of radiation oncologists’ behavior
Two a priori scales were composed: the Perception of Medical Information scale with 
5 items, and the Perception of Personal Attention scale with 6 items. The 5 items of the 
Perception of Medical Information scale are: ‘My radiation oncologist provided me 
 information regarding’: ‘the diagnosis’, ‘the prognosis’, ‘the treatment procedures’, 
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‘the effect of the treatment on the cancer’, ‘the possible side effects’. The 6 items of the 
Perception of Personal Attention scale are: ‘My radiation oncologist’: ‘showed 
 understanding for my situation’, ‘provided medical information adapted to me and my 
questions’, ‘listened well to me’, ‘showed great expertise’, ‘examined me thoroughly’, 
‘was honest with me’. Patients indicated agreement with these statements on a 10-point 
Likert scale. On the Medical Information scale, 1 represents: ‘the radiation oncologist 
did not say anything about this subject at all’, and 10: ‘the radiation oncologist informed 
me extensively about this subject’. On the Personal Attention scale, 1 represents: ‘I do 
not agree with this statement at all’, and 10: ‘I fully agree with this statement’. The 
 internal reliability of both scales was satisfactory: Cronbach’s alpha was .72 for the 
Perception of Medical Information scale, and .85 for the Perception of Personal 
Attention scale. Both scales were moderately related to each other (Pearson’s product 
moment correlation .55).
Quality of life measurement
Quality of life was measured with the QLQ-C30, developed by the European 
Organization for Research and Treatment of Cancer 34. This questionnaire is a  self-rating 
instrument, comprising 30 questions organized into 15 scales. For this study, we used 
the Global quality of life scale (2 items) and the Emotional functioning scale 
(4 items) only For the Global quality of life scale, a 7-point linear analogue range is 
used. Before statistical analysis, the raw item scores are linearly converted to a 0-100 
scale, with higher scores representing a better level of functioning. In the present study, 
the Emotional functioning scale was divided into 2 subscales (tension and depressive 
mood) of 2 items, each of which were scored on a 4- point response scale, with higher 
scores indicating more tension or depression.
Statistical methods and coding
Frequencies of radiation oncologists’ utterances, scored with the RIAS, were counted 
per (sub-)cluster and the proportion of all utterances per cluster were calculated. 
Kolmogorov-Smirnov tests indicated that the distribution of radiation oncologists’ 
 utterances in the (sub-)clusters was non-normal. Therefore we calculated the median 
(with minimum and maximum) number of utterances per (sub-) cluster, and mean 
 proportion (with SD’s) of utterances per (sub)cluster.
Perception scale scores were obtained by calculating the means of the responses. 
Because the correlations between patients’ perception scales and radiation oncolo-
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gists’ communicative behaviors, which were coded as frequencies, may be  confounded 
by variation in the length of consultations, we analyzed the correlation between 
patients’ perception and the radiation oncologists’ absolute and relative contribution to 
utterances per (sub-)cluster, by calculating Pearson’s and Spearman’s correlation 
coefficients,  respectively.
Student’s t-tests were used to assess whether the perception scales were related to 
Table 1  Patients’ demographic and disease characteristics 
Patients (N) 173  
Age   
 Mean years (SD) 58.9 (13.5)
 Minimum 27.5
 Maximum 82.5
Gender  
 Male 47 %
 Female 53 % 
Accompanied by proxy 90 %  
Education
 Lower education (< 9 years) 54 %
 Middle and high education (≥ 9 years) 46 %
Treatment intent    
  Curative 53 %
 Palliative 47 %
Primary tumor location)    
  Brain 10 %
 Breast 31 %
 Gastrointestinal 7 %
 Head and neck 8 %
 Lung 14 %
 Urogenital 23 %
 Other tumors 7 %
 QOL 
 Global QOL (SD) scale 0-100 *  63 (24)
 Emotional functioning 69 (21)
  Tension (SD) scale 1-4 ** 1.8  (.6)
  Depressive mood (SD) scale 1-4 ** 2.0  (.7)
* higher scores represent better global quality of life 
** higher scores represent more tension or more depressive mood
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patient gender and treatment intent. Pearson’s correlation coefficients were calculated 
to assess the influence on the perception scales of patient’s age, years of education, 
 global quality of life, depression, and tension.
Hierarchical regression analyses were performed with all variables that were  significantly 
related to the perception scales in order to examine the relative contribution to the 
 variance in the perception scales.
All statistical analyses were carried out using the SPSS for Windows (version 12.0). 
Results
Study sample
The 12 radiation oncologists working in the Department of Radiation Oncology were 
asked to take part in the study. Eight agreed (three staff members and five residents). 
Reasons for non-participation were participation in another research project or too-
busy work schedule. The mean age of the eight participants (seven men) was 33 years 
(range = 26–58); they had a mean of 6 years of clinical experience (range = 1–28).
During the recruitment period, 224 consecutive patients were invited to participate in 
the study, of whom 206 agreed (92% accrual rate). Non-participating patients felt too 
ill (n = 6) or failed to give a reason (n = 12) for refusing. Complete video, interview, and 
EORTC-QLQ-C30 data were available for 173 patients. Patients with (n=173) or without 
complete data (n=33) did not significantly differ in terms of gender, age, treatment 
intent, years of education, global quality of life, tension, and depression (data not 
shown). Table 1 shows the demographic and disease characteristics of the 173 
 participating patients in the present study.
Observed communicative behaviors
During the 45-minute consultation, radiation oncologists expressed a mean of 481 
 utterances, about 59% of the total number of utterances per consultation. The patients 
with their proxies expressed the other 41% of utterances, with a mean of 311 utterances. 
Table 2 shows the median, minimum, and maximum numbers, and the mean  proportion 
(with standard deviation) of all radiation oncologist utterances, grouped by RIAS  sub-
clusters.
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Patient perception and radiation oncologists’ observed communicative behavior
The mean score on the Perception of Medical Information scale was 7.4 (range 2.2 -10, 
SD 1.55), and that on the Perception of Personal Attention scale was 8.2 (range 4.0 -10, 
SD 1.2). Correlations between the perception scales and the numbers of radiation 
 oncologists’ utterances were about the same as those between the perception scales 
and the proportions of radiation oncologists’ utterances. Therefore, only Pearson’s 
 correlations between perception scales and proportions of RO utterances are shown in 
Table 3.
Correlations between radiation oncologists’ communicative behaviors and the patient 
perception scales were low to moderate and many correlations did not reach the 
threshold of significance. Patients’ perception of the medical information provided was 
significantly correlated with the radiation oncologists’ provision of biomedical and 
 psychosocial information (.16 and .18 respectively). Patients’ perception of attention 
paid to them was significantly correlated with the radiation oncologists’ provision of 
psychosocial information (r =.28), close-ended biomedical questions (r = -.21), 
 
Information giving  Biomedical  157 39 572 35.9 10.9
  Psychosocial 14 0 102 4.4 3.6
Question asking Biomedical open  9 0 78 3.0 3.1
  Biomedical closed 26 0 131 7.3 5.2
  Psychosocial  13 0 42 3.1 1.7
Relationship building Positive talk 79 15 235 18.7 8.5
  Emotional talk - concern 3 0 54 1.1 1.3
  Emotional talk - support  25 3 103 6.0 2.9
  Negative talk 0 0 15 0.1 0.2
Decision making Information + questions 4 0 138 2.1 2.9
Facilitating  Participatory facilitators 27 8 129 6.4 3.0
  Procedural talk 51 9 178 11.9 4.6
Table 2  Median numbers (with minimum and maximum) and mean  
proportions (with Sd) of radiation oncologists’  utterances in the 
RIAS (sub-)clusters
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 psychosocial questions (r = 16), their expressions of concern (r = .19), and their critical 
remarks (r = -.15).
Patient characteristics and the perception scales
Patient’s gender, age, years of education, depressive mood, and treatment intent were 
not significantly correlated with scores on the Perception of Medical Information scale, 
whereas patients’ global quality of life and tension were (r = .21, p = .01, and r = -.20, 
p = .02, respectively). Patients reported having been given more medical information 
if they had a better global quality of life and if they felt less tense.
Patient’s gender, age, years of education, global quality of life, depressive mood, and 
treatment intent were not significantly correlated with scores on  the Perception of 
Personal Attention scale; however, patients’ tension was – the more tense patients 
were, the less they perceived the radiation oncologist to be paying attention to them 
(r = - .17; p= .03).
   Patient perception of  Patient perception 
   Medical Information  of Personal Attention 
Radiation oncologists’   Proportion of utterances Proportion of utterances 
behavior  r r 
Information  Biomedical .16 * .04
  Psychosocial .18 * .28 **
Questions Biomedical open .10  .10
  Biomedical closed -.11  -.21 *
  Psychosocial .02  .16 *
Relationship building Positive talk -.06  -.01
  Emotional talk - concern -.03  .19 *
  Emotional talk - support .03  .07
  Negative talk -.02  -.15 *
Decision making Info & questions .06  .07
Facilitating Participatory facilitators. -.09  -.10
  Procedural talk -.10  -.11
Table 3  Pearson Correlation coefficients between the patient perception 
scales and proportion of radiation oncologists’ utterances in  
RIAS clusters
* p < .05
** p < .01
82
C H A P T ER 4
Regression analyses
Multivariate hierarchical regression analyses were performed to study the relative 
 contribution of patients’ quality of life and radiation oncologists’ communication to 
 scores on the perception scales. The variables that correlated significantly with the 
 perception scales were selected for the hierarchical regression analyses.
In total, this model explained 8% of the variance in patients’ perception of medical 
 information: patients’ quality of life contributed 5%, and radiation oncologists’ behavior 
contributed 3%. Patients’ tension was the only single variable that contributed 
 significantly. Patients’ perception of personal attention was explained for 18%: patients’ 
tension contributed 3% and radiation oncologists’ behavior contributed 15%. The 
 proportion of the radiation oncologists’ psychosocial information, psychosocial 
 questions and negative talk contributed significantly.
  Patient perception of  Patient perception 
  Medical Information  of Personal Attention 
  Beta R 2  Beta R 2  
Patient QOL  .05 *  .03 *
   Global QOL .14    
   Tension .16 *  .16 * 
Radiation oncologists’ behavior  .03 *  .15 **
 Biomedical Information .09     
 Psychosocial Information .13  .23 ** 
 Biomedical Questions Closed   -.11 
 Psychosocial Questions   .15* 
 Emotional talk - concern   .12 
 Negative talk   -.18 * 
Total R 2  .08 *  .18 **
Table 4  Multiple regression analyses showing the perceptions scales  
as dependent and patients quality of life (QoL) and radiation  
oncologists’ communicative behavior as independent variables 
* p < .05
** p < .01
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Discussion
Summary and relevance of the current  findings
In the present study we investigated the relationship between the quality of the 
 communicative behavior of radiation oncologists and their patients’ perceptions of their 
physician’s conduct during their first consultation. In general, correlations were weak 
and largely influenced by the tension patients experienced. Although the content of the 
 clinicians’ communications varied considerably between oncologists and patients, 
most provided ample medical information and almost all covered psychosocial and 
emotional aspects. As to being given medical information and personal support, in 
general  the patient ratings correlated poorly with the oncologists’ behaviors as 
 assessed by the RIAS.
As the information and support clinicians provide are crucial to cancer patients 35, our 
findings have added relevant information as to what is essential in the consultation 
room. Numerous earlier studies had shown that in their contacts with their physicians 
the  cancer patients’ basic needs are often not satisfied 14,20-25. Yet, few studies had 
 analyzed the relationship between a physician’s communications and how cancer 
patients’ judge the information and support provided. Similar to our results, studies in 
other medical  settings had also found few or no correlations between the patients’ 
impressions of the visit and third-party ratings of the physicians’ conduct 27-29.
Street (1992) concluded that a patient’s perception of a medical visit mainly depends 
on the relevance and understandability of the information they receive, and less on the 
amount of information 27. Indeed, our patients’ low capture of the information may 
partly be attributable to such a lack of transparency and relevance. Most cancer 
patients are generally not familiar with radiotherapy, and, as a consequence, their 
 comprehension of the information and their estimation of what is relevant will often 
remain marginal 2-12. In addition to the amount of new and unfamiliar information our 
patients had to  assimilate, the relatively long duration of the consultation (about 45 
minutes) may also have played a part; it must have been very tiring for them trying to 
concentrate on absorb so many new and complex details. Moreover, most patients 
probably felt tense during this first consultation with a new specialist about another 
treatment proposal, which may also have hindered the way they processed the 
 information. Taken together, consultations like the ones we have described are 
 demanding for both the patient and the clinician, which may in part explain the low 
 correlations we found between the actual medical information the radiation oncologists 
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provided and the patients’ perceptions of its content and  relevance.
While the oncologists provided much less psychosocial information, this information 
was apparently perceived better by the patients. The oncologists’ contribution to 
 psychosocial information was associated with the patients’ perception of personal 
attention and  medical information. Thus if the physician presented the biomedical 
 information in  relation of the patients’ personal circumstances, it helped patients to 
recognize the  content and relevance of the biomedical information.
The influence of the questions oncologists asked on the patients’ perception of being 
paid attention varied. Close-ended biomedical questions and psychosocial questions 
were associated in opposite ways with patients’ perception of receiving personal 
 attention. Apparently, patients do not perceive their physicians’ close-ended  biomedical 
questions as showing interest, whereas they do perceive questions about psychosocial 
topics, about life circumstances, and about the impact of having cancer on daily life as 
being caring and showing interest. The opposite impact of the different physicians’ 
questions on patients’ perceptions was only detected by making a distinction between 
the form (open- vs. close-ended) and the content (biomedical vs. psychosocial) of the 
questions.
Radiation oncologists’ expressions of concern about the patient’s medical situation 
were positively related to patients’ perception of being paid attention. This finding 
 suggests that when oncologists discuss medical concerns (such as ‘I’m not sure we 
can get rid of the cancer. It is a very aggressive type.’), patients feel that the doctors 
take individual care about them. Remarkably, there was no association between 
patients’ perceptions and the oncologists’ supportive talk. Supportive talk was not 
 correlated with patients’ perception of personal attention or with their perception of 
receiving medical information. This is rather striking, since supportive talk is suggested 
to enhance patients’  conversational memory 36 and to reduce patients’ distress 37. An 
explanation might lie in how we coded the data. Due to the small frequencies of 
 utterances in the ‘Emotional talk’ categories, we coded ‘reassurance’, ‘empathy’ and 
‘legitimize’ in the ‘supportive remarks’ category. These type of utterances may have a 
different impact on patients and correlate in opposite directions with patients’ 
 perception of personal attention. The correlations between patients’ perception of 
 personal attention with ‘supportive talk’ might have been larger if we had coded the 
categories separately instead of in  combination.
Oncologists’ negative talk had a significant negative impact on their patients’  perception 
of personal attention. Here, we have to explain what we mean by ‘negative talk’. Severe 
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criticism or disapproval of the patient (like ‘You seem not willing to listen to me’) 
 occurred in none of the consultations. The oncologists’ negative expressions we heard 
in the consultations were mainly minor corrections (‘I did not say that I would arrange 
a taxi for you, my assistant will do that.’), and signals of friction or irritation (‘No, I can 
not start your treatment today; other patients also want to be treated as soon as 
 possible’, or: ‘You kept me waiting for half an hour!’). This kind of negative remarks 
seem rather innocent and were hardly made by the radiation oncologists, but they had 
a significant negative impact on their patients’ perception of personal attention. This is 
comparable to the negative impact of the oncologists’ negative talk on patient 
 satisfaction found by Ong et al. 16.
We believe that the impact of negative talk on patients’ perception of personal attention 
is a signal of the supreme importance for cancer patients of a caring relationship with 
their physicians. If their physicians talk with overt criticism or disapproval, these 
 utterances are probably immediately noticed by patients and might threaten their trust 
in their relationship with their physician. Moreover, these critical remarks do not occur 
in a vacuum; if the radiation oncologist makes a explicit critical remark, the whole tone 
of the interaction is probably affected.
Only patients’ tension, and to a lesser degree their global quality of life, was correlated 
with their perception of the oncologists’ communicative behaviors. This supports the 
findings of Rutter and colleagues who reported that cancer patients’ anxiety and 
 depression were more important than doctors’ communication in determining patients’ 
satisfaction with the consultation 26. The variance in patients’ perception of personal 
attention was predicted by patients’ tension, radiation oncologists’ psychosocial 
 information, and radiation oncologists’ negative talk.
The explicit impact of tension can be explained by several factors. First, because of the 
threatening nature of a diagnosis of cancer, most cancer patients are quite tense when 
discussing another treatment option with an unknown doctor 5,7,9. Second, many cancer 
patients’ (and many healthy people also) associate irradiation with toxicity and adverse 
side effects, and these negative cognitions may cause additional tension 1-3,7,9,12. 
In addition, tension interferes with the ability of patients to process information 38-40. 
Not surprisingly then, that patients’ tension had a negative impact on their perception 
of medical information or personal attention provided by the radiation oncologists.
The impact of the provision of psychosocial information by the oncologists can be 
explained by the role of patients’ distress and how the radiation oncologists affect it. 
If physicians try to relate the biomedical information they provide to the patients’ 
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 personal circumstances, patients may become less distressed and thus better able to 
take in the biomedical information provided. Provision of psychosocial information may 
help patients to become less stressed during the consultation and thereby increase 
their ability to retain information.
Our study had some limitations. Firstly, a quantitative instrument such as the RIAS 
measures communication in terms of the frequency or proportion of utterances; 
 however, the meaning of communication cannot fully be explained by isolated 
 utterances. Interactions, the use of expressions, and the association of a comment with 
the rest of the conversation cannot be evaluated only on the basis of the frequency or 
proportion of utterances 41-44. In addition, in the RIAS, all utterances in a category have 
the same weight whereas in a conversation the importance of what is said depends on 
its context; this means that not all biomedical utterances have the same intensity 41-44. 
Secondly,  although the interrater reliability of the separate RIAS categories was 
 adequate, condensing several categories into clusters of verbal communication might 
have reduced the  sensitivity of the instrument.
Thirdly, while patients’ perception of their physicians’ communication is important, 
 medical consultations in general, and those in oncology specifically, have several other 
important goals for physicians and patients, such as collecting information in order to 
create the optimal treatment plan, answering patients’ questions, providing information, 
facilitating patients’ participation, improving patients’ ability to cope with their disease, 
establishing a caring relationship, etc. In the present study, we focused only on 
patients’ perceptions of their oncologists’ communication, but physicians and patients 
do not focus on one goal, to the neglect of others.
Conclusion
Despite these considerations, our findings contribute to the understanding of cancer 
patients’ perceptions of their physicians’ communicative behavior. We found that the 
relation between radiation oncologists’ communicative behavior and patients’ 
 perception of being given medical information and personal support is, in general, not 
very strong and is influenced by patients’ tension. Patient tension adversely influences 
patients’ perception of their interaction with their physician but other factors not 
 investigated in this study may also have a role.
In addition, patients’ perception of their physicians’ communicative behavior is not 
 associated with general patient characteristics. Obviously, patients’ temporary needs and 
possibilities play an important role in their perception of their physicians’  communication.
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Practice implications
Physicians working with cancer patients are often insecure about how to communicate 
with their patients. Although they try to provide relevant and adequate information and 
support, they are aware that not all patients perceive this information and support. 
The results of the present study imply that in radiation oncology consultations, during 
which a lot of medical information is provided, the answer to patients’ desire for 
 information is not to provide even more biomedical information but to relate the medical 
information to the patients’ personal circumstances. By discussing the impact the 
 cancer and its treatment may have on patients’ lives, patients become more receptive 
to the medical information and support provided by their physicians, which improves 
the  processing of this information 38.
Physicians working with cancer patients can improve their patients’ perception of 
 communication by adapting to their patients’ tension, by paying attention to the 
patients’ psychosocial issues and life circumstances, by showing their concern about 
the patient’s situation, and by refraining from too many critical remarks.
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Abstract
Objective: 
The present research paper investigates how cancer patients’ monitoring and blunting 
coping styles are reflected in their communications during their initial radiotherapy
consultations and in their evaluations of the consultation. Additionally, it is explored 
how a patient’s disease status (curative versus palliative) influences the effects of his 
or her cognitive styles.
Methods:
The study included 116 oncology patients receiving treatment from eight radiation 
 oncologists. For 56 patients treatment intent was palliative and for the remaining 
60  curative. The patients’ communicative behaviors were assessed using the Roter 
Interaction Analysis System (RIAS). Within three days the patients completed a 
 monitoring and  blunting inventory and after another six weeks they evaluated the 
 treatment decision and treatment information by postal questionnaire.
Results:
Monitoring was positively and blunting negatively related to the patient’s expression of 
questions, emotions and decision-making issues. After six weeks ‘high monitors’ as 
opposed to ‘low monitors’ reported having more doubts about the treatment decision 
and being less satisfied with the information received while ‘high blunters’ expressed 
fewer doubts and more satisfaction than ‘low blunters’ did. Significant associations 
were all attributable to the palliative treatment group.
Conclusion:
Cancer patients’ communicative behaviors vis-à-vis their oncologist hinge on their 
 cognitive styles and an unfavorable disease status enhances the effects.
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Introduction
When being diagnosed with a serious illness like cancer, many people are  overwhelmed 
by fear and a sense of loss of control over their lives. They have to face a multitude of 
uncertainties such as the consequences of the disease, the burden of treatment, the 
prognosis and the chances of a full recovery. Moreover, the medical information they 
subsequently receive can be very threatening and thus increase their distress. 
The opposite can also apply when positive or reassuring new details will reduce their 
uncertainty by providing a clearer picture of what they can expect 1-3. Detailed 
 information may also help patients to understand and cope with events, to regain a 
sense of control and to participate actively in the consultations with their doctors and 
crucial  decision-making moments.
Cognitive coping styles: monitoring and blunting 
According to Miller, individuals can use two main cognitive coping styles in dealing with 
potentially threatening information in uncontrollable and unpredictable stressful 
 situations: monitoring and blunting 4,5. Monitoring is defined as ‘the tendency to seek 
threat-relevant information’, and blunting as ‘the tendency to cognitively avoid  threat-
relevant information and to seek distraction from threat’ 6,7. Although the styles are 
conceptualized as  opposite tendencies, Miller claims they are independent: individuals 
can use either at different moments 8.
Studies that have investigated the effects of the two coping styles in threatening 
 medical situations 5,9-17 demonstrated positive and negative effects for both, depending 
on the individual’s circumstances and the occasion. When facing a health threat, 
 monitors benefit from the elucidation of present and future health issues  (‘predictability’) 
and may take appropriate actions based on this new-found ‘controllability’ 7. Miller et al. 
17  developed an educational intervention to increase understanding of genetic testing 
for breast/ovarian cancer and reported that high monitors showed greater increases in 
knowledge and perceived risk over a 6-month interval than low monitors did. For high 
monitors, information might clarify their situation, enable them to attach appropriate 
meanings to experiences and to work through their experiences 6. However, they might 
also remain focused on the negative aspects, thus sustaining high arousal levels. 
Blunters, preferring distraction, relaxation and reinterpretation strategies, benefit from 
processing the aversive events in a less negative fashion, although uncertainty can 
remain high 6,18,19. Additionally, blunters risk developing pathological avoidance  behavior 
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due to their reluctance to confront the stressor 20.
As to medical consultations, high monitors appear not only to desire more extended 
information than high blunters, they also value kindness and respect by their doctors 
more 6. Pieterse and colleagues likewise found that high monitors set great store by 
medical information about what to expect as regards emotional consequences and 
their cohort tended to have high preferences for receiving emotional support 21. Also, in 
Miller’s 1995 study among patients with metastatic cancer, high monitors were less 
 satisfied with the information they received and with the psychosocial aspects of their 
care relative to low monitors. Remarkably, high monitors do seem to prefer a more 
 passive role in clinical decision making 12. 
In general, patients benefit from communication that is tailored to their cognitive coping 
styles: high monitors are less anxious if they receive ample medical information, 
 attention, and reassurance, while high blunters are content with basic medical 
 information and need little else 6,9,10,22-26. 
Most studies assessed patients’ coping styles by reported preferences and not by 
 behavioral indicators. As high monitors are defined as information seekers, it follows 
that they will ask their doctors more questions than low monitors, thus prolonging their 
 medical consultations. Miller et al. did investigate coping styles in children relative to 
their communicative behaviors but found no relationship between their monitoring or 
blunting styles and question asking 27. Ong and colleagues 16 did find monitoring to be 
positively related to their adult cancer patients’ question asking during the initial 
 treatment  discussion with their oncologists. Blunting, however, proved not associated 
with any aspect of the patients’ verbal communications. Evidently, patients’ coping 
styles and information seeking behavior warrant further scrutiny. 
Cognitive coping styles in cancer patients
Cancer can be characterized as an uncontrollable health threat, which puts monitoring 
patients at a disadvantage. Gard and colleagues 28 reported high monitors to show 
more distress and depressed feelings than high blunters prior to treatment initiation, 
and Lerman et al. 29 observed increases in general distress from baseline to follow-up 
in high monitoring women receiving individualized breast-cancer risk counseling. 
Moreover, during and after treatment, a higher proportion of the high monitors 
 experienced  unpleasant side effects from chemotherapy, such as nausea and  vomiting, 
and during longer periods, than the proportion of blunters who suffered from such 
problems 30.
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The patient’s specific disease status may also play a crucial role. Therefore, research 
into cancer patients’ coping styles should address the curability aspect. As expounded 
above, monitoring is helpful when problems can be resolved but less so in 
 unmanageable conditions, making blunting less appropriate in the first and the  superior 
style in the latter situation. Accordingly, high monitors would fare better than high 
 blunters when curable cancer types are involved whereas with incurable cancers high 
blunters might come more easily to terms with the only available option of palliative 
care. Patients with  incurable cancer will receive more inauspicious information than 
patients with curable cancer. Our recent study on communications during oncological 
consultations concerning either palliative or curative treatment intent furthermore 
 yielded significant differences in the patients’ communicative behaviors 31. Although 
most patients infrequently asked for information, the patients scheduled for palliative 
radiotherapy asked slightly more questions about their prognosis than those scheduled 
for curative radiotherapy 31. The question whether treatment intent differently affects the 
communications and  information evaluation of patient’s with a monitoring and blunting 
coping style merits further investigation. 
Aim of the present study
Accordingly, the aim of the present study was twofold. We first wished to investigate 
how monitoring and blunting are reflected in the communications of cancer patients 
during their initial radiotherapy consultation and in their subsequent evaluation of the 
 consultation. Second, we examined whether the patient’s disease status influenced the 
effects of their respective coping styles. We expected that high monitoring as opposed 
to low monitoring would be related to more patient questions and emotional utterances 
and a lower participation in decision making, and that high blunting would correlate 
with fewer patient questions and emotional verbalizations. Furthermore, since a 
patient’s communicative style affects the clinician’s, we predicted that consultation 
duration would correlate positively with monitoring, and negatively with blunting.
We also explored how patients would evaluate the treatment decision and the 
 information received during that initial consultation six weeks after the consultation 
hypothesizing that high monitors would rate the communication concerning these 
topics as less  satisfactory than low monitors would, and the opposite for blunters. 
Finally, in view of the greater threat inherent to palliative treatment, we examined 
whether correlations between coping styles and evaluative outcomes would 
 predominantly occur in the palliative  treatment group. 
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Methods 
Study site, subjects and procedure
The present study is part of a larger research project on communication in radiotherapy 
consultations in the Netherlands, which includes video recordings of patient-radiation 
oncologist consultations with both palliative and curative treatment intent. The study 
was approved by the Medical Ethics Committee of the investigating hospital.
All participants were recruited from a consecutive series of newly referred patients 
visiting one of the eight participating radiation oncologists in an academic hospital in 
The Netherlands between April 2000 and May 2002. At the start of the consultation, the 
radiation oncologist briefly described the study and invited the patient to participate. 
Excluded were patients who had an insufficient command of the Dutch language, were 
younger than 18 years or had a life expectancy lower than 3 months. If the patient 
agreed to participate, the researcher (LMT) was called in to explain the study in more 
detail and provide written information. Following the patient’s consent, the remainder 
of the  consultation was videotaped (T1). After the consultation, the patient received a 
 questionnaire on monitoring and blunting coping styles and was asked to send in the 
completed inventory within three days (T2). Subsequent curative (CRT) or palliative 
 radiation therapy (PRT) treatment intent and patient demographics were obtained from 
the patients’ medical records. 
Six weeks later, the participants received a postal self-report questionnaire to evaluate 
the treatment decision and information received during the initial consultation (T3). 
We opted for a 6-week follow-up because in most cases the radiation treatment is 
(nearly) completed then and patients have gathered sufficient experience with the 
 treatment to be able to reflect on it. 
Instruments and assessments
Monitoring and blunting coping styles were assessed using the Threatening Medical 
Situations Inventory (TMSI) 7,14,32. Based on Miller’s general concepts of monitoring and 
blunting 4,5, van Zuuren and co-workers developed the inventory to measure the coping 
styles specifically within the context of medical threats 14,32. 
The original version comprises four descriptions of threatening medical situations 
 varying with respect to the two important stress parameters with respect to the two 
important stress parameters in threatening situations: predictability and controllability. 
In the present study, we used the shortened version as validated by Ong and 
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colleagues 16 including the two highly unpredictable situations (‘choosing for uncertain 
heart  surgery’, and ‘vague, suspicious headache’).
Following each situation three randomly sequenced monitoring and three blunting 
 statements are to be judged on a 5-point Likert scale (1 indicating ‘does not apply to 
me at all’ and 5 ‘strongly applies to me’). The monitoring items pertain to three different 
aspects: (a) seeks information relating to the threatening situation (e.g. ‘I intend to ask 
the specialist as many questions as possible’), (b) thoroughly explores the situation by 
reading about it (e.g. ‘I intend to start reading about headaches), and (c) gains 
 information about the situation from other doctors, patients or organizations (e.g. 
‘I intend to contact patients who have the same problem, to get information’). The 
 blunting items cover two aspects: (a) seeks distraction away from the threatening 
 situation (e.g. ‘I intend to do as many pleasant activities as possible during the coming 
weeks’), and (b)  maintains an optimistic outlook (e.g. ‘I am thinking: it will turn out 
alright’) 16. Monitoring and blunting total scale-scores were calculated by adding up the 
relevant item scores (range for both scales: 6-30). We obtained a Cronbach’s a of .75 
and .79 for the  monitoring and blunting scale, respectively. The scales were  unrelated 
to each other (Pearson’s product moment correlation = -.07).
Patient communications were evaluated by the Roter Interaction Analysis System 
(RIAS) 33. The RIAS permits classification of all the speakers’ utterances into mutually 
exclusive content categories. The categories were adapted to our study and  condensed 
into (sub)clusters as shown in Appendix A, which also lists examples of utterances per 
subcluster. Inter-coder reliability was established as being satisfactory in the 
 radiotherapeutic context for all categories 34. Since we were (only) interested in relations 
between patients’ cognitive styles and their communicative behaviors, utterances of 
patients and proxies were coded separately. The duration of the consultations was 
measured in minutes. 
Patient evaluations of treatment decision were assessed by one statement to be rated 
on a 5-point scale (1-‘I totally disagree’ and 5-‘I totally agree’): ‘Looking at things after 
having undergone radiotherapy, I am in doubt about the treatment decision’.
Patient satisfaction with the information provision was gauged with four statements all 
to be appraised on 5-point Likert scales ranging from 1-‘I totally disagree’ to 5-‘I totally 
agree’: ‘Looking at things after having undergone radiotherapy, my radiation oncologist 
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provided sufficient information about… (1) the treatment procedures, (2) the possible 
side effects, (3) the physical impact of the treatment, and (4) the emotional impact of 
the treatment’.
Statistics
All statistical analyses were carried out using the SPSS for Windows (version 11.5). 
Relations were assessed of TMSI scales with some main person characteristics: 
 gender, age, and educational level. The relations between the TMSI scales and gender 
were assessed using Student’s t-tests, age by Pearson’s correlations, and educational 
level (< 9 years being classified as ‘low’, 9-14 years as ‘intermediate’ and >14 years as 
‘high’) by Chi-square tests. 
Based on their medical records patients were assigned to either a CRT or PRT  treatment 
group. Student’s t-tests were applied to assess TMSI between-group differences and 
to compute whether consultation duration was associated with the patients’ TMSI 
 scores and treatment intent. Spearman’s correlations were used to assess the relationship 
 between TMSI scale scores and the numbers of patient utterances to RIAS clusters. 
To assess the effects of monitoring and blunting on consultation duration, ‘high’ and 
‘low’ monitoring and blunting subgroups were composed using the respective median 
scores as cut-off scores. Spearman’s correlations were also used to assess the 
 association between TMSI scale scores and the patient ratings of the treatment 
 decision and information received. In addition, Spearman’s correlations were assessed 
for the curative and palliative treatment groups separately.
Results
Study sample
During the recruitment period, 206 of a total of 224 consecutively invited patients 
agreed to participate (92% accrual rate). Non-participating patients indicated feeling 
too ill  (n = 6) or failed to give a reason (n = 12) for refusing. Due to technical problems, 
16 video recordings were incomplete, leaving 190 complete video recordings. Seventy-
four patients failed to return the T3 questionnaire. Thus, at T3 full video recordings and 
both questionnaires were available for 116 patients (61%), i.e., 60 CRT and 56 PRT 
patients. The participants whose T3 data were incomplete did not differ on treatment 
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intent, gender or age from the other participants but their educational level was 
 significantly lower (χ2 = 19.7, p = .00). Table 1 shows the patient demographics and 
disease status of the final sample. No differences were found in age, gender, and 
 educational level between patients coming for CRT or for PRT. 
The mean score for the monitoring scale was 16.5 (SD 4.7, range 7-30) and 19.5 (SD 
4.5, range 9-30) for the blunting scale. There was no CRT-PRT group difference for 
cognitive styles (monitoring: t = .02, p = .98; blunting: t = .32, p = .75). Control for 
potentially confounding variables also did not reveal any significant cognitive -style 
differences between male and female patients (monitoring: t = .44, p = .66; blunting: 
t = .37,  p = .71), nor were cognitive styles related to age (monitoring: r = -.12, p = .21; 
blunting: r = -.08, p =.36) or years of education (monitoring: r = -.05, p =.58; blunting: 
r = -.16, p = .13). 
Monitoring-blunting associations with patients’ communicative behaviors
Table 2 illustrates that patients’ monitoring style was positively related to the amount of 
patients’ psychosocial information, the number of biomedical questions and the 
Table 1  demographics and disease status of the cancer patients  
Patients (N) 116  
Age   
 Mean age in years (SD) 59 (13)
 Minimum 33
 Maximum 83
Gender  
 Male 51%
 Female 49% 
Accompanied by proxy 88%  
Education
 Lower education (< 9 years) 44%
 Intermediate (9-14 years) 33%
 High (> 14 years) 17%
Treatment intent   
  Palliative 56 (48%)
 Curative 60 (52%) 
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 emotional utterances they expressed. Monitoring was also positively related to active 
decision making: high monitors used more utterances to express their consent to the 
treatment proposal and asked more questions about alternative treatments or 
 abstention from treatment. 
Subsequent detailed analyses revealed a significant correlation between monitoring 
and question asking in the PRT group (r = .31, p = .01) but not in the CRT group (r = 
.19, p = .09), and a similar pattern was found for the relation between monitoring and 
 expressions of emotions (PRT group: r = .39, p = .00; CRT group: r = .08, p = .29). 
Associations between monitoring and decision-making involvement were comparable 
for the two treatment groups.
Consistent with our expectations, blunting was negatively related to question asking 
and emotional talk (Table 2). The higher their blunting score, the fewer (biomedical and 
 psychosocial) questions patients asked and the fewer emotions they expressed in the 
consultation. Blunting was also negatively related to amount of patients’ biomedical 
information and their expressions regarding treatment consent
   Monitoring Blunting
   n=116 n=116
Information giving Biomedical  .06 -.20 *
  Psychosocial .17 * -.03
Question asking Biomedical  .21 * -.21 *
  Psychosocial  .01 -.20 *
Relationship building Positive talk .05 -.18 *
  Negative talk .05 -.09
  Emotional talk .23 * -.21 *
Decision making Consent to treatment  .27 ** -.19 *
  Questions refraining  
  or alternative treatments .21 * -.10
Facilitating Participatory facilitators .11 -.17 *
  Procedural talk .07 -.07
Table 2  Spearman correlations between monitoring-blunting and patient 
communication 
* sign < .05
** sign < .01
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Detailed analysis revealed a significant correlation between blunting and question 
asking for the PRT group only (PRT: r = - .29, p = .02; CRT: r = - . 15, p = .09) and a 
similar pattern was found for expressions of emotions (PRT: r = - .30, p= .01; CRT (r = 
.08, p = .24). The correlations between blunting and decision making utterances were 
about the same in both groups.
Monitoring-blunting associations with consultation duration
Mean duration of the consultations was 40 minutes (range 12-80 min, SD 14 min). 
As expected, overall, the consultation duration was positively related to monitoring 
(r =.26, p =.00) and negatively to blunting (r = -.27, p =.00).
For the CRT patients consultation duration was similar for high and low monitors 
(approx. 40 min, t = .85 p = .40), but high blunters had significantly shorter 
 consultations than low blunters (36 vs. 46 min; t = -3.0 p = .00). Hence, in CRT 
 consultations blunting affected consultation duration but monitoring did not. In the PRT 
group, high monitors had significantly longer consultations than low monitors (46 vs. 
37 min; t = 2.1 p = .04) whereas no difference was found between high and low 
 blunters (both approx. 41 min; t = -1.1 p = .28). In PRT consultations it was monitoring 
that influenced the duration in the expected direction whereas blunting did not. 
Monitoring-and blunting associations with patient evaluations of the consultation 
Table 3 shows that in the CRT group monitoring and blunting were positively related to 
the patients’ doubts about the treatment decision at T3. Monitoring was negatively 
 associated with evaluations of procedural information provision and the emotional 
impact of the treatment while blunting showed no significant correlations with these 
items. This implies that in the CRT group monitors and blunters with high scores 
 expressed more doubts about the treatment decision and that high monitors evaluated 
the received information as less satisfactory. In the PRT group monitoring was  positively 
and blunting negatively related to the patients’ doubts about treatment decision. 
Monitoring also proved negatively related to 3 of the 4 information items whereas 
 blunting was positively related to all information items. Thus, the higher their scores for 
monitoring, the more doubts PRT patients had about the treatment decision at T3 and 
the less they evaluated the received information as sufficient. Inversely, the higher their 
scores for blunting, the fewer doubts PRT patients expressed about the treatment 
 decision and the more they evaluated the received information as adequate.
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Discussion and conclusions
Discussion
Our study was set out to test the relationship between cancer patients’ monitoring and 
blunting coping styles and their communicative behaviors during their initial radio-
therapy consultation and, six weeks later, their evaluation of the information they had 
received during the consultation. Overall, the results show a salient impact of cognitive 
styles on communicative behaviors as well as on evaluations of the information 
received. Furthermore,
our distinction between patients with a curative and those with a palliative treatment 
status proved highly informative and promising. 
Based on the literature we expected that monitoring would be positively related to the 
amount of questions because seeking information might reduce the patients’ 
 uncertainty about their situation, which is what high monitors need 4,6,7. Ong and 
 colleagues indeed found that the patients’ monitoring style was positively related to 
their question asking 16. We found a similar association, i.e. for the palliative but not for 
  CRT  PRT 
  Monitoring Blunting Monitoring Blunting
  T3 T3 T3 T3  
Evaluation treatment decision:
 Doubts about decision .25 * .29 * .33 ** -.27 *
Satisfaction with information received:    
 Treatment procedures -.22 * .02 -.24 * .33 **
 Side effects -.10 .07 -.34 ** .34 **
 Physical impact treatment -.12 .04 -.22 * .26 *
 Emotional impact treatment -.23 * -.06 -.11 .28 *
Table 3  Spearman correlation coefficients between CRT- and PRT-patients’ 
monitoring and blunting styles and their evaluations of treatment 
decision and information provision at 6-weeks (T3) 
* p < .05
** p < .01
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the curative group. Apparently, in patients scheduled for palliative treatment a 
 monitoring style enhances their search for reduction of uncertainty. 
As high monitors were found to desire more emotional support from their doctors than 
low monitors do 6,21, we expected a positive relationship between monitoring and 
 emotional talk. Interestingly, whereas Ong and colleagues found no such association 
16, we did, but, again, only for the palliative group. Note that Ong and colleagues made 
no distinction between palliative and curative care patients 16. Apparently, high monitors 
do not simply express more emotions than low monitors do, but they mainly do so when 
the situation is highly threatening and distressing.
As regards involvement in clinical decision making, Miller observed that high monitors 
preferred a more passive role than low monitors, emphasizing that high monitors 
 primarily need reduction of uncertainty, and that they, therefore, would be more inclined 
to yield control to another, more competent individual (i.e. the doctor) than low monitors 
would 12. Yet, consistent with Ong and colleagues 16, we found a positive relationship 
between monitoring style and the patients’ participation in the decision-making 
 process. Possibly, treatment setting may help to explain the disparity in findings. 
Miller’s study took place in a primary-care setting whereas Ong’s and the present 
 investigations were conducted in an oncological setting. In primary care, patient-
 physician contacts often concern a first consultation about a recent complaint. For high 
monitors, the consequent lack of relevant experiences might have contributed to an 
initial preference for a more passive decision-making role. Cancer patients, in contrast, 
have already received ample medical information prior to entering the treatment 
 setting. Their having had time to adjust to the idea of having cancer might now 
 contribute to a propensity to play a more active  decision- making role. Additionally, 
whereas Miller 12 and Ong et al. 16 investigated  relationships between monitoring and 
patient  preferences, in the present study we  examined monitoring relative to patients’ 
actual communicative behaviors. Apparently, a distinction is warranted between a 
patient’s wish to yield  decision-making control to  clinicians and patient behavior (e.g. 
asking questions and participation to decision-making) to lessen uncertainty. 
Because blunting entails the tendency to cognitively avoid threat-relevant information 
6,7, we assumed that, during the initial consultation, blunting would be inversely related 
to the amount of patient queries and emotional talk. Our high blunters indeed asked 
fewer questions and expressed fewer emotions than low blunters did, but once again, 
solely in the palliative group. Ong et al. 16 found no relationship between blunting and 
patient  communicative behaviors, but, as suggested earlier, this may be due to 
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 differences in the patient samples. A blunting style, then, does not simply curb a 
patient’s questions and emotional talk, it mainly does so in case of palliative treatment, 
i.e., in highly  threatening circumstances.
Although during the initial radiotherapy consultation the radiation oncologist and 
patient generally need to discuss many details about the disease, the proposed 
 treatment and the patient’s personal circumstances, which is inherently time-
 consuming, our study shows that the length of the dialogue also depends on the 
patient’s cognitive style. As hypothesized, we found that monitoring prolonged and 
blunting shortened the  consultations. Interestingly, in the curative consultations it was 
blunting that influenced the duration and not monitoring and this was the reverse in the 
palliative consultations. The differences in mean duration were considerable, 
 approaching 10 minutes. This cannot be solely attributed to the differences in the 
patients’ part in communicative behaviors, but it does indicate that their cognitive 
styles did also affect the radiation oncologist’s amount of verbal expressions. On the 
basis of consultation durations it seems that, when curative therapy was discussed, the 
radiation oncologists provided ‘standard’ information and its content seems to have 
been inhibited by the patient’s blunting style but was not enhanced by a monitoring 
style. In discussing palliative  treatment, the radiation oncologists were more likely to 
convey the ‘standard’ information even if the patients asked few questions and 
 expressed few emotions. Here,  communications were enhanced by a patient’s 
 monitoring style (i.e., the radiation  oncologists conveyed more than the ‘standard’ 
information), but were not inhibited by a patient’s blunting style (i.e. the radiation 
 oncologists did not provide less than the ‘standard’ information).
At the 6-week follow-up assessment our patients had all undergone radiation treatment 
and were able to compare their experiences with the information received during the 
initial consultation. Miller 12 reports high monitors with metastatic cancer to be less 
 satisfied with the information received and the psychosocial aspects of their care than 
low monitors. We accordingly expected monitoring to negatively affect and blunting to 
 positively affect the patients’ evaluations. Confirming our expectations, high monitoring 
was related to more dissatisfaction with the information provided in both patient 
groups. In a genetic counseling setting, similar results were found by Nordin 35. 
Although during the consultation, high monitors gave significantly more often their 
consent to the  treatment proposal, six weeks later they elicited more doubts about the 
treatment  decision, in both groups. The effects of blunting were mainly restricted to the 
palliative group where high blunters showed less doubts and more satisfaction, 
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 indicating that an avoidant information-processing style occurs predominantly in 
highly threatening  situations.
We wish to add some limitations to the above results and interpretations. Firstly, the 
 correlations found were all moderate to small, implying limited percentages of explained 
variance in communicative behaviors and satisfaction with information. Secondly, with 
regard to disease status, we assumed that information in palliative consultations is 
more threatening than information in curative consultations, which, of course, is a 
 simplification of the patients’ reality. Clearly, the message that no curative treatment 
can be offered will be a very  threatening one for most of the patients, but some patients 
in the palliative group had been aware of their unpropitious prognosis for quite some 
time and they may thus not have been overly perturbed by their radiation oncologist’s 
observations. Conversely, some patients in the curative group may have been  extremely 
relieved upon hearing that a cure seemed possible whereas for some others having 
been diagnosed with cancer had remained extremely threatening in itself. 
Thirdly, we argued that the higher levels of questions found for high monitors who are 
receiving palliative care reflect a desire to reduce uncertainty. However, while the 
 palliative care situation is clearly very distressing, one could argue that these patients 
actually have lower levels of uncertainty because they know that the treatment will 
 certainly not cure their cancer. On the other hand, the certainty to die from this cancer 
will raise several other, more existential, uncertainties, like: ‘How will I die?’, ‘Will I have 
much pain?’ , ‘How long will it take?’, etc. Moreover, it might be possible that patients 
are not completely convinced that they will not be cured, thereby making the situation 
 uncertain in their own minds. 
Fourthly, although monitoring and blunting had affected the patients’ evaluations of the 
received information six weeks after their initial consultation, we did not assess what 
this meant for their well being. We can, therefore, not conclude that for palliatively 
 treated patients, for instance, blunting is favorable and monitoring unfavorable. We do 
not know whether the perception that the information was insufficient increased the 
patients’  distress or whether it enhanced their coping capacity. Although confrontation 
with  threatening information might be distressing, it might at the same time stimulate 
 emotional processing 36.
Lastly, our measure of patient evaluations of treatment decision (‘Looking at things 
after having undergone radiotherapy, I am in doubt about the treatment decision’) 
might have been ambiguous in whether it is measuring patients’ doubts about the 
decision process or patients’ satisfaction with decision outcome.
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Conclusion
We found cancer patients’ cognitive styles to influence their communicative behaviors 
during the initial dialogue with their radiation oncologist. The stronger a patient’s 
 monitoring style, the more questions, emotions, and decision-making issues he or she 
expressed and the longer the consultation and more explicit the radiation oncologist’s 
explanations became. Six weeks after the initial the high monitors nevertheless proved 
more in doubt about the treatment decision and more dissatisfied with the information 
received than the low monitors.
The more pronounced a patient’s blunting style, the fewer his or her questions, 
 emotional talk, and decision-making issues and the shorter the consultation and 
 radiation  oncologist’s clarifications were. But, although blunting curtailed the exchange 
of  information, at six weeks blunting proved related to fewer treatment-decision 
 misgivings and to a higher contentment with the initial information.
Remarkably, all significant correlations between cognitive styles on the one hand and 
communication patterns and consultation evaluations on the other hand were due to 
the palliative-treatment group. For consultation duration there was an interesting 
 interaction between coping style and disease status: monitoring increased the duration 
of palliative consultations whereas blunting tended to decrease the duration of curative 
 consultations. Obviously, the oncologists adapted their communication styles to the 
needs of their patients when necessary and feasible.
Our findings regarding the monitoring coping style largely support the existing theory 
and earlier results and our findings regarding blunting fully corroborate current 
 theoretical notions about the concept. Moreover, by their power, the results for blunting 
have expanded our understanding of the impact of this cognitive style. Apparently, it 
requires the threat of a palliative treatment setting to activate and boost a patient’s 
blunting style.
Our results have several implications for the clinical practice. When dealing with cancer 
patients, health professionals should be sensitive to individual differences in  information 
needs. It may be opportune to explicitly gauge patients in advance on their  preferences: 
‘Do you generally think ‘I want to know every detail’ or do you tend to say ‘I’ll will just 
see what is going to happen’? The answer might be a first indication of the patient’s 
cognitive style. Additionally, health professionals should bear in mind that providing 
extensive information is no guarantee for patient satisfaction.
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Abstract
Objective: 
Several studies have shown that patients’ active participation to their medical  interaction 
is beneficial for their information processing and their quality of life. Unfortunately, 
cancer patients often act rather passively in contact with their oncologists. We  investigated 
whether cancer patients’ participation in radiation therapy consultations could be 
 enhanced by specific communicative behaviours of the radiation oncologists (ROs). 
Methods:
Eight ROs and 160 patients participated; 80 patients in the pre training group, and 80 
patients in the post training group. The ROs were trained to use specific communicative 
behaviours that are supposed to encourage patient participation. In the training special 
attention was paid to communicative requirements in the first minutes of the 
 consultation. The communicative behaviours of the ROs and the cancer patients were 
measured by the Roter Interaction Analysis System, and compared before and after the 
RO training.
Results:
From the start throughout the entire consultation, patients in the post training group 
 participated more in interactions than patients in the pre training group -: they 
 discussed more psychosocial issues, expressed more concerns and contributed more 
to decision-making. 
Conclusion:
Cancer patients’ participation in the initial radiation oncology consultations can be 
 increased by training of ROs.
Practice implications:
The results suggest that doctors working with cancer patients should receive 
 communication training and feedback on a regular base.
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Introduction
Since many years, we know that patients who actively participate in interactions with 
their physicians generally obtain more information than patients with a more passive 
attitude 1-4. In addition, the received information is also understood and remembered 
better by active patients 2-4. Moreover, participation in medical interactions can help 
patients to cope better with their illness and treatments, and might help them to reduce 
their  anxiety 4,5. Unfortunately, cancer patients often do not participate actively in their 
medical  interactions, and seem to wait if their doctors provide the information they 
desire 6. Patients’ participation is often measured by the number of questions patients 
ask 4,6-11, or by assessment of their contribution to the conversation 12, their expression 
of concerns 10,13, their discussion of experiences with the illness 14, their agenda setting 
talk 15, and last but not least, by their involvement in the treatment decision making 16-18. 
In radiation oncology consultations preceding palliative radiotherapy, we found that the 
patients’ participation mainly consisted of describing their disease experiences and 
their life circumstances 19. Their participation in terms of asking questions, expressing 
 concerns, discussing their agenda and contributing to decision-making was rather low. 
A study with non-cancer patients showed that patient participation was enhanced by a 
brief communication training for doctors 20. There are indications that cancer patients 
can also be encouraged to participate more actively by specific communicative 
 behaviours of their health professionals’, such as asking psychosocial questions, 
 limiting closed biomedical questions, asking more open biomedical questions, 
 enquiring about patients’ concerns, expressing empathy and involving explicitly the 
patient in treatment decision making 14,21. 
In stimulating patients to participate in the interaction, not only the content of the 
 communication is important, but also at what phase the stimulating behaviour is applied 
22. Inviting a patient to participate after a lengthy biomedical interrogation is bound to 
fail.  To stimulate patient participation, an inviting start of the consultation is as critical 
as the content of the entire consultation 23,24. In a previous study, we found that a higher 
number of close ended questions by the physician in the first 5 minutes of the 
 consultation was negatively  related to patients’ psychosocial talk, emotional talk, and 
questions about the treatment in the entire consultation 25. 
Several studies showed that health professionals working with cancer patients can be 
trained to manifest specific communicative behaviours in their consultations 26,27. Some 
studies assessed training effects on oncologists’ self-reported behaviour 28,29, while 
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other studies assessed health professionals’ behaviour in interactions with simulated 
patients 26,30, or with real cancer patients 27,31,32. To our knowledge, however, the effect of 
oncologists’ communication training on cancer patients’ participative behaviour has 
not yet been reported. 
The aim of the present study was to examine whether patients in the intervention 
 consultations participated more actively in the first minutes and in the entire 
 consultations than patients in regular-care consultations. We designed an intervention 
in order to help the radiation oncologists (ROs) to apply the wanted communicative 
behaviours.  The intervention consisted of training and individual guidance of the ROs. 
In developing the intervention, we focused on the specific behaviours shown to 
 stimulate patient  participation and paid attention to help the ROs to invite their patients 
to participate right from the first minutes of the consultations 13,14,21,22,24,27,32,33. 
Methods
Study site, subjects and design
This study was part of a larger study investigating several aspects of patients’ 
 communicative participation in radiotherapy consultations with palliative and with 
 curative treatment intent before and after a training session for the ROs. The study was 
approved by the Medical Ethical Committee of the University Medical Centre 
St Radboud Nijmegen, the Netherlands. In the present paper, data will be reported on 
ROs’ and patients’  communicative behaviours before and after training of the ROs. 
The study was  conducted at an University Medical Centre, where the 12 ROs working 
in the Department of Radiation Oncology (7 staff members and 5 residents) were 
 invited to take part in the study. Eight agreed, 3 staff members and 5 residents. The 
other 4 ROs were unavailable for our study, due to other research projects or their 
 working schedules. The mean age of the 8 participating ROs was 33 years (range = 
26–58), with 6 mean years of  experience (range = 1–28). 
Patients were recruited from a consecutive series of newly referred patients from April 
2000 – May 2002 and asked to participate before the start of the consultation by their 
RO, who briefly described the study. If a patient was willing to participate, the  researcher 
explained the study in more detail and provided written information. The subsequent 
consultation was videotaped after receiving patient consent. Treatment intent, tumour 
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site and extent and demographic characteristics were recorded from the patients’ 
charts. Patients were not asked to participate if unable to speak and read Dutch, under 
the age of 18 years or having a life expectancy less than 3 months.
Before the communication training started, 10 videotaped consultations per RO were 
required. After the training was completed, a second group of at least 10 consultations 
per RO was included. 
During the recruitment period, a total of 224 consecutive patients were invited to 
 participate, 119 pre, and 105 post training. In the pre training group, 11 patients refused 
to participate, and 9 video recordings were incomplete, resulting in 99 pre training 
 consultations, 55 consultations with discussion of curative treatment, and 
44  consultations with discussion of palliative treatment. In the post training group, 
Figure 1  Inclusion procedure
PRE TRAInInG
119
eligible patients
108
participants 
99
consultation
video’s available
PoST TRAInInG
55
curative
44
palliative 
105
eligible patients
98
participants 
91
consultation
video’s available
51
curative
40
palliative 
11 refused:
 4 felt too ill, 
 7 gave no reason
40
curative
40
palliative
40
curative
40
palliative
Pre training:
80 patients
Post training:
80 patients
Inclusion of consecutive consultations up to n=40
 7 refused:
 2 felt too ill, 
 5 gave no reason
9 failed video’s 7 failed video’s 
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7 patients refused to participate, and 7 video recordings were incomplete, resulting in 
91 post training  consultations. In 51 consultations curative treatment was  discussed 
and in 40  consultations palliative treatment.  
To obtain an equal number of consultations with palliative and curative treatment intent 
in the pre and post training groups, we included consecutive consultations with 
 comparable treatment intent in the pre and post training groups. Since the post training 
group contained 40 consultations with palliative treatment intent, in both study groups 
 40 palliative and 40 curative consecutive consultations were included (2 x 80 
 consultations). (See Figure 1 for a flowchart of the inclusion process). 
Intervention
The intervention comprised four components: I. training the ROs in specific 
 communicative behaviours by plenary sessions and II. individual oral feedback; III. a 
brief guideline in the patient file as a reminder of the trained behaviours, and IV. after 
each included  consultation, the ROs received a checklist of guideline related  behaviours 
completed by the researcher present at the consultation. 
I. The training comprised two 3-hour plenary sessions, which were guided by an 
 experienced communication trainer (KvS). The sessions focused on the ROs’ learning 
communicative behaviours intended to facilitate patient participation 13,14,21,27,32. 
The trained behaviours are: 1. Discuss agenda setting, 2. Investigate patient’s medical 
and psychosocial status quo, 3. Explore patient’s ideas about the diagnosis,  prognosis, 
and implications of radiation therapy, 4. React supportively to the patient’s story, 5. 
Start the medical history with open questions, 6. Give information about diagnosis, 
prognosis, treatment intent, and emotional impact of the treatment, 7. Discuss  treatment 
decision and request patient’s consent (see Appendix 1 on page 125). The ROs were 
asked to apply the first 3 items in the initial minutes of their consultations, while the 
order of the other items was left to each individual RO. Item 4, ‘React supportively to the 
patient’s story’, was to be expressed for the duration of the consultation if appropriate. 
In the two plenary training sessions, the trainer explained the ROs the rationale behind 
the communicative behaviours that were trained and the supposed impact on patient 
participation. This was followed by a group discussion and the ROs practiced the 
 specified communicative behaviours with trained patient simulators. 
II. The ROs were asked to apply the trained behaviours in real patient consultations that 
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were videotaped. The video’s were used for individual feedback sessions with the 
 communication trainer on the RO’s use of the trained behaviours. This was repeated 
three times for each RO; three 1-hour sessions with oral feedback on three different real 
patient consultations. So each RO attended the 2 plenary training sessions and 
received 3 times individual feedback on real-patient consultations, Data on that 3  real-
patient consultations have not been used in the present study.
Then, the ROs were asked to apply the trained behaviours in consultations with another 
group of participating patients. 
III. Before a consultation was videotaped, a brief guideline with the wanted behaviours 
was placed in the patient’s medical file.
IV. After each videotaped consultation, the RO received a checklist that summarized 
the manifestation of guideline related behaviours during the consultation. These check-
lists were filled in by the researcher present at the consultation. 
Measuring communicative behaviours
We analyzed the verbal communicative behaviours in the videotaped consultations 
using the Roter Interaction Analysis System (RIAS). The RIAS permits classification of 
all RO and patient utterances into mutually exclusive content categories. The  categories 
can be condensed into clusters or subclusters of categories 34. Based on the results of 
our previous studies on radiotherapy consultations, some adaptations were made in 
the RIAS in order to analyze communication on topics relevant to our studies 18,19 (see 
Appendix A on page 164-165 for the (sub-) clusters used). Inter-coder reliability was 
satisfactory in all  categories (mean reliability, 0.88 for all categories; range, 0.65 - 0.99) 
19. Utterances by accompanying proxies were added to patients’ utterances.
To assess whether the intervention enhanced ROs’ use of the trained behaviours in the 
first minutes and in the entire consultation, we measured the frequencies of utterances 
in the categories corresponding to the trained communicative behaviours. To assess 
the frequencies of the 3 communicative behaviours that had to be implemented in the 
initial minutes of consultations, we analyzed the first 100 utterances, which in most 
 consultations reasonably approximates 5 minutes of talking. To assess the 
 implementation of the trained behaviours in the entire consultations, we measured all 
utterances of the ROs during the consultations. 
To answer our research question whether patients participated more actively in the first 
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minutes and in the entire consultations in the post training consultations than in the pre 
training – consultations, we selected the following items as indicators of patient 
 participation: patients’ relative contribution to their consultation, their contribution to 
agenda setting, provision of information of their ideas about diagnosis and prognosis, 
provision of psychosocial information, expressions of concerns, biomedical questions 
and their contribution to decision making. We compared the frequencies of patients’ 
utterances in these categories in the pre training consultations with frequencies in the 
post training consultations. 
Statistical methods and coding
Data were analyzed using the SPSS (version 11.5). Student’s t-tests and chi-square 
tests were used to compare patient characteristics in the pre and post training groups. 
Frequencies of utterances as observed with the RIAS were counted per speaker per 
category. Kolmogorov-Smirnov tests indicated that there was a non-normal distribution 
in almost all categories. Therefore, we present the median and range of the number of 
utterances per selected category and used the non-parametric Mann-Whitney-U test to 
compare the number of utterances in categories in the pre - and post training groups. 
We do not present the relative contribution of speakers to the RIAS categories because 
an increase in the relative contribution in one category always means a decrease in the 
relative contribution in another. We were interested in an increase in the number of 
 utterances in categories corresponding to the communicative behaviours for which 
 training had been provided. 
Because several patients of the same ROs were included, we will control for he amount 
of nesting ‘within’ ROs, by calculating intraclass correlations coefficients for the 
 selected outcome measures. In case of significant intraclass correlations coefficients, 
multilevel analysis will be performed.
To assess whether the intervention influenced the duration of consultation, we  assessed 
the mean consultation duration in both groups. 
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Results
Study sample
Table 1 gives patients’ demographic information and disease characteristics. 
Posthoc comparisons of the distribution of consultations over the ROs, patient gender, 
proxy accompaniment did not reveal any differences between the groups. All intraclass 
correlations coefficients were non-significant indicating that the variance in 
communicative behaviours between the ROs was very small and the 160 consultations 
are considered as independent observations.
Table 1  Patients’ demographic and disease characteristics in  
pre and post training groups
  Pre training group Post training group P-value
Patients (N) 80 80  
Age    
 Mean years (SD) 58.9 (13.5) 58.4 (12.2) .80
 Minimum 32.3 27.5 
 Maximum 82.5 82.7
Gender    
 Male 43% 52% .27 
 Female 57% 48%
Accompanied by proxy   91% 89% .79 
 Treatment intent
 Curative 50% 50% .53
 Palliative 50% 50%  
Primary tumour location   .44 
  Brain 10% 10%
 Breast 30% 32%
 Gastrointestinal 4% 10%
 Head and neck 11% 5%
 Lung 10%  15%
 Urogenital 25% 21%
 Other tumours 10% 7%
* Higher scores represent better QOL 
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ROs’ communicative behaviours in the pre and post training consultations 
To assess whether the intervention was effective in changing ROs’ communication 
towards the use of more patient participation facilitating utterances, we compared ROs’ 
communication in the pre and post training consultations. Table 2 shows the median 
and range of ROs’ utterances in the trained communicative behavioural categories in 
the first hundred utterances and in the entire consultations. In the first hundred 
 utterances, the ROs expressed approximately the same number of utterances on 
agenda setting and on questions about the prognosis in both consultation groups. In 
the post training group, they provided more utterances to questions about  psychosocial 
aspects, to questions on the diagnosis, and to supportive remarks. 
In the entire consultation, the ROs also made more supportive remarks post training 
than pre training. In the post training group, they asked less closed biomedical 
Table 2  Median (and range) of Ros’ utterances in targeted categories  
in pre and post training  groups 
   Pre training group  Post training group 
   Mdn Range Mdn Range
First 100 utterances      
 Agenda setting  5.0 (0 - 16)  7.5 (0 - 29)   
 Question asking, Psychosocial  1.0 (0 - 10)  4.0 (0 - 16)  **
 Question asking, Biomedical, diagnosis  0.0 (0 - 1)  0.0 (0 - 6)  **
 Question asking, Biomedical, prognosis  0.0 (0 - 0)  0.0 (0 - 1)   
 Support  1.0 (0 - 10)  2.0 (0 - 12)  **
Entire consultation                    
 Support  20.5 (3 - 103)  26.0 (7 - 82)   *
 Question asking, Biomedical, closed general  33.0 (0 - 131)  19.0 (0 - 113)  **
 Question asking, Biomedical, open general  4.0 (0 - 57)  15.5 (0 - 78)  **
 Information, Biomedical, diagnosis 8.0 (0 - 65)  13.0 (0 - 95)  **
 Information, Biomedical, prognosis 9.0 (0 - 47)  9.0 (0 - 50)   
 Information, Psychosocial 11.0 (1 - 102)  17.0 (1 - 88)  **
 Question asking, Psychosocial 9.0 (0 - 31)  17.5 (1 - 88)  **
 Decision making (question asking  
 + information giving in 3 categories)  3.0 (0 - 62)  7.5 (0 - 138)  **
 Question, opinion of treatment  0.0 (0 - 2)  0.0 (0 - 6)  **
Mdn: median number of utterances within the category per speaker  
* difference significant at .05 level
** difference significant at .01 level
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 questions, more open general biomedical questions, more psychosocial questions, 
and provided more diagnostic information. Information on prognosis was about the 
same in the pre training and post training groups. The ROs discussed the treatment 
decision with more utterances per consultation and asked patients more questions 
about their consent to the treatment proposal in the post training group than in the pre 
training group. Consultations pre training and post training did not differ with respect to 
duration (44 (SD 15) and 48 minutes (SD 16), respectively, Student’s t-tests: p-value = .14). 
Patient participation in the pre and post training consultations 
Table 3 provides the median and range of patients’ utterances in the selected  categories 
for both groups. In the first hundred utterances, patients in the post training group 
 contributed a higher proportion to the interactions than patients in the pre  training – 
group. More specifically, they said more about their agendas, gave more information on 
their ideas about the diagnosis and told more about their psychosocial circumstances.
Table 3  Median (and range) of patients’ utterances in targeted categories  
in pre and post training  groups  
   Pre training group  Post training group 
   Mdn Range Mdn Range
First 100 utterances      
 Proportion of utterances 45.5 (19 - 68) 48.0 (31 - 80)  *
 Agenda setting  0.0 (0 - 2) 0.0 (0 - 8)  *
 Information, Biomedical, diagnosis 1.1 (0 - 9) 2.0 (0 - 13)  *
 Information, Biomedical, prognosis  0.0 (0 - 2) 0.0 (0 - 2)  
 Information giving, Psychosocial 7.0 (0 - 35) 18.0 (0 - 62)   **
Entire consultation                  
 Proportion of utterances 40.8 (29 - 53)  41.7 (33 - 52)   
 Information giving, Psychosocial 58.5 (15 - 194) 86.5 (22 - 304)  **
 Concerns 3.0 (0 - 38) 6.0 (0 - 37)  **
 Question asking, Biomedical, general  10.0 (1 - 90) 8.0 (1 - 47)   
 Question asking, Biomedical, diagnosis  0.0 (0 - 5) 0.0 (0 - 15)  **
 Question asking, Biomedical, prognosis  0.0 (0 - 23)  0.0 (0 - 14)   
 Decision making 0.5 (0 - 17) 3.0 (0 - 60)  **
 Information on opinion of treatment 0.0 (0 - 17)  3.0 (0 - 60)   **
Mdn: median number of utterances within the category per speaker  
* difference significant at .05 level
** difference significant at .01 level
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In the entire consultation, patients in the post training group contributed about the 
same proportion of all utterances as patients in the pre training – group. In the post 
training group, patients discussed more their psychosocial circumstances, expressed 
more concerns, and asked more questions about their diagnosis. Questions  concerning 
general biomedical topics and prognosis were approximately the same in the pre and 
post training groups. Patients in the post training group discussed the treatment 
 decision with more utterances and expressed their opinion on the treatment proposal 
with more utterances per consultation than those in the pre training – group.
Discussion and conclusion
Discussion
After training of ROs we found significant changes in patients’ participation to the 
 consultation. In the post training group, patients participated more actively in almost all 
targeted categories, right from the initial minutes of the visit and continuing through 
the entire consultation. In the initial minutes, patients contributed to a greater extent to 
the consultation, expressing more what they wanted to discuss in the consultation 
(agenda-setting talk), telling more about their ideas about the diagnosis and more 
about psychosocial issues. In the entire consultation, patients in the post training group 
did not talk more, but provided more psychosocial information, expressed more 
 concerns and asked more questions about their diagnosis than patients in the pre 
training – group. They also engaged more actively in treatment decision-making. 
The more active patient participation in the post training group is probably related to 
the ROs’ increased participation-encouraging utterances after training. In the post 
training consultations, the ROs started their interactions with more psychosocial 
 questions, more questions about diagnosis and about patients’ ideas about diagnosis, 
and more  supportive remarks, than in the pre training – group. In the entire  consultation, 
they  provided more verbal support, asked less closed biomedical questions, more 
open biomedical questions and more psychosocial questions. Information on  diagnosis 
and discussion of treatment decision making also increased. No differences were 
observed in the ROs’ explicit discussion of their agenda, of the amount of general 
 biomedical information, and of information and questions about the prognosis.
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The changes found in communication are both important and valuable. Patients’ 
 participation in interactions with their doctors can help them to cope better with the 
illness and treatments, and might help them to reduce anxiety 4,5. In their study on 
 communication in health professionals and simulated patients, Maguire et al. 26 found 
that an increase of supportive remarks was related to higher disclosure of simulated 
patients’ concerns and psychosocial information. This stimulating effect on simulated 
patients’ disclosure was related to health professionals’ restriction of closed biomedical 
questions, and their manifestation of more open biomedical and psychosocial 
 questions 26. Our study shows similar results in real-patient interactions. In the post 
training group, the ROs changed their communication towards more support, less 
 closed biomedical questions, more open biomedical questions and more psychosocial 
questions, apparently resulting in more disclosure of patients’ concerns and 
 psychosocial information. Inversely, patients’ increased expression of details about 
their psychosocial background and their agenda at the start of the consultation is 
likely to have helped the ROs to enhance the adaptation of their communicative 
approach to the individual patients.
In the post training group, the ROs started with more questions about the patients’ 
ideas on the diagnosis, and patients provided more information on these ideas right in 
the first minutes of the consultation. In the entire consultation, patients asked more 
questions about the diagnosis and the ROs provided more information about this 
 subject in the post training group. This greater amount of exchanged diagnostic 
 information is also likely to have helped the ROs to better adapt the information they 
provided to the  knowledge levels of individual patients.
Since many years, patients’ question asking has been regarded as an important 
 indicator of patient participation in medical interactions 7,8. Several studies that aimed 
to increase patient participation, showed a significant increase in patients’ questions 
after a patient-directed intervention (such as providing patients with a question prompt 
sheet prior to their consultations or encouraging them to ask questions) 4,6,9-11. In our 
study, patients in the post training group asked only more diagnostic questions; 
 questions about the remaining topics were not increased by the intervention. These 
results seem in contrast to our findings of increased patient participation in the post 
training consultations. However, some additional remarks have to be considered. First, 
our physician-directed intervention might not be the optimal way to enhance patients’ 
question asking. Secondly, a more fundamental issue has to be raised. In measuring 
patients’ questions, the study focus is on patients’ participation by showing actively 
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their need for their  doctors’ expertise. We suggest that patients’ expressions of their 
personal ideas, of their feelings and concerns, and of their personal life circumstances, 
are manifestations of their participation by showing their own expertise. In comparison 
with the pre training – patients, patient participation in our post training group was not 
enhanced with respect to asking for their ROs’ expertise. Possibly, the ROs provided 
sufficient individually  adapted information to satisfy patients’ desire for information of 
the medical expert. Patient participation by more actively showing their own expertise, 
however, was  increased in the post training group. 
Discussion of decision making increased in the post training consultations, both in the 
ROs’ and patients’ communications. More specifically, the RO asked more about 
the patients’ consent to the treatment proposal and patients more explicitly expressed 
their consent. This indicates more active involvement in the decision-making process.
Certain limitations should be noted. Firstly, we included consultations with consecutive, 
consenting patients over a 2-year period. Consequently, we cannot ensure that the 
 greater extent of patient participation found in the intervention group is exclusively 
related to the RO intervention. Other influences during this time, such as social 
 developments and individual maturation might have contributed to enhanced patient 
participation. Secondly, we examined communication with quantitative measures of 
specific verbal utterances. This is a restricted measurement of both patients’ 
 participation and doctors’ facilitating them. The impact of different utterances on the 
interaction process will  greatly vary. Moreover, neither all facilitating nor all participation 
is expressed verbally, but  nonverbal behaviour was not measured in this study.
Conclusion 
Our study demonstrates that oncologists’ specific communicative behaviours can 
encourage real cancer patients to participate more actively without an increase in the 
duration of consultations. .The specific communication can be instructed effectively to 
oncologists in a relatively short training with plenary sessions and individual feedback 
on real patient encounters. We hope our results will contribute to improving the quality 
of care for cancer patients by enhancing patients’ ability to cope with the often far-
 reaching consequences of their disease.
Practice implications
The results of this study have some implications for clinical practice and future 
research. This and several other studies have shown that health professionals working 
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with cancer patients can be trained to use specific communicative behaviours in their 
clinical consultations 26,27,30-32. The present study also demonstrates that cancer patients 
do indeed participate more actively in consultations with oncologists who have 
 undergone specific communication training. This significant finding suggests that 
 doctors working with  cancer patients should receive communication training and 
 feedback, probably on a regular base (e.g. each year), similarly to their ongoing 
 medical training. Our findings of enhanced patient participation without an increase in 
the number of patients’ questions also point to an issue that should be considered in 
patient participation studies. When doctors facilitate patients’ participation and patients 
become more active, doctors might more easily recognize patients’ desire for 
 information and patients will not have to  explicitly ask all their questions. The impact of 
this reciprocal effect should be carefully considered in future research when  interpreting 
patients’ involvement in question asking. 
 Discuss agenda setting  
 
 Investigate status quo  
 
 Explore patient’s ideas about: 
 
 React supportively to the patient’s  
 story
 Medical history  
 Give information about
 Treatment decision making
•		indicate	time	available;	indicate	own	needs;	e.g.	 
to take history and perform physical examination
•		obtain	list	of	issues	the	patient	wants	to	discuss
•		obtain	description	of	personal	context	of	symptoms;	
start with open question
•		also	enquire	about	the	social	context
•		diagnosis	
•		prognosis
•		implications	of	radiation	therapy
•		empathise,	legitimise;	address	emotions 
•		start	with	open	question;	use	close-ended	questions	
for clarification
•		diagnosis
•		prognosis	&	treatment	intent
•		emotional	impact	of	treatment	
•		other	biomedical	information:	as	usual
•		discuss	treatment	decision	
•		request	patient’s	consent
Appendix A  Guideline of the trained communicative behaviours to  
stimulate patient participation
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Summary and general discussion
In this final chapter, the results reported in Chapters 2 to 6 are summarized and placed 
in perspective. Subsequently, a number of methodological issues are discussed and 
the clinical implications of the most important findings are outlined. The chapter 
 concludes with directions for future research.
The primary objective of this thesis was to investigate which factors contribute to the 
extent to which cancer patients participate in their consultations with their radiation 
 oncologist in which the proposed radiotherapy, to be delivered in an outpatient cancer 
clinic, is discussed. Before examining the relationship between the doctors’ 
 communicative behaviours and their patients’ contributions, we compared the nature 
and extent of patient involvement when palliative or curative treatment intent was 
 discussed and  investigated associations with the patients’ cognitive styles. We also 
requested the patients to evaluate their doctors’ communicative skills, and did so again 
before and after the radiation oncologists had been trained to use more patient-
 activating communication techniques.
We start off with a summary and discussion of the results of each study separately.
Summary of the results
In our first study, reported in Chapter 2, we posed the following research questions: 
 How do patients scheduled for palliative treatment and their proxies participate in the 
 consultation with their radiation oncologist? Do the radiation oncologists use the 
 communicative behaviours that have been suggested to stimulate patient participation? 
How often are treatment decision and consent explicitly discussed?
To answer our queries, the consultations of 8 radiation oncologists dealing with 54 
 oncology patients prior to palliative treatment were studied. To gauge patient 
 participation, communicative behaviours of the patients’ and their accompanying 
proxies’ were  charted as well as the extent to which the physicians exhibited behaviour 
that has been proposed to encourage patient participation. The respective 
 communicative behaviours were assessed using the Roter Interaction Analysis System 
(RIAS). In addition, patients were interviewed by telephone two days after the 
 consultation to establish at what moment they had given their consent to the treatment 
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proposal and to explore the nature of the information they had received before their visit 
to the radiation oncologist. 
We found that the contribution of the patients and their proxies was substantial as far 
as communicating their own story was concerned. Conversely, they rarely  spontaneously 
expressed their needs for information, asked few questions, seldom presented a list of 
topics they wished to be discussed and expressed only few concerns about their 
 situation. The radiation oncologists facilitated patient participation by providing ample 
biomedical information, by asking various psychosocial questions and giving their 
patients room to relate their personal experiences with cancer and by regularly making 
supportive remarks. Although the decision to accept or refuse the proposed radiation 
treatment was rarely discussed, in nearly half of the consultations the patients  explicitly 
consented to the treatment proposal without their radiation oncologists’ explicit asking 
for consent. Finally, as we learned from the telephone interviews, most patients had 
been aware of their diagnosis and prognosis prior to the consultation and had already 
decided to undergo radiotherapy before visiting the radiation oncologist.
These results suggest that, prior to radiotherapy, rather than mere information, the 
 majority of patients diagnosed with incurable cancer seek support in a caring 
 relationship with their doctor. This finding is in accordance with the conclusions of 
several other  authors 1,2 who stated that to incurable cancer patients acquisition of 
medical information and involvement in the treatment decision might be less important 
than a doctor who cares and pays attention to the impact the cancer has on their lifes. 
It is in the context of a caring relationship that provision and repetition of threatening 
information stimulates emotional processing 3.
Based on our and earlier findings, it is evident that in the consultations in which they 
need to discuss palliative treatment, communicative tasks of radiation oncologists are 
 demanding and complicated. To most, building a caring relationship with their patients 
in a situation in which extensive biomedical and technical information has to be 
exchanged does not come naturally, which is why it is crucial that these specialists are 
helped and trained to combine these two major tasks and to relate to their patients in 
such a way that they can actively participate in the decision-making process  concerning 
their palliative treatment.
The research questions of our study discussed in Chapter 3 were: In what way do 
 consultations in which palliative or curative treatment is discussed differ with respect to 
information sharing, emotional talk and decision making?
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The communications between 160 cancer patients, their accompanying proxies, and 
the same eight radiation oncologists of the first study were recorded during the 
 consultation prior to radiation treatment. Half of the patients had been referred for 
 palliative and the other half for curative treatment. The communication behaviours of 
the patients, their proxies and the radiation oncologists were again analyzed with RIAS.
Our evaluations revealed various dissimilarities in the two categories of consultations. 
The radiation oncologists provided about the same amount of general biomedical 
information in both session types but they communicated more prognostic information 
and also asked more questions about their patients’ medical and psychosocial 
 conditions in the palliative treatment consultations. The patients and their proxies of 
both treatment groups expressed not many concerns about their situation and asked 
few questions, although the palliative group asked slightly more questions about their 
prognoses. What stood out was that the radiation oncologists expressed less support 
and more concerns towards the palliative group than they did towards the curative 
group, suggesting that they tried to accentuate the former patients’ unfavourable 
 situation. In both groups,  explicit decision-making received little attention by all 
 consultation participants, which may be another indication that, irrespective of 
 treatment intent, most cancer patients tend to focus on active treatment in their first visit 
to the radiation oncologist.
In sum, the content and nature of radiotherapy consultations is affected by treatment 
intent: the patients (and their proxies) asked more about the prognosis when they were 
scheduled for palliative treatment and the radiation oncologists had gathered more 
 wide-ranging information necessary for the recommendation of palliative radiation 
 treatment.
In our third study, described in Chapter 4, we tried to answer the following questions: 
How do cancer patients’ perceptions of information and support received relate to the 
 information provision and supportive behaviours of their radiation oncologists? Which of 
the clinicians’ communicative behaviours influenced the patients’ perceptions of the 
information and support provided?
Again using the RIAS, we assessed the communicative behaviours of our eight  radiation 
oncologists videotaped during their initial consultations with 173 oncology patients 
 scheduled for radiation treatment. Two days later, the patients completed a Quality-of-
Life questionnaire and a questionnaire gauging their perceptions about the medical 
information the clinicians had provided and the personal attention they had received.
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Even though the oncologists provided ample medical information, the patients’ 
 perceptions of the information they had received proved to be poorly related to their 
doctors’ behaviours. In contrast, the physicians’ provision of psychosocial information 
did coincide with the patients’ perceptions of the amount of personal attention they had 
received and also with their assessment of the medical information provided. Based on 
these results, we concluded that if oncologists present the biomedical information in 
relation to the patients’ personal circumstances, this facilitates the patients’ recognition 
of its content and relevance. The patients’ assessment of how much attention they had 
received was also affected by the questions the oncologists asked. The direction of the 
effect varied according to the type, wording and content of the questions: close-ended 
biomedical questions tended to diminish the patients’ perception of receiving personal 
attention, while open-ended psychosocial questions augmented it. The patients’ 
 perception of being paid attention to was also positively affected by the oncologists’ 
expressions of concern about their medical situation. Although few, the critical remarks 
the clinicians made had a significant negative impact on their patients’ perception of 
the personal attention received. We believe this once more underscores the huge need 
cancer patients feel for a caring patient-doctor relationship.
When we analyzed the influence of several aspects of the patients’ self-reported  quality 
of life on their perception of the oncologists’ behaviours, we found that the more tense 
patients were, the less medical information and personal attention they reported to 
have received. This is consistent with the literature about information processing under 
 stressful circumstances. Obviously, many cancer patients are quite tense when 
 discussing treatment options with a new, unfamiliar doctor 4 and, since tension 
 interferes with their ability to process information 3,5,6, it is understandable that the strain 
our patients were under negatively affected their perception of the medical information 
or personal attention they received from their radiation oncologists.
In conclusion, the associations between the oncologists’ communicative behaviours 
and the cancer patients’ perceptions of these exchanges were rather weak and 
 depended on the patients’ tension levels.
The research questions of our study reported in Chapter 5 were: How do cancer 
patients’ cognitive styles influence their communicative behaviours and their evaluation 
of the interactions with their radiation oncologist?
The communicative behaviours of 116 oncology patients visiting their radiation 
 oncologists prior to radiation therapy were assessed with the RIAS. For 56 patients 
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 treatment intent was palliative and for the remaining 60 curative. Within three days of 
the visit the patients completed an inventory measuring their monitoring (the tendency 
to seek threat-relevant medical information) and blunting (the tendency to cognitively 
avoid threat-relevant information and to seek distraction from threat) cognitive styles. 
Our analysis of the patients’ coping-style inventories demonstrated that for the  palliative 
group a monitoring style was positively related to the number of questions the patients 
asked, which was not the case for the curative group. Apparently, in patients scheduled 
for palliative treatment a monitoring style enhances their search for reduction of 
 uncertainty. Furthermore, high monitoring was positively related to the proportion of 
emotional talk, but, again, only in the palliative group, indicating that high monitors do 
not simply express more emotions than low monitors do, but that they mainly do so 
when the situation is highly threatening and uncertain. We also found a positive 
 correlation between a marked monitoring style and the patients’ active participation in 
the  decision-making process. Although in some studies high monitors were found to 
prefer a more passive role than low monitors 7,8, it needs to be noted that these studies 
investigated relationships between monitoring and patient preferences, whereas in our 
study we  examined monitoring relative to the patients’ actual communicative 
 behaviours.
Because blunting entails the tendency to cognitively avoid threat-relevant information, 
we assumed that blunting would be inversely related to the volume of patient queries 
and emotional talk. High blunters indeed asked fewer questions and expressed fewer 
 emotions than low blunters did, but once again, solely in the palliative group. Seemingly, 
a blunting style does not simply restrain patients from asking questions and expressing 
themselves emotionally, it only does so in highly threatening circumstances.
At the 6-week follow-up assessment, when all patients had undergone radiation 
 treatment, we asked them to compare their experiences with the information their 
 radiation oncologist had provided during the initial consultation. In both treatment 
groups the high monitors reported more doubts about their treatment decision and 
more  dissatisfaction with the information provided than the low-monitors. The effects of 
 blunting were restricted to the palliative group where high blunting had elicited fewer 
doubts and less dissatisfaction.
Overall, the results reflected an apparent impact of the patients’ cognitive styles on 
their communicative behaviours as well as on their evaluations of the information 
received, albeit predominantly in those patients that suffer from incurable types of 
cancer. Our findings regarding monitoring largely support the existing theory and 
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 earlier results and those pertaining to blunting fully corroborate current theoretical 
notions about the  concept. The results considering the blunting cognitive style suggest 
that apparently the threat of a palliative-treatment setting is required to activate a 
patient’s blunting style.
In our final study, described in Chapter 6, we tried to answer the following questions: 
Do radiation oncologists use trained communicative behaviours in the interactions with 
their patients? More importantly, is an increased use of specific doctors’ behaviours 
 related to a rise in the patients’ participative behaviours? 
We again observed our eight radiation oncologists while they were seeing 160 patients 
to study their respective communicative behaviours with the RIAS before and after the 
clinicians had received special communication training. Half of the patients were 
 allocated to the pre-training group and the other 80 to the post-training group. The 
 oncologists were trained to use specific communicative behaviours that are assumed 
to encourage patient participation. These included joint agenda setting and assessing 
the patient’s medical and psychosocial status quo by using open-ended questions, 
 exploring the patient’s ideas about several specific medical issues, expressing  support, 
providing information about the prognosis and emotional impact of the treatment and 
explicitly discussing the treatment decision. Special attention was paid to the 
 communicative requirements in the first minutes of the consultation.
After training, the radiation oncologists proved to use more participation-encouraging 
utterances right from the start but also during the ensuing interactions than they had 
prior to their training. Their post-training interactions comprised fewer closed-ended, 
and more open-ended biomedical questions and more questions on both psychosocial 
and diagnostic issues, they inquired more extensively about the patients’ ideas about 
the diagnosis and provided more verbal support than they did prior to the training. They 
voluntarily provided more diagnostic information and more often explicitly brought up 
the issue of treatment decision.
After training of the radiation oncologists we also found significant changes in patients’ 
participation to the consultation. The patients in the post-training group participated 
more actively, right from the start of the visit and continuing all through the session. In 
the initial minutes, patients expressed more what they wanted to discuss in the 
 consultation and told more about their ideas about the diagnosis and more about 
 psychosocial issues. Although in absolute terms the patients in the post-training group 
did not talk more, they did provide more psychosocial information, expressed more 
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concerns and asked more diagnosis-related questions than the patients in the  pre-
training group.
Furthermore, decision making featured more prominently in the post-training 
 consultations, both in the communications of the oncologists and in those of the 
patients. More  specifically, the physicians more often asked the patients’ consent for 
the treatment proposal and patients more often explicitly volunteered their consent 
indicating that the physicians’ post-training behaviours had induced patients to be 
more actively involved in the decision-making process. Despite the patients’ enhanced 
involvement, the  duration of the post-training consultations did not differ from the 
 lengths of the pre- training consultations.
With this study we demonstrated that a relatively short training period sufficed to have 
our oncologists effectively acquire and exploit specific communication skills. The 
results of the post-training consultations showed that their changed approaches 
encouraged their patients to participate more actively without prolonging the duration 
of the  consultations.
Methodological reflections
Study design
In this section we will discuss the potential implications of a number of aspects 
 pertaining to the methods of investigation that were used throughout the reported 
research project. To begin with, in our combined investigations we evaluated the 
 consultations of 206 unique patients and their proxies with one of eight participating 
radiation oncologists. Obviously, the limited number of oncologists raised several 
methodological concerns. We were aware, for instance, that the divergent style of one 
or more physicians could have notably affected the results, which is why we controlled 
for the amount of nesting of the RIAS categories within the group of oncologists by 
calculating intraclass  correlation coefficients for the selected outcome measures. As 
the resultant coefficients were low and non-significant (< .05), signifying that the 
 between-physician variance in  communicative behaviours was very small, we felt 
 justified in treating the 206  consultations as independent observations. It was also 
 possible that some of our  oncologists had mainly seen patients referred for palliative 
treatment while others had received more patients scheduled for curative treatment. 
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However, additional analyses found no evidence of such an unequal distribution, which 
meant that the observed  differences in the physicians’ communications in the two 
patient groups had not been affected by this potentially confounding factor.
A second point of concern was our choice of study design for the pre- and post-training 
evaluations (Chapter 6). Of course, a randomized, controlled paradigm would have 
been preferable, with the oncologists being randomly allocated to a training or a control 
 condition with the first receiving the communication training and the second not. 
However, we decided against this design because of the limited number of  participating 
oncologists. Moreover, all worked at the same department, seeing each other daily in 
various treatment meetings. In view of these factors, a pre-post design seemed the 
most appropriate with all oncologists starting in the pre-training condition. After each 
 oncologist had seen at least 10 patients (i.e. after approximately 100 patients), all 
 oncologists were trained after which they saw a second cohort of patients (again 
 minimally 10 per oncologist). Although with this design we were unable to exclude 
 possible time effects (e.g. individual maturation), it has to be noted that the main focus 
of our study was not on the post-training effects on the physicians’ communicative 
 behaviours, but on the question whether specific newly acquired communicative 
 behaviours would enhance patient participation.
Generalizibility
All patients that had joined our study had a life expectancy in excess of three months 
and were sufficiently able to speak and to understand Dutch and to give their written 
informed consent. Consequently, our cohort may not be fully representative of all 
 oncology patients seen at the local radiotherapy department because these will include 
more severe terminal cases and less educated patients. We, moreover, cannot  preclude 
effects of comorbidity, of which we had failed to consistently take stock. More 
 specifically, co-existing conditions may have affected the patients’ behaviour during 
the consultation, their quality of life as well as their evaluation of the consultation. We 
also lacked data on the time between the initial diagnosis of cancer and the studied 
pre-treatment  consultation. These limitations hamper definitive conclusions as to the 
extent to which our results are generalizable to the entire cancer population.
Approximately 90% of the patients were accompanied by at least one proxy, most 
 frequently by their spouse (65%), or by an adult son or daughter (13%), or by another 
family member (10%), and sometimes by a close friend (3%). Some 10% of the patients 
were accompanied by more than one proxy, while another 10% of the patients attended 
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the radiology consultation alone. Since the patients’ relationships with their proxy or 
proxies was so diverse, our findings about the proxies’ contributions to the 
 communications did not lend themselves for generalizations about the relevance of 
proxies for cancer patients.
The work conditions and procedures of our eight radiation oncologists may also 
impede the generalizibility of our findings. As mentioned, all worked in the same 
 academic  hospital and all had a heavy caseload and adhered to the same  departmental 
 procedures. The length of the pre-treatment consultations, for instance, was set at a 
generous 45 minutes. As in many other western oncology settings, both within and 
 outside The Netherlands, less time is allocated to such sessions, it may be questioned 
whether there similar results would be obtained.
Analysis of patient-doctor communications
Because the focus of all studies reported in this thesis was on the verbal  communicative 
behaviours of cancer patients and their oncologists and on associations between these 
behaviours, it was crucial to obtain detailed information about all doctor-patient 
 interactions. To optimize our observations, we chose to videotape each consultation to 
enable us to also take nonverbal aspects of communication into account in our 
verbal-exchange coding. Theoretically, the presence of a video recorder could affect 
the nature and the content of the communications. However, this was not the case in 
the present and other studies, e.g. 9,10, as both the patients and the clinicians reported 
they had forgotten about the video recorder soon after the start of the consultation. 
Very few patients refused to participate when they were told the dialogue would be 
recorded on videotape, allowing us to record more than 200 consultations over a two-
year period, thus demonstrating the feasibility and acceptability of this method of data 
collection.
We opted for the Roter Interaction Analysis System (RIAS) to analyze the patient-
 oncologist exchanges as the system has many advantages (also see Chapter 2). It has 
been widely applied in studies of doctor-patient communications, its coding method is 
easily learned and can be applied directly to the recordings without transcription, and, 
where many other coding instruments have been shown to be relatively subjective, its 
reliability has been confirmed 11. Furthermore, the system’s flexibility allowed us to tailor 
coding categories to our specific research questions.
However, like all methods designed to analyze human interactions, the RIAS has 
several drawbacks. First, it solely generates frequency data given that only the number 
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of  utterances per category is assessed. How the information is conveyed is not coded 
separately. Clearly, for an utterance to be understandable to the listener, it is crucial that 
the information is delivered in a clear and intelligible way. We largely overcame this 
 drawback by including (non)verbal aspects of the utterances in the coding process of 
the videotaped consultations. Secondly, as it is only the content of the utterances that 
is being categorized, all utterances in a category are given the same weight,  irrespective 
of their frequencies or proportions within the category. In a conversation, however, the 
importance of what is said depends on the context in which it is said. Thus, not all 
 utterances pertaining to biomedical information, for instance, have the same meaning 
or weight for the speaker and for the receiver. Additionally, frequency data only allow 
limited conclusions to be drawn on the interactive nature of the communication: the 
capacity for one party to influence the behaviour of another, or to adjust behaviour in 
response to another, is less visible than in most qualitative analysis methods 12-16.
Also coding and clustering of (infrequent) categories may present problems. Even 
though the interrater reliability of the separate RIAS categories can be adequate, the 
fact that several categories often are condensed into clusters of verbal communication 
 reduces the sensitivity of the instrument. Due to the small frequency of utterances in 
the ‘Emotional talk’ categories, for instance, we combined several categories and were 
thus unable to distinguish between reassurances and expressions of empathy.
General discussion and implications 
for clinical practice
The main conclusions from the descriptive parts of our research (Chapters 2 and 3) 
were that oncology patients coming to discuss palliative or curative treatment shared 
quite a lot about their medical and personal circumstances, but did hardly ask any 
specific questions. Yet, despite the lack of questions, all the radiation oncologists 
 provided ample medical information about, among other topics, the diagnosis, 
 prognosis,  treatment proposal, treatment procedures and possible side effects. 
Meanwhile, most patients did hardly express any emotions or concerns about their 
situation or physical condition, and did not focus on extensive discussion of the pros 
and cons of the  proposed treatment.
Together, these results demonstrate that, irrespective of whether it was palliative or 
140
C H A P T ER 7
 curative radiotherapy that was being discussed, the majority of our cancer patients 
 preferred to focus on the treatment rather than on their emotions: they seemed to 
 contain their emotions to enable themselves to discuss the treatment and fathom its 
 consequences. In doing so, they were not just focused on receiving information, they 
also sought support from their doctor, implicitly asking him or her to discuss the impact 
the cancer and the potential treatment had and would have on their lives. These 
 observations are in line with the conclusions several other researchers reached, 
 suggesting that for many cancer patients, acquisition of medical information and 
 involvement in the treatment decision-making process seems less important than a 
caring relationship with their doctors 1,2,17-20.
The radiation oncologists in our study indeed seemed to value building up a caring 
relationship with their patients since they gave them ample opportunity to talk about the 
psychosocial aspects of their illness. On the other hand, like the patients, they 
 predominantly adhered to a biomedical approach and seldom discussed possible 
 concerns or other emotional issues. The importance of allowing patients to tell their 
stories should not be underestimated. Patients who discuss their lives and the impact 
the cancer has with their doctors have been shown to have a better understanding and 
recall of the information provided and are better able to adjust to their illness than 
patients who do not 21.
We found that the discussion of palliative or curative treatment options requires 
 different approaches, both of the physicians and the patients. During the consultations 
with a palliative treatment intent the oncologists asked the patients more questions 
about their medical and psychosocial circumstances, which corresponds with the 
requirements for this type of treatment intent: the individual patient’s condition is a 
decisive factor in the radiation oncologist’s choice of treatment plan. Remarkably, in the 
palliative treatment consultations the radiation oncologists expressed more concerns 
and offered fewer  supportive remarks than in the curative treatment consultations. 
Apparently, under these circumstances they tend to emphasize the patients’  unfavourable 
situation without much extra emotional support for the patients. However, due to our 
coding system we were unable to examine whether this meant that the oncologists 
conveyed less empathy or legitimation, or that they expressed less reassurance in the 
palliative group, thus  preventing us from further delineating possible differences in the 
emotional support they conveyed to the two patient groups. Future research using 
more detailed coding methods might shed more light on this issue. Additional studies 
might also help clarify whether patients with incurable cancer need more support from 
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their doctors or if they want to avoid ‘emotional talk’ and prefer doctors to not  emphasize 
their unfavourable position by offering supportive remarks.
Chapter 4 showed that three days after the consultation the patients’ perceptions of 
what was discussed was only moderately related to the oncologists’ verbal 
 communications and that their valuations were influenced by the level of tension they 
reported. This effect has earlier been documented; several studies demonstrated that 
under stressful  circumstances processing of information is hampered 3,6. Evidently, 
attending physicians need to be better aware that both the strain their patients are 
under and their temporary needs play an important role in how they interpret and 
 perceive what is being  communicated to them. Understandably, most cancer patients 
will be quite tense when discussing issues that might be crucial for their recovery or 
their quality of life. To enable them to process and comprehend their situation, the 
treatment options and implications, they need the support of a caring doctor. Within the 
establishment of a relationship, the patient’s tension is likely to diminish and the 
 discussion and repetition of threatening information will eventually boost the  processing 
of emotional and cognitive information. By adapting their communicative style to the 
patient’s mental state, by paying attention to psychosocial issues and the patient’s life 
circumstances, and possibly also by  expressing their empathy with the patient’s 
 situation, oncologists can improve their patients’ perception and grasp of the content 
of the communication.
Besides their pre-existing tension, we propose that the patients’ problems to capture 
what is being discussed in the consultation room are also partly attributable to the 
 quantity of and the threatening and perplexing content of the medical information. 
The resultant anxiety and incomprehension may additionally explain the small number 
of questions they posed. It is highly likely that some patients needed more time to 
 process the vast amount of information and were at the time unable to ask relevant 
questions. Moreover, some may have refrained from asking questions fearing this 
would lead to even more threatening or taxing information. Hence, in pre-radiation 
consultations, rather than providing ever more medical information to fulfil the patients’ 
obvious desire for information, the oncologist needs to relate the most relevant medical 
information to the patients’ personal circumstances. By talking about the impact the 
cancer has had on their lives and by discussing the possible effects of the proposed 
treatment, patients become more receptive to the information and support their 
 physicians provide, which will improve the way they process the information.
Within the context of augmenting patient-specialist interactions and thus the patients’ 
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grasp of their situation, our endeavours recounted in Chapter 5 demonstrated that it is 
also important to consider the patient’s coping styles and to chart to what extent they 
monitor (actively confront) or blunt (seek distraction from) possibly threatening medical 
information. This proved especially opportune for the patients that had been referred 
for palliative treatment. Unexpectedly, it was only in this group that monitoring was 
 positively and blunting negatively related to the number of questions they asked. 
Apparently, only in highly threatening circumstances does a monitoring style enhance 
patients’ efforts to reduce their insecurity and a blunting style prevent them from active 
inquiries. Six weeks after the initial consultation, the high monitors in both groups 
 reported having more  doubts about their treatment decision and being less satisfied 
with the information  provided, but again only in the palliative group did the high blunters 
express fewer  doubts and less dissatisfaction. This suggests that in oncological 
 settings physicians should be both sensitive to individual differences in information 
needs and bear in mind that providing extensive information is no guarantee for patient 
satisfaction. They should gauge their patients’ cognitive styles by asking about their 
preferences in dealing with information. An example: ‘Do you always want to know 
every detail, or do you think that the doctor knows best and therefore should not tell you 
all the details?’ And even if patients who indicated so are informed as  comprehensively 
as possible, doctors still should not expect that this will fully satisfy them. For most 
cancer patients, many  uncertainties will remain, regardless of the amount of  information 
they are offered. Especially the so-called high monitors are likely to remain  uncomfortable 
and to keep demanding more, and more detailed, information all through their 
 treatment. We found that this seems to apply even more for patients with incurable 
cancer scheduled for  palliative treatment.
The results of our first four studies illustrated that for radiation oncologists the demands 
on their communicative skills are quite high and complex. On the one hand they need 
to build a caring relationship with their new patients in a highly stressful situation, while 
at the same time, in order to inform patients amply and to reach an optimal treatment 
 decision, they need to communicate a vast amount of medical information. They need 
to be aware of and respond to the notion that the patients’ grasp of the situation will be 
hampered both by the tension they are under and by the complexity and threatening 
content of some of the information. To complicate matters even further, in trying to 
adapt their style of communication, they cannot rely on the proportion of questions their 
patients ask or their sharing or concealing their emotions and concerns, as we found 
that most of the cancer patients participating in our investigations were not very 
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 articulate when not stimulated to.
We felt this demanding, ‘double role’ of the medical specialist merited more detailed 
attention. Hence, in the study described in Chapter 6 we offered to train our eight 
 radiation oncologists in modifying their communication techniques to enable patients 
to more actively participate in the discussion and decision-making process concerning 
their radiation treatment. We based the content of the training programme on findings 
from other studies of effects of doctors’ communication on patient behaviour.
Considering the time-span of the consultation, we judged a clear structure of when and 
how the various topics needed to be discussed to be essential to facilitate the patients’ 
participation and their comprehension of what was being discussed. Therefore, in our 
training programme we advised the radiation oncologists to start their consultations by 
explaining how much time they had at their disposal and by describing their agendas, 
e.g. by relating what topics needed to be discussed and why. They were also instructed 
to invite the patient to tell what he or she wished to discuss and to explore how the 
patient was feeling, and the patient’s cognitions about his or her disease and the 
expected prognosis had to be determined. We also asked the oncologists to  repeatedly 
check the extent of the patient’s information uptake and comprehension, and to 
 complement the vast amount of information about the disease and proposed treatment 
with a discussion of likely emotional consequences. Finally, the oncologists were urged 
to explicitly raise the issue of treatment decision and consent.
Scrutiny of their post-training consultations showed that the oncologists indeed applied 
the trained behaviours more than they had before their training. More importantly, we 
found that the patients, from the start throughout the entire consultation, discussed 
more psychosocial topics, expressed more concerns and contributed more to the 
 decision-making process, implying that the oncologists’ post-training behaviours had 
indeed induced patients to play a more active role. Remarkably though, overall the 
patients in the post-training group did not ask more questions than the patients who 
had been seen in the pre-training condition. The proportion of questions patients ask 
has long been regarded as an important indicator of patient participation in medical 
interactions 22-25. In our study, the oncologists’ training only raised the number of 
 diagnostic questions patients asked; the volume of questions about the remaining 
topics remained the same.
But how can we explain this isolated lack of effect and the discrepancy with the 
 otherwise convincing augmentations? By asking questions patients express their need 
for their doctors’ expertise. By expressing their personal ideas, feelings, concerns and 
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by  offering details of their personal life circumstances they show the doctor their own 
 expertise. We suggest that through the patients’ enhanced sharing of their expertise, 
the oncologists were better able to adapt their style of communication to the individual 
patients, which meant that, consequently, the patients felt less need to ask questions. 
This seems reasonable although we cannot rule out that, despite their enhanced 
 participation, the patients’ ambiguity as regards potentially threatening information had 
not diminished. We will come back to this issue in the next, our final, section.
In conclusion, the first few minutes of the consultation appeared to be crucial for the 
patients’ active participation, and with that, also crucial for their perception of their 
 doctors’ communications and appreciation of the consultation. Much was gained by 
the doctor and patient first discussing the items on their respective agendas and by 
 exploring the patient’s personal situation rather than immediately starting off with an 
exchange of information. Our study demonstrated that when medical specialists adopt 
a more participation facilitating style of communication right from the start of the 
 session, patients tend to react more or less immediately by volunteering more details 
about their personal lives and by expressing their concerns. The study also showed 
that specialists can easily learn to use communicative behaviours that facilitate patient 
participation, which suggests that doctors working with cancer patients should receive 
special  communication training and feedback, preferably on a regular base (e.g. once 
a year), as part of their ongoing medical training.
Implications for future research
Based on the findings of our first four studies, we instructed the participating radiation 
oncologists to use certain techniques when communicating with their patients. 
The  training yielded several significant effects, but the question remains whether this 
new approach indeed leads to better care. Future research will have to establish, for 
instance, whether this patient-activating style of communication indeed enhances the 
patients perception of what is being discussed, whether it boosts their information-
processing capability, i.e. whether they comprehend and are able to recall the received 
information better, and whether this all raises their level of satisfaction with the  treatment 
decision.
The effect the physicians’ communication style has on the way their patients’ cope with 
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the emotional aspects of the situation when only palliative treatment can be offered 
also merits further investigation. Although several studies reported that, in general, 
cancer patients learned to cope better with their disease and its consequences when 
doctors made an effort to elicit their patients’ concerns and show empathy 26,27, ours 
and several other studies indicate that patients diagnosed with incurable cancer tend 
to be mainly focused on treatment-related information and are generally not eager to 
discuss their emotions in their first contacts with the specialists delivering anti-cancer 
treatment 1,2,20,28. Considering the huge amount of unfamiliar, technical, and often 
 threatening information these patients have to deal with, it is understandable that they 
need to keep their  attention focused on the exchange of information and thus need to 
prevent themselves from getting confused by their own, sometimes very intense, 
 emotions. It would be  interesting to verify whether this group of cancer patients indeed 
predominantly desires factual information and rather do without emotional exchanges 
in this stage of their  treatment and hence also prefer their doctors to refrain from 
 emphasizing the graveness of their situation and restrict their empathetic remarks. 
If this is the case, and if doctors follow their patient’s preferences, does this also imply 
that these patients are better off in the long term? These questions first need to be 
answered before we can formulate  definitive recommendations as to the optimal 
approach of patients whose only option is palliative treatment.
Although in the previous section we offered a tentative explanation for our findings 
 relating to the topic, the issue of patients posing or abstaining from posing questions 
also warrants further scrutiny, especially since the number of questions asked is 
 frequently taken as the main indicator of patient participation. In our study on the 
effects of communication training, all post-training signs of patient participation were 
raised except for the question-asking index. When patients participate more actively -
whether or not induced by specific behaviours of the physicians- doctors will more 
easily  recognize whether their patients crave (more) information and may thus already 
 anticipate their patients’ questions, who, as a consequence, do not need to raise the 
issue  themselves. In future, when interpreting patient involvement based on ‘question 
asking’, the effect of this reciprocal phenomenon needs to be taken into account. 
Moreover, as the proportion of questions has been found to be related to the patients’ 
cognitive style -with a pronounced monitoring style inducing more questions- the 
second challenge is to further delineate what it means for patient’s active participation 
when patients ask many, or few, questions.
Our investigations illustrate that there may be a substantial discrepancy between what 
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people report to have been told (or have not been told) and what information has 
 actually been provided. Indirect measures, i.e. patients’ post-consultation assessments 
of what the doctor has told them, clearly do not indicate whether they have been given 
the  particular information but have forgotten it, whether they failed to understand it or 
whether they felt unable to ask questions (e.g. because the doctor’s questions or 
 responses inhibited the patient). Evidently, future investigations of the attention 
 oncologists pay to their patients’ informational and emotional needs should not rely 
entirely on patient reports of their doctor’s behaviours.
Lastly, but certainly not less importantly, we feel it is desirable to widen the scope of 
research into patient participation in oncological settings. Cancer patients who require 
radiation therapy will mostly need to visit the radiotherapy department frequently during 
a period of several weeks. In that period, and often months or sometimes even years 
afterwards, they will have to deal with many health professionals representing various 
disciplines: the radiation oncologist, the radiotherapy technicians and assistants, the 
nurses of the oncology department and the various receptionists. Our research project 
was restricted to the patients’ initial contact with their radiation oncologist. In order to 
get a clearer picture of how the communication with cancer patients can be optimized 
and active participation can be continually facilitated at every stage of their illness, we 
need to monitor the entire process the patients is taken through by evaluating their 
contacts with the various professionals at the radiology department. And, although 
more  challenging, it would be even more worthwhile if we were to chart what happens 
to patients when they are first being diagnosed and treated for cancer. How do the 
medical interactions and decision-making processes evolve and what is the patients’ 
involvement? How can we facilitate their participation, from the first first-tier clinical 
visits right through to the third-tier consultations? If such longitudinal cohort studies 
were to cover all the aspects we have investigated in this thesis as well as those that 
we have omitted, this is likely to substantially deepen our insights into the needs of both 
cancer patients and the attending health professionals.
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Inleiding
Dit proefschrift gaat over de participatie van patiënten met kanker aan het eerste 
gesprek met hun behandelend radiotherapeut (bestralingsarts). Met participatie wordt 
bedoeld de actieve deelname aan een gesprek, bijvoorbeeld door de arts vragen te 
stellen, door te vertellen wat de gevolgen van de ziekte zijn voor het persoonlijke 
 dagelijks leven, door zorgen omtrent de ziekte te uiten, door mee te besluiten over de 
behandelingen, e.d. Uit eerder onderzoek is gebleken dat patiënten die actief 
 participeren aan de gesprekken met hun arts, en betrokken zijn bij de keuzen ten 
 aanzien van de behandeling, meer profijt hebben van de informatie en ondersteuning 
van hun arts dan de patiënten die zich afwachtend opstellen. Actieve patiënten krijgen 
meer informatie te horen, die ze ook beter begrijpen en onthouden dan patiënten die 
zich passief gedragen. Bovendien blijkt actieve participatie aan medische gesprekken 
bevorderlijk te zijn voor de verwerking van en het leren omgaan met het hebben van 
een ziekte.
Ook al zijn de voordelen van actieve participatie evident, in de klinische praktijk blijken 
veel patiënten juist een afwachtende houding aan te nemen, zeker als de gesprekken 
over een ernstige ziekte zoals kanker gaan. Wanneer kanker wordt geconstateerd 
 worden veel patiënten als het ware ‘verlamd’ door het gevoel de controle over hun leven 
te verliezen. Zelf kunnen ze niet veel tegen de ziekte doen en ze hebben het gevoel hun 
lot in handen te moeten leggen van de behandelaars. Door de levensbedreigende aard 
van kanker luistert de communicatie van de behandelende artsen extra nauw. 
De meeste kankerpatiënten hebben, om te kunnen omgaan met de ziekte, en de 
 behandelingen, veel informatie en emotionele ondersteuning nodig van hun artsen. 
Gedetailleerde informatie helpt vaak te begrijpen wat te wachten staat en bevordert 
terugwinning van een gevoel van controle. Emotionele ondersteuning of empathie van 
de arts geeft patiënten vertrouwen in de arts en daarmee ook in de behandelingen die 
geboden worden. 
De rol van de arts reikt echter verder dan informatie verstrekken en empathie tonen. 
Uit eerder onderzoek is gebleken dat bepaald communicatief gedrag van de arts 
invloed kan hebben op de participatie van de patiënt. Met name door open vragen te 
stellen en de patiënt ruimte te geven zijn of haar eigen verhaal te vertellen, kan de arts 
de patiënt stimuleren actief deel te nemen aan gesprekken over behandeling en mee 
te beslissen over welke behandelopties het beste aansluiten bij de individuele 
 omstandig - heden. Deze invloed is aangetoond bij patiënten met minder bedreigende 
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ziekten, en bij  simulatiepatiënten die zich inleefden kanker te hebben. In de klinische 
setting was dit effect echter nog niet onderzocht en dat vormde de aanleiding voor ons 
 onderzoek. 
Voor patiënten met kanker is de fase waarin behandelingen worden aangeboden vaak 
een stressvolle periode. Ze krijgen veel medische informatie te horen die soms 
 bedreigend is, maar ook inzicht biedt in wat hen te wachten staat. De informatie gaat 
onder andere over onzekerheid van het behandelresultaat, de bijwerkingen van de 
behandelingen, de technische uitvoering van de behandelingen, de consequenties 
voor het dagelijks leven, e.d. Bij de uiteindelijke keuze om een bepaalde behandeling 
toe te passen speelt het begrip ‘kwaliteit van leven’ een belangrijke rol. De  behandelend 
arts is voor de patiënt meestal een onbekende specialist waar nog geen vertrouwens-
relatie mee is opgebouwd. Toch moet die arts in samenspraak met de patiënt afwegen 
of de mogelijke winst die een behandeling kan opleveren opweegt tegen de belasting 
die de behandeling voor de patiënt met zich meebrengt. 
Radiotherapie is één van de meest toegepaste behandelmethoden voor kanker en 
beoogt de kankercellen te doden met behulp van bestraling. Afhankelijk van ondermeer 
het stadium van de ziekte en de conditie van de patiënt, bepaalt de radiotherapeut welk 
behandeldoel haalbaar lijkt en welke behandeling daartoe wordt aangeboden. Het 
behandeldoel wordt curatief genoemd als de behandeling erop gericht is om iemand 
te genezen. Bij ongeveer de helft van de patiënten met kanker die bestraald worden is 
de ziekte uiteindelijk ongeneeslijk vaak omdat er metastasen (uitzaaiingen) ontstaan. 
Ook dan is vaak  radiotherapeutische behandeling mogelijk, maar met een palliatief 
behandeldoel. De behandeling is er dan op gericht om klachten te verlichten, de voort-
gang van de ziekte af te remmen en mogelijk levensverlenging te realiseren.
Het doel van dit proefschrift is om inzicht te krijgen in factoren die een rol spelen bij de 
mate waarin kankerpatiënten actief deelnemen aan het eerste gesprek met de radio-
therapeut. Daarbij werd tevens nagegaan welke communicatie van de radiotherapeut 
de participatie van patiënten met kanker stimuleert.
Onderzoeksmethode
Het onderzoek werd uitgevoerd op de afdeling radiotherapie van het Universitair 
Medisch Centrum St Radboud. In twee jaar tijd (2000-2002) werd aan opeenvolgende 
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patiënten van acht radiotherapeuten en assistenten in opleiding gevraagd aan het 
onderzoek deel te nemen. Indien de patiënt instemde, werd het eerste consult 
(behandel gesprek) van de patiënt (en zijn of haar naasten) met de radiotherapeut op 
video opgenomen. Zowel van de patiënten als van de artsen werden achtergrond-
kenmerken en uitkomsten  verzameld door middel van vragenlijsten en (telefonische) 
interviews. De communicatie tijdens de consulten werd in kaart gebracht door gebruik 
te maken van het Roter Interaction Analysis System (RIAS). Het RIAS is één van de 
meest gebruikte analyse-instrumenten voor medische interacties. Van elke gespreks-
deelnemer werden alle  uitingen rechtstreeks van videoband geclassificeerd in een van 
de 23 gespreks categorieën. 
In totaal stemden 206 patiënten in met deelname aan het onderzoek. Bij de analyse 
bleken, door technische gebreken, niet alle 206 video-opnames te analyseren, en niet 
alle patiënten hadden de vragenlijsten volledig ingevuld. Bij de deelonderzoeken is 
daarom steeds alleen het aantal patiënten betrokken waarvan volledige data ten 
 aanzien van de betreffende onderzoeksvragen beschikbaar was. 
Samenvatting van de onderzoeksbevindingen
Hoofdstuk 2 beschrijft wat de inbreng is van patiënten en hun naasten in het consult 
met de radiotherapeut voorafgaand aan palliatieve radiotherapie. Daarnaast is onder-
zocht òf, en in welke mate, de radiotherapeuten het communicatieve gedrag gebruiken 
dat patiënt participatie zou kunnen bevorderen en hoe vaak het behandelbesluit 
 expliciet besproken wordt. 
De consulten voorafgaand aan de palliatieve behandeling van acht radiotherapeuten 
en 54 patiënten met hun naasten zijn op video opgenomen en met behulp van het RIAS 
geanalyseerd. Vervolgens werd de patiënten twee dagen ná het consult telefonisch 
gevraagd op welk moment zij hun instemming aan het behandelingvoorstel hadden 
gegeven, en welke informatie zij reeds hadden ontvangen voordat zij de radiotherapeut 
bezochten.
De resultaten lieten zien dat de inbreng van de patiënten en hun naasten aanzienlijk 
was voor zover het communicatie over hun eigen verhaal betrof. Echter, ze uitten zelden 
spontaan hun behoefte aan informatie, stelden weinig vragen, vertelden bijna nooit 
welke onderwerpen zij bespreken wilden en ventileerden nauwelijks eventuele zorgen 
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over hun situatie. De radiotherapeuten faciliteerden patiënt participatie met name door 
veel  biomedische informatie te verstekken, door hun patiënten de ruimte te geven om 
hun persoonlijke ervaringen met de kanker te vertellen, door diverse psychosociale 
vragen te stellen en door regelmatig ondersteunende opmerkingen te maken. 
Hoewel de beslissing om de voorgestelde bestralingsbehandeling te accepteren of af 
te wijzen zelden echt werd bediscussieerd, stemden de helft van de patiënten 
 uitdrukkelijk in met het behandelvoorstel zonder dat de radiotherapeut er expliciet om 
gevraagd had. Dit is niet zo verbazingwekkend aangezien, zoals uit de telefonische 
interviews bleek, de meeste patiënten voorafgaand aan het consult met de radio-
therapeut, al op basis van de informatie van andere artsen besloten hadden om zich 
radiotherapeutisch te laten behandelen.
Geconcludeerd is dat de meeste patiënten met ongeneeslijke kanker, voorafgaand aan 
radiotherapie, niet alleen op zoek zijn naar medische informatie en niet meer zozeer 
bezig zijn met het behandelbesluit, maar ook steun zoeken in de relatie met hun arts 
waarbij aandacht is voor de invloed die de kanker heeft op hun leven. 
In hoofdstuk 3 is beschreven op welke wijze de communicatie van radiotherapeuten, 
patiënten, en hun naasten, verschilt in consulten waarin palliatieve of curatieve 
 behandeling wordt besproken. Hierbij is met name gekeken naar verschillen met 
 betrekking tot de uitwisseling van informatie, en het bespreken van emoties en van het 
behandelbesluit.
De consulten voorafgaand aan de radiotherapie van acht radiotherapeuten met 160 
patiënten en hun begeleidende naasten zijn op video opgenomen en met behulp van 
het RIAS geanalyseerd. Met de helft van de patiënten werd palliatieve radiotherapie, en 
met de andere helft curatieve radiotherapie besproken. 
Er werden een paar verschillen gevonden tussen de consulten waarin palliatieve en die 
waarin curatieve radiotherapie werd besproken. In beide groepen uitten de patiënten 
en hun naasten weinig zorgen over hun situatie en stelden weinig vragen, maar in de 
 consulten waarin palliatieve radiotherapie werd besproken vertelden ze meer over hun 
medische situatie, stelden ze iets meer vragen over de prognose en namen de naasten 
meer het woord. De radiotherapeuten gaven in beide groepen van consulten ongeveer 
dezelfde hoeveelheid algemeen medische informatie, maar zij gaven meer informatie 
over de prognose, en stelden meer vragen over de medische en de psychosociale 
conditie van de patiënt als palliatieve radiotherapie werd besproken. Opvallend was dat 
de radiotherapeuten minder emotionele ondersteuning toonden en meer zorgen uitten 
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ten opzichte van de groep die voor palliatieve radiotherapie kwam. Dit geeft de indruk 
dat de artsen de zorgelijke situatie van de patiënt wilden onderstrepen. 
De conclusie van dit hoofdstuk is dat de communicatie van alle gespreksdeelnemers 
wordt beïnvloed door het behandeldoel. Bij de bespreking van palliatieve radiotherapie 
wordt de medische situatie van de patiënt uitgebreider besproken dan bij curatieve 
radiotherapie. Met mogelijk als reden om de palliatieve behandeling beter op de 
 individuele patiënt te kunnen afstemmen. 
Hoofdstuk 4 beschrijft het verband tussen enerzijds de informatieverstrekking en de 
emotionele ondersteuning die radiotherapeuten bieden en anderzijds de waarneming 
van patiënten van die communicatie. Het doel was om te onderzoeken welke 
 communicatie van de arts de waarneming van de patiënt beïnvloedt. 
Consulten van acht radiotherapeuten en 173 patiënten werden op video opgenomen en 
met behulp van het RIAS geanalyseerd. De patiënten werd gevraagd om twee dagen 
later een vragenlijst in te vullen over hun kwaliteit van leven, en door middel van een 
gestructureerd telefonisch interview werd de patiënten gevraagd in welke mate ze de 
communicatie van de arts over verschillende onderwerpen hadden waargenomen.
De resultaten lieten zien dat de radiotherapeuten in bijna alle consulten veel medische 
informatie verstrekten. De waarneming van de patiënt omtrent het ontvangen van 
 medische informatie was echter niet gerelateerd aan de medische informatie voorziening 
van de radiotherapeut. Opvallend was dat patiënten de medische informatie in sterkere 
mate hadden waargenomen als de arts tevens psychosociale informatie verstrekte. De 
psychosociale informatie van de artsen hing ook samen met de beleving van de patiënt 
dat persoonlijke aandacht was ontvangen. De relatie tussen de communicatie van de 
arts en de waarneming van de patiënt ervan was echter klein. De gespannenheid van 
patiënten bleek hun waarneming van medische informatie en van persoonlijke  aandacht 
negatief te beïnvloedden. 
De belangrijkste conclusie van dit hoofdstuk is dat de relatie tussen wat de radio-
therapeuten vertellen en patiënten daarvan waarnemen beperkt is en deels afhangt van 
het spanningsniveau van de patiënt. Radiotherapeuten kunnen de herkenning van 
 medische informatie door de patiënt enigszins bevorderen door deze informatie zoveel 
mogelijk aan te sluiten bij de persoonlijke situatie van de patiënt.
Hoofdstuk 5 beschrijft de relatie tussen enerzijds de cognitieve copingstijl van  patiënten 
en anderzijds de communicatie van patiënten in het consult, en hun evaluatie van het 
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consult achteraf. Cognitieve copingstijlen gaan over de manier waarop mensen 
omgaan met bedreigende informatie. Er zijn twee stijlen te onderscheiden: ‘monitoring’, 
het actief zoeken van bedreigende informatie, en ‘blunting’, het vermijden van 
 bedreigende  informatie. Monitoring kan onzekerheden helpen te verminderen, terwijl 
blunting helpt om aan andere, minder bedreigende, dingen te denken. De cognitieve 
stijl werd in deze studie gemeten met behulp van de verkorte versie van een vragenlijst 
die voor de  medische setting is ontwikkeld: de ‘Threatening Medical Situations 
Inventory’ (TMSI). 
De communicatie van 116 kankerpatiënten in het consult met de radiotherapeut werd 
geanalyseerd met het RIAS. Met 56 patiënten werd palliatieve behandeling besproken, 
met de overige 60 een curatieve behandeling. Binnen drie dagen na het consult vulden 
de patiënten de TMSI in om de mate van monitoring en blunting te meten. Tevens 
 hebben we de patiënten na zes weken gevraagd het behandelbesluit en de 
 communicatie van hun radiotherapeut te evalueren.
De resultaten lieten zien dat in de groep waarmee palliatieve radiotherapie werd 
 besproken, monitoring gerelateerd was aan meer vragen van de patiënt in het consult. 
Bij de patiënten met wie curatieve radiotherapie werd besproken had monitoring geen 
invloed op het aantal vragen van de patiënt. Tevens was er een positieve relatie tussen 
monitoring en het uiten van zorgen en de inbreng over het behandelbesluit, maar ook 
deze beide relaties werden alleen gevonden als palliatieve radiotherapie werd 
 besproken. Een blunting copingstijl, daarentegen, was negatief gerelateerd aan het 
aantal vragen van de patiënt en aan het uitten van emoties. Ook deze verbanden 
 werden alleen  gevonden in consulten waarin palliatieve radiotherapie besproken werd. 
In de vragenlijst die de patiënten 6 weken ná het consult invulden, evalueerden zij het 
behandelbesluit en de informatie die de radiotherapeut in het consult voorafgaand aan 
de behandeling had gegeven. Monitoring bleek in beide patiëntengroepen gerelateerd 
aan twijfel over het behandelbesluit en aan ontevredenheid met de informatie. Een 
 blunting copingstijl was juist gerelateerd aan minder twijfel over het behandelbesluit en 
aan grotere tevredenheid met de informatie; dit effect was echter beperkt tot de 
 palliatieve behandelgroep. 
We concludeerden dat er een effect is van de cognitieve copingstijl van de patiënt op 
diens communicatie tijdens het consult en op diens evaluatie van het consult 6 weken 
later. De relaties waren grotendeels te vinden bij de patiënten die palliatief behandeld 
werden, wat erop wijst dat monitoring en blunting vooral invloed heeft als de situatie 
zeer bedreigend en onzeker is.
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In hoofdstuk 6 is onderzocht of training van radiotherapeuten effect heeft op de 
 participatie van patiënten aan het consult. De consulten van acht radiotherapeuten en 
160 patiënten zijn op video opgenomen en met behulp van het RIAS geanalyseerd. 
De helft van de consulten vond plaats vóór, en de andere helft ná de communicatie 
training. In beide groepen werd in de helft van de consulten palliatieve radiotherapie, 
en in de andere helft curatieve radiotherapie besproken. 
De korte training was erop gericht om een wijze van communiceren te gebruiken 
 waarvan in ander onderzoek was aangetoond dat simulatiepatiënten er door 
 gestimuleerd werden om actiever te participeren aan consulten. In onze training ging 
het daarbij met name om: bepalen van een gezamenlijke agenda, bespreken van de 
actuele medische en psychosociale situatie van de patiënt met behulp van open 
 vragen, nagaan wat de patiënt verwacht van de radiotherapie, bieden van emotionele 
ondersteuning, de patiënt informeren over de prognose en de emotionele belasting van 
de radiotherapie  behandelingen, en het behandelbesluit expliciet bespreken. De  training 
was erop gericht om vanaf de eerste minuten van het consult de beoogde verandering 
aan te brengen. 
De resultaten toonden dat de radiotherapeuten na de training vaker de getrainde 
 communicatie gebruikten dan ze voor de training hadden gedaan. Dit verschil was 
zowel in de eerste minuten van het consult aantoonbaar als ook in de rest van het 
consult. Na de training gebruikten de artsen minder gesloten medische vragen, meer 
psycho sociale vragen, en zij vroegen de patiënt meer naar opvattingen en ideeën over 
de diagnose en boden meer emotionele ondersteuning. Zij bespraken ook vaker het 
 behandelbesluit. 
De patiënten participeerden na de training direct vanaf het begin van het consult 
 actiever aan het gesprek. Dat bleek met name doordat zij vaker aangaven wat ze wilden 
 bespreken, wat hun cognities over de diagnose waren, hoe hun psychosociale situatie 
was, en waar ze zich zorgen over maakten. Na de training was er meer communicatie 
over het behandelbesluit; de artsen vroegen vaker expliciet om toestemming voor het 
behandelvoorstel en de patiënten benoemden hun toestemming vaker expliciet. 
Opvallend was dat, ondanks hun actievere deelname aan het gesprek, patiënten na de 
training niet meer vragen stelden dan de patiënten voor de training hadden gedaan. 
Geconcludeerd werd dat een relatief korte training voor radiotherapeuten effectief was om 
de communicatie van de artsen in de gewenste richting te veranderen en dat de patiënten 
daarop reageerden door in de consulten meer actief deel te nemen aan het gesprek. 
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In hoofdstuk 7 zijn de belangrijkste conclusies samengevat en worden aanbevelingen 
gedaan voor de klinische praktijk en voor verder onderzoek. Participatie van de patiënten 
aan het gesprek blijkt afhankelijk te zijn van het besproken onderwerp. Enerzijds bleken de 
patiënten tamelijk actief te participeren door te vertellen over hun lichamelijke  conditie en 
persoonlijke omstandigheden. Anderzijds waren ze niet actief in het stellen van  vragen, 
het bespreken van het behandelbesluit, en uitten ze nauwelijks zorgen en  emoties. 
Ongeacht de mate van participatie bleken patiënten vaak weinig op te nemen van het 
gesprek met de radiotherapeut. Met name hun gespannenheid belemmerde de 
 verwerking van wat de arts verteld had. Wel bleek dat de arts door de persoonlijke 
 situatie van de patiënt te bespreken kan bijdragen aan een betere waarneming van de 
informatie die hij of zij aan de patiënt probeert over te dragen. 
Uit ons onderzoek naar de factoren die een rol spelen bij de mate waarin patiënten aan 
gesprekken met hun arts participeren, bleek het palliatieve of curatieve doel van het 
behandelvoorstel een betrekkelijk kleine rol te spelen met iets meer activiteit van de 
patiënt als palliatieve behandeling werd besproken. Van meer invloed was de  cognitieve 
copingstijl, met name in combinatie met een palliatief behandeldoel. Bij bespreken van 
palliatieve radiotherapie leidde monitoring tot een grotere mate van participatie, en 
 blunting tot een geringere participatie van de patiënt. 
Opvallend was dat, ofschoon in de literatuur vele voordelen van patiënt participatie zijn 
beschreven, monitoring niet alleen gerelateerd was aan meer participatie, maar ook 
aan twijfel over de behandeling en aan ontevredenheid over het consult, en blunting 
juist met minder participatie, minder twijfel, en meer tevredenheid over het consult met 
de radiotherapeut. Kennelijk hebben patiënten niet altijd hoe dan ook profijt van actieve 
 participatie. Met name in een oncologische setting kan een patiënt door monitoring ook 
meer bedreigende informatie te horen krijgen. De cognitieve en emotionele verwerking 
hiervan kost veel tijd en energie en is afhankelijk van veel persoonlijke factoren. Wellicht 
dat het positieve effect van blunting hier ook mee te maken heeft. De patiënt die 
 informatie niet actief opzoekt krijgt minder vaak de potentieel bedreigende informatie 
te horen en kan zich richten op andere, minder bedreigende, aspecten van het leven. 
Het waargenomen effect van de artsentraining op de participatie van de patiënten geeft 
antwoorden op de onderzoeksvraag welke communicatie van de radiotherapeut 
invloed heeft op de participatie van de patiënt. De communicatie van de radiotherapeut 
in de eerste minuten van het gesprek bleek daarbij van groot belang. Als de arts zich 
in die fase van het gesprek niet meteen richtte op de medische situatie, maar de patiënt 
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 uitnodigde om eerst diens persoonlijke situatie te vertellen, en de patiënt vroeg wat hij 
of zij in dit consult besproken wilde hebben participeerden patiënten vanaf het begin 
van het consult actiever in het gesprek. De verhoogde participatie bleek vooral uit de 
 bespreking van de persoonlijke situatie en het uiten van zorgen, maar was niet terug te 
vinden in het aantal vragen van de patiënt. Dat is des te opmerkelijker omdat het stellen 
van vragen in de literatuur vaak gezien wordt als een belangrijke indicator van patiënt 
participatie. 
Hoe kan verklaard worden dat de artsentraining leidde tot verhoogde participatie van 
de patiënt op een paar aspecten terwijl juist op een cruciale indicator van participatie 
geen invloed werd gevonden? Mogelijk heeft dit deels te maken met het expertise 
gebied van de patiënt. Door vragen te stellen uiten patiënten hun behoefte aan de 
expertise van de arts. Daarentegen laten patiënten hun arts juist hun eigen expertise 
zien door het  vertellen van hun eigen verhaal, de persoonlijke zorgen, emoties, en 
ideeën omtrent de ziekte. Wellicht dat door de grotere inbreng vanuit de eigen  expertise 
van de patiënt de radiotherapeut beter in staat was om het gesprek af te stemmen op 
de individuele patiënt, waardoor voor de patiënt minder vragen onbeantwoord bleven. 
Meer participatie maakt informatie echter niet minder bedreigend. Door de aard van de 
ziekte blijven voor veel mensen met kanker grote onzekerheden bestaan. Het is dan 
ook begrijpelijk dat veel patiënten vooral focussen op de behandeling die de arts hen 
biedt, daarbij steun zoekend in de vertrouwensband met arts.
Implicaties voor de klinische praktijk
Onze bevindingen laten zien dat de communicatieve taak voor radiotherapeuten 
 gecompliceerd is. Ze moeten in korte tijd een zorgzame relatie opbouwen met een 
nieuwe patiënt die meestal tamelijk gespannen is, terwijl uitgebreide, en vaak 
 bedreigende, medische informatie moet worden besproken en een behandelbesluit 
moet worden genomen. De arts kan daarbij niet eenvoudig afgaan op de inbreng van 
de patiënt: de meeste patiënten lijken vooral bedreigende informatie te willen  vermijden, 
en uiten nauwelijks zorgen of andere emoties die hen bezig houden. Als een patiënt wel 
vragen stelt, is het niet zeker of de patiënt achteraf tevreden zal zijn over de verstrekte 
informatie. Bovendien nemen patiënten weinig op van wat de radiotherapeut probeert 
over te brengen. 
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Het helpt patiënten niet om hen in deze situatie nog meer medische informatie te 
 verstrekken. Dat zou de verwerking van informatie zeker niet bevorderen Radio-
therapeuten, en andere oncologisch specialisten, kunnen het proces van verwerking 
van medische informatie bij patiënten wel stimuleren. Ze kunnen vragen naar de 
 specifieke leef omstandig heden en voorkeuren van de patiënt en de medische 
 informatie laten aansluiten op wat de patiënt hen vertelt. Ze kunnen rekening houden 
met de gespannenheid van de patiënt door informatie regelmatig samen te vatten en 
te herhalen. Ook kunnen ze de persoonlijke informatiebehoefte van de patiënt proberen 
te achterhalen door  bijvoorbeeld te vragen of de patiënt altijd alle details heel precies 
wil weten of de details juist liever over laat aan de arts. Ze kunnen de patiënt uitnodigen 
te vertellen wat hij of zij denkt dat de behandeling kan bieden, en welke onderwerpen 
hij of zij wil bespreken. Dat kan de patiënt stimuleren actiever aan het gesprek deel te 
nemen, waardoor de emotionele en cognitieve verwerking van informatie bevorderd 
wordt. Daarnaast krijgt de arts door een actieve participatie van de patiënt meer inzicht 
in de specifieke problematiek van de individuele patiënt en kan hij of zij de behandeling 
beter op de patiënt af te stemmen.  
Dit proefschrift laat zien dat radiotherapeuten de hierboven beschreven  communicatieve 
gedragingen in een vrij korte training kunnen leren. Het kan echter niet verwacht 
 worden dat hun communicatiestijl ook blijvend veranderd is. Daarom is het belangrijk 
dat radiotherapeuten regelmatig ondersteund en getraind worden om de volgende 
belangrijke taken te combineren: een relatie op te bouwen waarin patiënten steun 
ondervinden en tegelijkertijd actief kunnen deelnemen aan het gesprek en de  beslissing 
over de  behandeling. 
Suggesties voor verder onderzoek
Uit dit proefschrift blijkt dat de participatie van patiënten met kanker aan het behandel-
gesprek met de radiotherapeut niet optimaal is maar gestimuleerd kan worden door de 
arts. Ons onderzoek betrof enkel het eerste contact met de radiotherapeut  voorafgaand 
aan de radiotherapeutische behandeling. Dit is slechts één van de vele contacten die 
kankerpatiënten op de afdeling hebben. De mate waarin patiënten aan dat consult 
 participeren geeft geen uitsluitsel over hun activiteit in andere medische gesprekken. 
Participatie heeft deels met persoonlijke stijl en voorkeuren te maken, maar verandert 
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voor een deel ook door ervaringen en door het verloop van de ziekte. In de loop van 
de vaak wekendurende behandeling, en soms nog maanden of jaren daarna, spreken 
de patiënten niet alleen regelmatig de radiotherapeut, maar ook vele andere hulp-
verleners zoals radiotherapeutisch laboranten, oncologie verpleegkundigen, e.d. 
Bovendien hebben patiënten voordat de diagnose gesteld is en het behandelvoorstel 
besproken is, andere (oncologische) specialisten bezocht en veel onderzoekingen 
ondergaan. In de loop van deze gang door de kliniek zal het  verwerkingsproces bij 
patiënten zich verder ontwikkelen. 
Om meer inzicht te verkrijgen in participatie van patiënten met kanker in diverse 
 medische interacties, in de factoren die daarbij een rol spelen en in de effecten 
 daarvan, is een andere onderzoeksopzet noodzakelijk. Longitudinale studies die de 
communicatie in het medische circuit volgen kunnen inzicht geven in de verschillende 
aspecten van patiënt participatie en de processen die daarbij van belang zijn. 
Daarnaast dient de keuze voor de analysemethode uiteraard aan te sluiten bij de 
onderzoeksvragen die beantwoord moeten worden. Hierbij dient de persoonlijke 
 communicatiestijl en -behoeften van patiënt en arts meegewogen te worden in de 
beoordeling van de gespreksvoering. 
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Dankwoord
De periode dat ik aan dit proefschrift heb gewerkt eindigt met dit dankwoord. 
Mijn promotie is geen sprint maar een duurloop geworden, die zonder de stimulering, 
betrokkenheid, en het vertrouwen van velen niet afgerond had kunnen worden. 
Een aantal van hen wil ik hier graag noemen. 
Mijn dank gaat in de eerste plaats uit naar de patiënten en hun naasten die aan het 
onderzoek hebben deelgenomen. Ondanks de moeilijke periode waarin u zich bevond 
was u bereid om onderzoekers en een videocamera bij het gesprek met uw radio-
therapeut toe te laten en tijd te besteden aan interviews en vragenlijsten. Met veel 
respect denk ik terug aan onze ontmoetingen waar ik veel meer van geleerd heb dan 
ik in dit proefschrift heb kunnen beschrijven. 
Ook de radiotherapeuten die aan dit onderzoek hebben meegewerkt wil ik van harte 
bedanken. Richard, Willem, Emile, Dominic, Baukelien, Theo, Hans, en Marcel, jullie 
lieten ons meekijken in jullie gesprekken met patiënten en waren bereid om ter wille 
van dit onderzoek onderdelen van je communicatie aan te passen. Ik ben jullie erg 
 dankbaar voor jullie openheid, tijd, en energie, en ik heb groot respect voor jullie werk. 
Mijn beide promotoren professor dr. Kraaimaat en professor dr. Leer, en mijn copromotor 
dr. Richard van der Maazen wil ik hartelijk danken voor hun bijdrage aan dit project. 
Floor, vanaf ons eerste gesprek op die middag voor kerst, heb je me het vertrouwen 
gegeven dit onderzoek uit te voeren. Met jouw grondige kennis van onderzoeks-
methoden en jouw relativerende opmerkingen heb je m’n wilde ideeën en teksten in 
goede banen geleid. Veel dank voor jouw vertrouwen en engelengeduld bij de 
 begeleiding van m’n duurloop. Ik heb veel van je geleerd.
Jan Willem, je bent wat later bij dit onderzoek betrokken geraakt, maar jouw inbreng 
was meteen onmisbaar. Dankzij jouw daadkrachtig ingrijpen op cruciale momenten is 
aan dit proefschrift ooit een begin en nu ook een afronding gekomen. De vanzelf-
sprekende manier waarop je me op de afdeling alle ruimte en ondersteuning gaf heeft 
gezorgd voor continuïteit in het onderzoek en was hartverwarmend voor de duurloper. 
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Richard, je hebt een centrale rol gespeeld bij dit onderzoek. Zonder enige aarzeling liet 
je me direct toe in jouw consulten, introduceerde je me in de wereld van radiotherapie, en 
las je alles wat ik schreef. Jouw overtuiging dat het me zou lukken hielp me op momenten 
dat het tegen zat weer op gang. Je had steeds weer tijd om m’n vragen  te bespreken, in 
alle rust, ook als dat in jouw drukke agenda niet zo goed uitkwam. Onze vele gesprekken 
 gingen over meer dan over onderzoek en radiotherapie, over alles wat ons bezighoudt, 
het leven, de borders. Ik vind het geweldig jou als copromotor te hebben! 
Professor dr. van Daal, beste Willem, bedankt dat je één van de initiatiefnemers van dit 
project bent geweest en voor de vrijheid die je me liet bij de uitvoering. Ook de andere 
leden van de begeleidingscommissie, Chris Verhaak, Mariëlle van Roosmalen, Karel 
van Spaendonck en Annelies Snijkers wil ik bedanken voor hun inzet. Chris, bij jou begon 
de eerste fase van dit  onderzoek. Je verdiepte je grondig in het onderwerp, en na de 
 pilotstudie schreef je het voorstel voor het vervolgonderzoek. Later droeg je dit 
 geesteskindje vol vertrouwen aan me over en heb je me goed op weg geholpen. 
Mijn dank en waardering hiervoor. 
Mariëlle, dankzij jouw praktische aanpak kwam er meteen structuur en duidelijkheid in 
de onderzoeksgegevens. Karel, jouw expertise en jouw bijdrage aan de training 
 hebben bijgedragen aan de onderzoeksresultaten. Annelies, dank voor de zorgvuldige 
en rustige manier waarmee je de eerste fase van het onderzoek volgde.   
De medewerk(st)ers van afdeling Radiotherapie wil ik bedanken voor de gastvrijheid, 
collegialiteit en belangstelling waardoor ik me helemaal thuis voelde op de afdeling. 
Een paar mensen wil ik met name noemen. Jacqueline Arnts, jij stelde jaren geleden 
de vraag waar dit onderzoek ooit mee begonnen is. Ik denk met veel plezier terug aan 
de gesprekken die ik met jou en jouw collega Heleen Lintz voerde. Jullie hebben me 
geholpen te snappen waar het echt om gaat als je ziek bent.
Titia van Veenendaal, Peggy van de Berk, en alle anderen van de receptie, jullie 
 stonden altijd zonder veel woorden voor me klaar en zeiden ‘ja’ tegen mijn praktische 
vragen die  jullie werk bezorgden. Het enige criterium waar jullie alles aan toetsten was 
het belang van de patiënten. Vele uren heb ik bij jullie op de poli ‘in de weg’ gezeten. 
Bedankt voor jullie hulp en gastvrijheid. Cathy McKell en Marieke Honer, bedankt voor 
de  gezelligheid en de hand en span diensten. 
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De collega’s van afdeling Medische Psychologie ben ik dankbaar voor de prettige werk-
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Function
Cluster
Information giving 
and counselling *
Question asking
Relationship building
Facilitating
Communication behaviour
Subcluster and categories
Biomedical 
  general medical topics  
 diagnosis 
 prognosis; life expectancy; 
  chance of cure 
Psychosocial
  psychosocial information  
Biomedical questions
 general medical
 
 diagnosis
 prognosis; life expectancy; 
  chance of cure
Psychosocial questions
Positive talk
 social talk, jokes
 agreement 
Negative talk
Emotional talk
 support: (empathy, 
 legitimization, 
 reassurance)
 concern
Participatory facilitators
 paraphrase/ check
 asking for general opinion 
Procedural talk
 agenda setting  
 & orientation
Examples
Radiotherapy can make you feel tired.
The pain in your head is caused by the 
cancer in your brain.
We estimate you have months, not 
years, to live. / There is no chance that 
you will be cured of your cancer
To see other patients can be stressful 
for you.
How did you discover the breast 
tumour?
That tumour, can’t it be an infection?
How long will it take the cancer to 
come back? 
Is your family supportive?
Nice colour you’re wearing.
Hmm. / I see./ Yeah.
You’ve kept me waiting for half an 
hour!
I can imagine that you’re worried. / 
Don’t worry, we’ll closely monitor you, 
even after the treatment is completed. 
But I’m not sure we can fully get rid of 
the cancer. It’s a very aggressive type.
So, you had surgery 3 weeks ago.
You don’t want to continue taking 
dexamethasone?
Today I’m going to talk things through 
with you, I’ll be looking at your scar 
and I’m going to check your heart.
Appendix A  overview of the Roter Interaction Analysis System (RIAS)
    functional grouping, subclusters, and individual categories  
used and examples of actual utterances for each category
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A PPEn d I X
Function
Cluster
Facilitating
Decision making 
Communication behaviour
Subcluster and categories
 other ( instructions  
 & procedural issues)
Information giving
 consent to treatment **
 other treatment options
 
 refraining from treatment
Question asking
 consent to treatment  ***
 other treatment options
 refraining from treatment
Examples
Please lift your arm. / You can get a 
taxi form at the reception desk. 
OK, everything is clear. Let’s do it. 
An operation would be too dangerous 
for you.
If you are not treated, the cancer will 
soon cause problems.
So, what do you think? Should we 
have a go at it then?
Would an operation be an alternative?
What will happen if I don’t want this 
treatment?
*  Medical and psychosocial counselling are radiation oncologists’ categories only
**  With respect to the radiation oncologists, this category reflects their opinion about  
the treatment proposal for patients
***  With respect to the patient and proxy, this category reflects their questions concerning the 
radiation oncologists’ opinion about the proposed treatment for the patient concerned
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